var title_f38_3_38960="FNH Bopta scan";
var content_f38_3_38960=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Focal nodular hyperplasia of the liver seen on Gd-BOPTA scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial T1-weighted MR image of the liver showing focal nodular hyperplasia in the left lateral segment of the liver (arrow). This image was acquired three hours following intravenous administration of gadobenate dimeglumine&nbsp;(Gd-BOPTA). The bright signal intensity of the lesion is due to accumulation of the contrast agent to a greater extent than in the adjacent liver parenchyma, and is not due to increased vascularity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan B Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38960=[""].join("\n");
var outline_f38_3_38960=null;
var title_f38_3_38961="Microscopic view head louse";
var content_f38_3_38961=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Head louse nit",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 262px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microscopic view of a head louse nit attached to a strand of hair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38961=[""].join("\n");
var outline_f38_3_38961=null;
var title_f38_3_38962="Coats disease";
var content_f38_3_38962=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66416&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Coats disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 596px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJUAegDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooAKKKKACiiigAooooAKKKKACiiigAooooAUDJrT06zEpGVBHuKqWsW966fQLYmQqR0rnr1OWOh24WjzPmZd0/Rrd8b7eI/VAa37XQbE8NY2x+sS/4Vd0+1HGBXQQ24SPJFeLUxEr7nrQpR7GPbeH9L436bZn6wL/AIVs6f4d0ZmAfSNOb62yH+lWIosgHFaVimGFc86srbmrpR7Fqz8KeH2AzoWlH62cf+FaqeEPDYjyfD+kH/tyj/8AialsTwDWuHDoAKw9tPuzCVON9jDXwd4bPP8Awj+kf+AUf/xNNfwj4c7eH9I/8Ao//ia6IDC0GPNNVZ92ZOMb7HNDwj4c/wCgBpH/AIBR/wDxNDeEPDmONA0j/wAAo/8ACuiaI5pChA5qvaz7sOWPY5hvCXh0H/kAaT/4Bx/4UxvCfh7/AKAOk/8AgHH/APE10jR801o6ftJ92NKPY5v/AIRPw/n/AJAOk/8AgHH/AIU7/hE/D2P+QDpP/gHH/hXQ7KNvFP2ku7HaPY5p/Cnh7HGg6V/4Bx/4VFF4X8P7iG0LSvxs4/8ACuldQRVOZdjZFHtJ9y4xi9LGNJ4W8PjpoWlf+Acf+FU5/CmhEfLo2mj6WsY/pXRltwqNxwTQqs11GoR7GBa+FdDB+bRdMb62sf8AhVtfDHh/voWlf+Acf+FakPOcU7oaHUm+rBwjfYoJ4X8O99B0n/wDj/8AiamXwt4cxzoGkf8AgFH/APE1eU8UrPjgUuefdk+zi+hlyeFvDpPy6DpI/wC3OP8AwqJvCnh//oBaV/4Bx/4VtKe5pWbIo9pPuw5Iroc3N4V0EdNE0sf9ukf+FZF/4X0YA7NI09fpbJ/hXaSCqVzFuBq41Z9yuSPY8x1Lw9pyZ26faL9IVH9K5PVNHt0zst4l+iAV6zqdqMHiuN1m3GGAHNdtKtLuZypLseW3lqEY7VA/CqBGDXXahZn5jiuau4SjHivWpVOY8zE0eV3RVooorc5AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAN3TrYtgr1rqNIQwXC+auA3es/SIcY4Bx1rqIbdZodq43DmvIxFW7se/h4KKsb1mFjUMenrW3Z/vYweCKwNKxND9nlOHHrXS6db+RFsznHSvKqaHao8qsSLHxgVZtRhgKcqd+1ORcNmsrjNq0x5da1muVrBtZSMCtizlIFYt2MKkdDURAalWMd6qxSkNz0qyr5ppnJJMWSLjIqCReuathuKgnIq0yUyj0bmnMvFDipFG5Qaou5WZaZirJFROKYJlWQYqpON2auy9DVZwApJoNIspxnGQe1QzPvOF6UDdLMwTpVhIAvXrVbG2kdWRRKyinEnPSrJUAYppQEikTzXI9x28ChAScmrPlDbmhFFMXMuhCwNITirDKKryDmkSmNJyKhccVN2qCeQIpoLRk6mBtIrlL6035JFddLGZjntWfeW/GMVvTlYqSsjz3VLMYIxXHaraYzxXqGo2uc8VyWr2WQ3Fd9Grys5KkLqzPO5U2tio61dTtijE4rKr14S5lc8ipDkdgoooqjMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPSdMtASpwRXRxWvyhk4b1qlpkXC8VvW0fHPNfO1Zts+ig2iO2tmlfk7JV7jvW5ai7ijyxDqvb2qG2h5DKcNWva/OmCOehFck5XOqNTQntSHRWByGHFWNgB5rLjc2MpSQHyico3p7VrxfvQGHSsSpK2q2JoByK1bcjArMjXB4q7A2CKykYTNaLtVocLWdFJ0q4JBsNJHLJDxJg0yRskVSefDUCUlhk1ohWLBpUPyGoC3FIshKfSrFYnIz0qCXIoSbJIPXtQWyDmmh2sVjksRWdqUu3ESfeard1OsAJJ+Y9BVO0geaYzyj6CqXc3gre89iW0g8pBnqetWNu7mptoxinJHxSvciUr6lZlxx3pVjx1qcx7XyelPKcZFMTkV34WogSKmdcnFMK4oAKY6ZqREJoPFK4IpyjYpPpWYczSkdq0r9sRGqthF8pYjrTvodENI8wvlBUxVC7jznitZ1qlcrmqiyNzm723yDxXO6jZ5B4rtpYdwNZN9acHitlUsTKNzyvXLHAbiuGr13XLX5W4ryKvZwM+aLPKxkbNBRRRXccQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAez2AAANbtr8wrjtHuJmuWDEkY6eldVZuQODwK+aqxaPo+XlNm34q8i8h0OGH61mxYJHX14rRhy2ABwe9csy4MtSRi5g2nHPUUy28zTZFViXtmOM91NWLXIG1uo/Wpb2MPaSD2yKyv0N4zt7r2LkeCMirCVn6ZL5lsn0xV9elRIymrOxMrkVMLj5aqjpSdKEYNDmYkk09G5FQg805DgitEJlvdleKBxUatUijtTTIGsuSPUVHcziAZJySOlSyERqSegFULZDd3HmuDsHQVUTSCT1ew63snuX86bkHoK0BCVGMVYiYLj0qZirDik5XInUcikE5p4GBmnkcmnKKVyLldiCPmNShRspkideKW2O6LnscVQPYryDBqN+asTLzUOOKLjQinApjnNP7Um2kUZuonCgVNbKBCtRaouQuPWrMC4hUH0oZu/gRG61TuBWhIOKz7g1USUyoBzVW9i+Q8VdHWo7sfIaOo2cLrkPDcV4ZXv8ArSZ3V4BXt5Y9JfL9Tysdugooor1DgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD2GBNkq+Wo3E88VuWiFpOR8q9Pc1Qs0VOgwa1bYjoOTXzE5H0V7l6LAIA/KtK1DY6hf1rPtkwc9zV+CUKxVuCPXvWEiomhEjliQwGOOBVoBlUlmBH0qOAgip3wEBJ4BBNc7LuVrYGzuCrD9y54Poa0Qefao/lmBUqfxGKfDkDY3UdDSbKlK+r3JAeaXFIOtPpJmLGY54py/qKKB1rRMgkQnirCnioEIxUV3P5MWF++egppXFa7sMu5WuJxDF0H3qvW8axIFXgCqdjF5Slm5kbk1fjGRnvTb6Dm7e6h38NTJ0zUSjHanjJHJpGTFxSrxSr6DtT6CRyorLzVa2jwswB4DkCpycDiq9nJ+5JxwxJ/WmNbMa6EGmFKnkOTTCpIouBVIw1LipWWmHgGhlpmbdjzLlUHQVdC4UCq9su64dj2q03Shms3sitOcA1lztya0LpuDWXOatCWwxW5ptwcxmmZx1qvPL8po6g2YOsdGr57r6B1Mlg1fP1e1lm0vl+p5uO+z8wooor1TgCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD2i1uEkIwcGtmzwFBrmorRlIINathM0TBZOlfNTS6H0zinsdEj7QKtQupG5h0qjEQ4BFWY3G0g9a5WKJr28gcgL+dXFGRjdx71n2rrtAGM4q6j9BnmspFMsw5DEZ+mamOdw9agXPBB5FSRncfmbLDsKzF5kjdc0+Pkc1G1LE1TsyWSY5p1NzSM+Bk9KtMzsNkkEO5mPHWoLUfaJ/OkJwDwKgyby4xz5a1qwoEUAAYHFaXsaP3F5k6AHPpUiDjjOKij+8R+NTqOak52OC07bjpSindcYoIuIvWn9qaDg5xS5Bp3EMlJ8psdcGo4ABEgH90VK3SqUUhihZTy6NtA9fSmXFXWhaOPxpN1Vzbsw3SO28+h6UQMwby5ByOh9aB8vYlbqaiYYU1MelRS8IaVwiUrT/WPU8hwKgs+r/Wi5cAGq6ms9ylcvzVKQ5qSd8saqu/WqYyGZsVRlYkmrUzZqqw600DMrUB8pr59r6E1Hoa+e69rK9pfL9TzMd9n5hRRRXqnAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHt0QwBkVYaIOox1qJFzVmIGvlmz6NOw22vHgba+cVeW/Q8Gq0kKyD3pi2fPJqXZ7nRFxerOksZEdFKmtOJgOtcrp0/wBnkKO3y1cnvywPlngd6xlHUfs3J2Rt3moiEBYsNIabDaXU8olml2g/3TzWRYSlZo3lGQehNdTC+QKzkuXYqf7pWiOhSVRiR92OhqQNg0oI21HKfSs2c7dybdxVO+lJAjT7zU8vxVW2Pm3Luei9KqIRj1NK0iEUYA61bSqsZ59qsIcUXMZau5OOxHUVNG2RzxVdWzxUgORxwaLmbLANPzUCtxzT1ai5DRL2xQQKYDk8U7OKdxAaiaFDKJCo3DvUhNNzRcauDdKrMd1woH8PJqZ24NV7c5DP3Y07lx2JyahuGwh5pzNVK7lz8gPNCHFXY2A4Qn1qpdy+9TyN5ceM1lXMuTWiNd3cjlbJqB2pWeoHfFACOagdqSSSoGfNXFAUNQbg18/173fng14JXs5YrKXy/U8zHbx+YUUUV6pwBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB7nGeanjbFVIm4BqcSCvlWfRJFsngkVUM0hYhaf5p2022yJuRwalG9PTciaOV2yc1bgRwu3qTWjHGpHSrEUKg5AGalzNlXsiSKBvsKg/eXmtTT5xLEOfmHBqvB0wag5tLoOP9W3X2rB6kp8+h0GSVxmmFjnBqESh0GDwaVxjBHSszKwy4k2I1N07/VZ7k1BfZKcVPZfLGtNbDekTUQ8VKrcYqqr1NGaRztFlc5FTK3NVlapFagzZYDZpwNQBjinhqLiaJgcdKXdUW6gtRcklLU3JpmeKN1MdhspyjD2qrHNtiC45HFWHNQOBg4HNNMuNtmVpL7nYo+ao1B3F3qIKEuGJ7026m2qea0Rs0lsRXk/Xmsx5MnrSXE2WNV2erJJHeoHfNBJNRucAiqSFcileogSQaWQZNNbhataA2Z1+eDXhNe46i2Aa8Or2Mt2l8v1PMxu6CiiivTOEKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPa7c5WpwOap2UmVFaC8ivlZaM+gjIkiTNWIYRkZqOI4NWYzWTZfMy1EMAVbix3qmhFWEeoY7l1DtxipJQs0RVu9QRPkdealyD061mzSLKtpdNBP9nl6fwmtUOSOtYuoxFwHX7y1Y065MseGPzCk9Vc2muZcyL0mGBpYWxxULPzTFfDVBgzTR6sI9ZqS1YSSgzaNBXqQP2qkj9OalV6RDRbVqkDVUV/en7s0yWizv7Uu6q24Uu/mgLFjdTS1QGSmmSmFictUEsgUcmopJgBWdd3JY4Bqoq5cYXHTTZkJrNvLjJPNSMJGHyjrUDWkjcscVqi5FJ3pm6rbWWByahe3x0FaIhsZvqN2pzLjqMVBJkj5apIQ1mGaZM421G4I61TuJiARVWuS2UNUl2qa8ar1PVZvlbmvLK9jLlZSPOxm6CiiivSOIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPVtOnyBW1E+VFcfptz05ro7SbcvWvm60LM9uLNXdgZqxFIKoK2Rilikw1czRsjYR6lV8d6z0kqdZKzaKRoRy81ZR81lo/PWrKSYrORaLkuGWs5Sbe4yD8pq0Zciq10oZDgVKN4S6MvGYEAg0xpOayYrhl+Q9qsGXIocbETjY045ferKTe9Y0cpPSrcRc44xSsYmqs1TedWcmR1NSBiPSpsFjRSbpzUwlrMSU9wBU6S8daLCaL3m0m81UE3PWniWnYViYyH0NMaWm+ZUikN2oSArOGf1pFg9ua0EjB6ipPLUdqtOwXM9YT0oeHFXW46Co2BzyKpMNyg0R9M1Xli9q19oNRSxDHNWpisYkidciq7RrngVsSwE9BgVTeLaea0TQ0jJuYxtPrXOakNue1dNfNgH0rlNWlGCDWkNyZeZy2s3GAwFcDXWa3NgtzXJ172EjyxPLxbTaSCiiius4wooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA6fTrnGOa6ewuOBzXB2c20jmuk0656c15WJpHq0Z8yOwilyBzUm/5uKy7SfIHNXN3IIry5RszqiaMcnFWo5Md6zIW4qyr4rKSKRoBxnNTq59azQ/HFTRyZFZNFo0A/HNI78daqrIe9KX3cVFjRMRgCc1NDEW+8eKbGoHJqcPihsblcsxqiDpU6zIO9Z/mGgNk80rEGmswPQ0FxVFDUwziixNyyJPeniSqgzUqUWAtB6PMPrUSipFXNFhEyOSauwGqka4q1FxSAvJwKUkVX8zAoEmTTFYsAZpxjHpTYmFS7qlsREYhUZUA881YLVDJzRcaZE+0iqF5GoQ1blO0GsXUbnapFaRZRjarIFBFcPrdyF3YNb2s3mN3Nee65f7iwBr0sNTc2c1WdjF1a43yHBrKqSZy7kmo6+ghHlVjx6kuaVwoooqyAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAljbBrXsLjGOaxBViCQqazqQ5kb0anKztrG5yBzWxFMGAri7K5xjmt2zuM45rx61Gx6tOSep0cLcVOJPes62kyBzVpRmuGS1Nky2snapI2qtGKsouayZVydGJFTxn1qJF4qRVrNhcmD4pd1RqpqVE5qQAc1LGDTkQVKqgUgHRrU4Xio1YCn7+KAHhalQVXD1IslMGiyoFSLiqwkp4kpCsXEIqXeAKpLJ70NJx1oGkWHnx3p8MmayXky3Wrdo9D2NOXQ14nqbzKopJx1p3mVmzJotF6az4FVjKO9Vbm7CjrQkIfe3ACnmuU1e8AyKm1PUOCA1cfq+oAK3NdNGm5MznOxm69egBua4LUbgySHnNaOs3/AJjkA1gsSTk19JhKHJG7PLr1b6IbRRRXacoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAKAWOACT6CneVJ/cf8qdbnbMDjOMn9K6vxT4cufD8tlHdTxSG5i85fLBGOcEc9R6HvQByXlv/AHG/KlCOOdjflV/gtgClKkDgEUAQ27unJVgB7VsWV2F6sB65NZygBPm7daQnZkAZ9DWU6KnubwxEoHW2eoQ8ZmjH1YVqwanZ7QWuoAPUyCvPABye9PVQ5wAQK5JZfCXU2WNkuh6WmpWP/P5bf9/V/wAamTVdPHH261yOv75f8a8vdQq9DUaDJPr3rN5XD+ZlfX5dj1tNW0//AJ/rX/v8v+NSpq+nf8/9p/3+X/GvIcOvuO4oBI5xgVP9kw/mYfX5dj2NdY03/oIWf/f9f8akXWdMH/MRsv8Av+v+NeMsoySoPPOfekZihAOM560v7Ih/Mx/2hLse1rrel/8AQSsv+/6f408a1pZGRqVlj189f8a8P5Y8Y96VThSNwpf2PD+Zh/aEux7gNb0r/oJ2P/f9P8aX+2tL76nY5/67p/jXh24AAbvmo3YJbr2Bp/2RD+Zh/aEux7iNb0nP/IUsf/AhP8aUa3pX/QUsf/AhP8a8MJPUqcZ9KeB0xz60f2RD+Zh/aEv5T3Ndc0r/AKClj/4EJ/jTxrulD/mKWP8A4EJ/jXhIBXksMfypu3fu5OaP7Ih/Mw/tCX8p72Ne0n/oKWJ/7eE/xpkniHSgMDU7H/wIT/GvB12jJJPHpTlwU+7n3o/siH8zGsxkvsntp17TC3/ISs/+/wCv+NWodf0pAN2qWI+twn+NeDKDg5JBz3pCMkZ6e9DyiD+0yv7Tl/Kj6EXxHpOP+QrYY/6+E/xoHiXSCcDVbA/S4T/GvnvceQDz6U7lccDPUVP9jQ/mZLzGX8p73P4o0oD5dTsj9J1/xrJvPEtgwOy/tj9JVP8AWvGBkFmHc4pwOTlDVLKKa+0yHjpPoeg6jrtu2dlxEx9nFclq2ptJuCZP05rOcY5GDmoxu555HauqlgYU3cyliZSKMvmO2SrflTPKk/uN+VaRUjG88k9KA21vkBOa7djmM3ypP7jflR5b5xsbP0rTUna2cYpgbIwzHHrigDNIKnBBB9DSVNdHM7H6fyqGgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCW14nX8f5V0eta1ea00bXpi+RnkIijEe+R8F5Gx1Ztoyfauctv9cv4/yrQUYznr2FAChioBHHYYpsjEEFvypFHPr60oAyNwyD3oACdyjb+OaUkcAAZ9qRRx1x7U4vtAwvX1oAjVj2ODnpTssMZ4al3clcAH6daOgOQSaAEbOz5Wz604AjBz1poUgZzx6UshPG0jmgBC4AYHIJ6VIW/dgFgQOuKh2kvlhUmFBO04BHWgBSMEYyV7ZpHYHjHTvSbiRyaR+FBzQAq7FB57/nQSWGDimgKQMkc+1JyCQDx7UAJt2S5IBB55qQgBhjBGaaGwMDGT2pY1+T5wDk0AO+8DtIxnNMYKGbOcdsU7aD8uCFJ9aRgR7duKAEGSenHrSknOUJ/Gnd+OQOtAIB3KOvY0ANI6DoT1owVb5c47Uvy46k/SgS7ME8A0ANK5O4k5704ntzn0pQAfmB3c05sKp3DBNAEShsc8e9OzzyxPvQABjGcY5NIQVjJwSD6UAKBuXk8DnmlMnoQOOgpnByMnIHY00EAkHOemaAJCpdc54yOaQodww3GaPujA6CjLD5sZAoAUEZG4AUADBIOG9PSm9TnoDT+mBnI9aAG/L6c+tL/Eq54NITleeT2pAAeWGCPSgCjcjEzD6fyqKprr/Xt+H8qhoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAltv9ev+e1aIxyQ2WPtWda489c+/wDKr4HI+YfhQAuVXHY+nrQvK8np2pNvc9aWLaTyCaAGZ7dc+lOQAsAQcetBGCeMAdKVWIHfNADtp2+oGcUnUgHt3zSEkN7GlYDIIoAac7MbTmgKytngAU/eqDBBOaQYOeD+NAASpJOSxI9aa4U4U53UFiuFx+QqRQGUnIz70ANjGBtwTjtQOflJqSGJ2BA3Fj6CnNayIpZ+CP71AFY+mOKXofl6CpHjJwe2Oo6U+OJnGEUZ7d80AQ9ie/XpT0jJA6/Wu78I/DPXfEEqmC0dIT/G4wBXt+g/CPw74Z09r3xHdQyzIPuMcKTQB8reVKTkxNx0NR4Yk5UgDivpDU7zwxZ6zFaJpUE0LfMxQ5wtdZqnwr8KaxpcN9p9s9vHOuVYHIz70AfIRHOMEEjv3oOUIz6ete5eLvgxNYWEt3YyGQqMmNhg49q8el0ySORl2n5CQc9jQBnlCFyuPfmkC+YfUj9Kumyk25zkdxSG2kI2/d9MUAUlz6AAcZp28YweauNZTY3GNvy4NNFk5Y5XgetAFRDtGFYsB2xSsdvyr19KebeReowueopjHaRntQAwYzvA5qTcu4Fun0qNeYyCSCD6VJzwMYoARQSTgd6YSRwpJzUnyk/KwzQCVAJHB70AMYscdOOlO3DaRnGB0pWKBlKjPrimnHmHjANAAApUle/rTsEAcgjrTdmCWzwOop6kEKox/U0AZ11zO34fyqGprz/j5f8Az2qGgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCW3OJlP1/lV8Hgc8GqFt/rlx15/lV5SeMDB7n1oAAB2BzTk5bntSggZK5yexpp3DgGgBWBJBXNKAScZwCO1N/eAcHAHahslgQOetABwcgPj0zTlLRkHA4pgO4ltuPbFKWUjoeuaAHuMgFuvpTdpKYx1p0aPLJtTOa3NN0p5JMlsRr95j/KgDNtrF5FUFTnsK6fwv4TvNblMdrGGVfvynhVq1pelT6zfLp+lIVj/AOWkh/hFeuX1rJoXhiK20WEO0a/Of7x9aAOXt/h7bWsQV9TUS99o6fpWR4g8IX9lC0sWy/tgOSg+ZRXOX+oeIbi9ZS1yrFugBr1j4fJqtvYl9Rl3My4COO1AHjbadbTRlY+P7wPBBq5pcUOi3trPJbecqtkow4NereKPBena1C8lugtr7BKyR8Bj6GvMYnukeXR9RXbNCTtJ60AfQHhn4kw39jHZaDb20V8MBkkH8sVzviHxjDpmqXK380Op6gw5Q58mE+/vXiNjql3ouqytbBY7gqV346D1FTWTG5nBmJlG7fIx/iNAFzxA5u/E0V0bpEaYbj5Wdqj0r1HwP8SbTT7e2sNUQrCjbRNGfu+7A15PcSwNdeZ5EaKvAz3p96Y7iw86CHZIDhtv8Q96APcfih4w02zktreyvJLi5nXcJEI2bTXh2ph7u+nYKCCevc1kXF1J5W0FmZPuk/wewrUSVo9JaWRcSOPmPc0AUZZbeNWV1HHFbPhjQbjXX22EQEKcvOw4Ws/QNOXV7hJ7iMC2i/h/vmu8tI7uzjI0+4EUQ6wR8ACgCX/hEvDVu4h1XUpGmPXkY/Cquq+ALGe0efw1f+dt58p+rfSuP8aeH9X88XaRyzRScq45rf8AhfY67aXSzXAkgsxyRJnH4CgDjJ7Jg8sUyss8ZwQe1YlzaN8zxrgg/MK9Y+JVnDdaidU0xGjZBiePH3h61wNwm754x8mOvrQBy/c7uD29KdkMeTnipryJonznCHpxUCKSe2O9ACBCUyhwR1HtT9yoADz3IpuAuRnrTmAIIXn3NACSEYyq7QKauPLyBx60FcAc5NAzg8Yz2HSgBoOVPJB6UoChsgnpzSuOuOTSk8AkjI7UAULvP2hsjB4/lUNTXR3XDE57dfpUNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAEtrzOuPf8AlV9iwXgjI9qoW4JmUDrz/Kr4UgjqcDnNACB+Mnrmhsli3HPTFHPUAEH1pQPkCoDmgBSCQO2fWjblsFsGlXCqeN3400kn6Z4NADgcMuSCBSMCXGeB6Uu04JyOOxrd8KaNJq1+XcEW8I3OewoAn0fTSiRsR+9l4Gew9av6tJ9lUx24IWMYOf4j61txlLFZb+VF2IMRKemK5a4u21BJ534dnzt9BmgD2D4caeth4cjklTE9yd7OPSusUhm3HJ/Gsbw2VfQrHY3HlYrWQkhQcDtigCIW8LSNIsSk54JWrA3AcMMjtjgUKFUYOSD6UsSKFI3HPXmgB4XIx3POR615h8W7L7Jf2OphQHZgrkd69ThTKsyjkLnJrzr4zShdJtIiAZSdwFAHFeIrYW+opLIgaOVAQF70toEa8j8hQkOzkD1qfxEUm0jRpWJG1cP603TWTKNGMRFsZ/vUAJ9jjlkJYBue/akCkaXdGEndGfzrU0y3SYXhwf3ZyKpJ8ujXJ7tJzQBzU8u6SOOSLypHx0P862/F8Qs9Ls7dGw8ignjmqzwxST2rzOpuElXC+oyK1fikPN8QIkYPlpbqyADpxQBoaHbJa6bBGCBlct7mt3TE5Y4J49a5uwut1jbMOmzB9jW/4fufNGMZfpg96AOnjuGFrbwR5IX5mGM1Lq8dylgt60pWN+FQjj8qxtUv1s12J8spHJrHutZuLiCOKSV3jXnb6UASyvlWMp3BwVbvmvNHJjvbi3x8qMSOe1d2LnJABGG5Ga4S6JfUb+QAkA4yKACeyE9tsZQN5zG1c5c27W87Ry/Kw4xXofhKJNb0u401oT9qhXzEYdQB3/Ss260aTW9OmkgUPe25KsFHLAd6AOHBzwBj3zQpwSMnFOnheOQq4wR97PakUMGwDn60ANZQxJz8x54NOBLIAFxzQyDp3PU01WCjAz6UAO4IwD83fNI2McjkHtSKQOffHNLkgcDNAFC6/wCPh8DH/wCqoamujm4c/T+VQ0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAS23+vXGe/8qvAkMQcnjmqVpn7QuOvP8qv5KjJPPYUAGHA4/ClJPl/Nj8KYeSO2e2aUHg54xQAhyVOCeaFwVAFPPC5yfelGCrdj0FAEtjayXNxHDB8zuwGBXtsmiw+F/BsMMmFuLgb5T3x6VX+CXgtHP8AbV/H8if6tWHDGtnxLbt428f2uiWD7oIiPtEgHAHpQB51qjy3sNhuieK0llChyOG57Vd8f6EmjXsc1qhFrNEFyOmcV0vxot49HlttHtJN8FrgxEDBU1madqUXiXw9Np99L/pMafIGP8qANz4YazHdaR9gkI8+2PA74ruuWAwBk9/WvnTT5L3R7zzrQlZ4WwWPQj3r03RPiLauiLqsbW8nTcoyrGgDu2JjK9Wz+lPAZucbjmsaHxfoskGVvY/XmqR8baY0zR2aS3VxjO1OB+NAHWRtHHvechFxyT0AryfxbeDxBf6nqEYX7HaJ5cef4jx0rZhkv/GU5s59Th0yFjxFggv7E1L4/wDDkXh/wrBLAAC52OQPve9AHE69aMfCmhPJ8qE5ZqTwu0MssyQs2wN/EOBXTajZrf8AwhtLlcN9lm2/TpXJ+Di0RuVQDDHJBoA6fQEAh12JmAlWMsp9RWRbwmXSFVhkuTwtdF4Lt7Ge611tRleOVbciPH3Scd6ybS2NrpzBX3OCSvPbmgDkbS3t31mzjBkafzgDn612fiuIJ8RI0eIyoIApiHfjtXKeFbeWTxnYxyLu8yfJxXXeMbjb8U1aIZ2SqmPx6UAYF/BdaHcul1BLBZzEtCXH3K1dCu0iV52cFccY9a9l8fS6XZaatxrNlFeXLwKIY5ORHx6V4y2jS6jp15fWBW12HKoowre2KAKt5qL3Llic81D9pK5CnOfTtWZLPc2Ugh1DS5vNK53IMA/SpbOLU78MLDTpEIGWeQY2j1oAuXd2LWzeaYgNjEa9yah8BaJP4j1uKxY4gLebPIegHoawDDNJetvJuJd21QOcn2r1nw3dDwT4UlvJrKM3E332b+VAGZ8UdCi0bV7C+0OYQxzjyXVDjFZvgC4PhrxsltqqkW9wfveue9Zd7rN14q1rfqJ2wtysUfAT0xXo1x4QbxZ4INzA4GraYMqF+86Dp+PFAEnxQ+FcWpRyapoEfzkbygHDj1FfPd7aS2s8kcyMrocFSMYr6z+DfiSS90dbDW5D9ptzsQt6ehrL+Mvwzh1awn1fSolS7iG5wv8AEPpQB8qBc9yT60gHOW6+lWp4HgmaJ1wynGOmKqyZ3EEkkH8qAHsvBxnp0pCPm4IPp7UqAsuDjHrUec8DIx6UAUroATuBUNS3RzOx+n8qioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAmtf8AXr+P8q0CvfHP0rPtc+euOvP8qvrlhuJ/WgBw2LgFc+9NfAyoHvxTuikH7uc4HWlwM5zx096AIypZTtJCj1NdZ8P/AA2/iXxJa2kSkxAhpGHpXLhAVcjIHTntX0l+zf4cFvpNxq0i8scK3pQB2niKFdC8OJa2YAMce2ONeCOOpqP4S+Gf7L0S4vmT/Tb1i7SN1C1NqJOs6sLaNctLII898V12vTLo/h++SIBUgjEStnp0zQB8yfF+XzvEct55jP5hKKucgVxOntNb3CXdqMlPlBPTPvW78TbwS61AVhaKPbxn+I+tUNLuYrXR54nO6WY5CEdPegDUjZZLqI3URT7RxJkcZPetfwo+m2t5Lo3iC1jMTv8AJKy8qD6Gux0DRLXVNCsp2h8zKbJB3+tc58Q/Ct9pKQyGNposZjlA5A9DQB2d78GtEuZoRp+7yJAHeUNkYPpW5pvwztfD1m02kok1wgPzv1dfSvM/hn8RL/Qr1LW9kM9ix2kOc7RX01pU1tqNpHdWbh7d15A7Z9aAPl/XrEW+qtPbFkYPloiMFDn+VdP4h1Q+JfhhLa3O37Zp75Dd2X/Jrv8A4n+DIbi1a5sFVbxPnyP4hXl9haXsei6kEQJlSJNw6/SgCl4Lu47n4YeIdOk/1i4kjGO+RXH+DiWRkfO/HJ71q+DpzBY6vGVyroRWP4PlQXjFjhskYNAG6BMjypCQoYZfPcU+ICW3xtIDDGc1JqssbTQMjDGcHnrUrTolrJgAccAdqAMrwUoj8fWEYA8uPL/oat26/wBrfFZScmN7vJ+gasvwq/l+MRMxPCHp261reEIo7nxpdNJv2KWbK8EH60AdZ8VNROteJ5I48JDEFiC9gAMf0rrPh34NS6tBe6luazXiKEcBj6n1rza3t59S177NETmSfGW54zX01p9lbaRYojTKIbeEcscDdigDndR8OaWyLNdwxeRbncHkGNv/ANavG/iV4us7nUJ7Dwuqqso8uaRF2hvoKufGr4hPft/ZGlTFLdf9ay/xGuI8EeEtR1y4jkjRorf+KUjqKAKWhXUGi3bTGATTqNqEjIBPf60zxhrN9rKRWzL/AKPB87BehPv+detXXg6xs7L5IdyxAk7u59TXi+o3yRnUYSu1y3y46YoAydHuzZ6hDKVLYlGRnqOlfV3wutobTVZhaK5hurcSlH7AjJFfJULiK7hkbBAIb8c19Z/DHWI76/0m5TapeDyZFHQcUAVNe8KrpvjJYbXdCLoefAV4Bb0P4mvRbWH7TbAylfMkTy5kPQH1qn49t3lXT79Dh7SbaG9s/wD1q0tPDSRkpKhjbD5xz0oA+MPjRo66L4yuo4gBGzFsAV542Cxxkg16r+0Fd/aPG10P7rYFeWEeWvuOtAEY3YAPAHQUu4tyBjPBoZ9z84IA7U/5OCQcYoAzbr/Xtj2/lUNS3OBM2OlRUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUATWn/HwvOOv8qv7QMDHX0rPtjiZSff+VaAIZAQvT1oAVy27g7e1CthRgZ570gbONx6UrsTtHVRQBNAPOmjQdXYA19qfDrTo9K8B6bCgIR03OPXivkDwbZrd+JLGAocPKB+tfb98qWOlwogVY4bcKqn6UAYngu1D67qF/HkpFkRk9FNUPibqy2unQQMCzli7L/ePvXW+DY1j0Ms4H71yzY44rxH42+IW8+doThidifSgDyTxdqFzretzTzAN5fAC9FFUtPia8uoY1DMQQCRVWB3ZmAJVm5bnrXfeC9IEZS6uEZR1znAoA9U8Exiy0sL5bkAABT610VybTU7Q2lwnyjt3BrgdR1ufTNCnuIY/3K8I3XJrhfDPjDV9b1Nop3cDPWMEYFAG9478B/Z2a70uQbzyYx3qr8P/ABpeaVeLZ3M8kJU7SCeK177X7yyx9rYz2oHb7y1yutWen6u4vbF9k5+8OlAH0Xeaxb63pFtOGCtGcMQflavO7/V1gTVYlbbDKNvAHy1wfg7XJ7R5tL1GWRrbBMYB71BdauY47hGfLOxGfagDMtGFnJfsWHOdo9awZwjXCy2hKED5gO5qSWSWZmggYsZGwAa17Xw1cReX0bONw9KAM6GS5FzAWyVpdQ1Ca3mkiQlgeh9K7eTRI0tkUkmTHasS/wDDcs7jylOB3oAzdGuobQwtIS0zffb0rofCl7HBqV9KBjcDtJrm7rw/fWq+djftNR2N3IlxhyfTBoA9X8AlF8a2hcgK+SpPQmpfix4uNmJdPiuXeXedxBrmtG1+306ynvXGbi3X937NXNRWb6nL9u1WQnzGMzknt6GgC14V0SPUJ01TW5Uhsg/yiQ8vXuPhrW9FjYwaVLbMNu0oCRt/OvFtH0Gbxfeh5vNgsY2/cgfdIFN8X+HdR0bW0utIhfycAboxyPrQB7jqjNcWd1DvO9wdo7V86eNNMktb93aPCA8kd66G28ZavptvumllPHzB+1ULzX7XxFbO8yESZwSooA424tU+zxyCQfMPu16v8ENbMd5Z27vtaKUAnPUZryq/txBL5TAnnKHsK2vAVy9t4hUg7W4Ix/FQB9papB52l6tbbmYlfOiB7cZrO8H3z39mokGxURgfXIq34XvI9SgtJiTsmh8o+5xis7w1J5NxdRHBeKUoV7kGgD43+LM73PjPUSX+USkZP1rjZkwMc468V6J8ctKfTPHV+HjZY5JCw/GvO/mK8ZK0AN+4vKgg9MdqU7to5A9B3pCc9FOO1ObhASKAM66/17fh/Koqmu/+Ph8dOP5VDQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBLbf65cjPX+VaCtg9MKR0NZ9vxMv4/yrRQh9ucbffigBmVAwM9fSpOQAO3bimkEfdAwafg7Ac8r6UAeg/BG0S88d2Kyc7WDdM19XeKWjS1mkl3YBCKp5zXzl+zJZ/afHQlIwiRkjj61794raa4uLOJhxJNyPxHSgDeu5INM8I7gOfJyoBwSSOlfKfxMluGvY3uSVZiSsR6ivpfxTNE01ta7gyW6BpFB6YHevlb4hao2q+LrqQrhFO1Fz0oA5uGDyx5pJzuyfavQ7PUpZ9OiQjCBMAdAayND0ePUPKt5m8uM/MT61tzRJDL5SD5I/lUCgC/pOptB5drqKCeyc4MZHT6V0N54VmtfJvfC8cEUTcujAYI+tccf308SAnOeOK9Gvr97Dw9bwKSCR83vQBR1TQWvLSMptE2PnUcjNeYa5pdzot07uny/wCweldeuvXsUjNG5X261BqFymrQP5ihbgjr2b2oA4O2uWiuI7iImTJ+b2FVr6SQ6gQh+STkCtGxtlj1GaFlKk8FfSrGv6S0KW80IIZDnPXNAEHhcJDrcMVwq7Jj8jHsa9OhszvY7cFThs15kkbtJB+72ujB1NezaOy3OlwymF97gB2IoAw72No+pAUcE1c021EqZUny/fvWpf6fBcwlMksvXFW9MijtrZQ+1FXoTQBj3VlDZR3FxcACFIyW3V4tKDLNc3SpsVnJQegr0/xxdy3aPDGT5Ge38Vec3sVw9u6RRkc7QfSgCihlbS5CMsS3A9avaIbrUJY9PcNsYjee9dNp2hmPS4kWLc+3cxPaqWjFYpLq6Qjcp2A0Aehx6xZeHbSO2s18ycKAR/CtVF8YTTu6TQrhuBgcVxyBmlLu2SfU960dNtZbmdVGF9c8UAdNcvpslnJ/aNlE/mIdhC964fTre102Z3itkO4nKkZBFdjq0GzTgituZO1cyg4ZWA/rQByniizX7bHNDuW1kPB/un0rMsJn0/VYJw3zQuP++c1200IaKWN0DBhke1cXrlqYmVgCOx9KAPq/wLrMK2dmXdUt5dsiMOgbvXQXfl2PjnO9RDeRhgAP4q+fvhfr73Hh6706Rw0lsvmRKfvZHpXr1xqU9/pHhzWJVHmRt5UgHUYJ60AcZ+0n4aN3pqavGo3J8r8c18tsWGQoxg/jX3j8SNO/tjwXqaAhiI/NUjtXwpfqY7uSM/wMc+9AFcZZWQZBpGO0DIzz0oB4LDOOnvSliQOnTg0AZ13/AMfD49v5VDU13/x8P+H8qhoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAmtP+Phfx/lWgSF2gDis+1z9oXHXn+VXwD2PJoAXcuV4OP50oyxUHrnNK/wAigcHnrQSPMHIyB1oA9/8A2VbcHXb+4PzKkJ6evpXruvyvB4i0ppEyozJtPQV51+y9aNHoesXCgHChc/iK7zxg5fW9OiLEM0QDewxQBxh12UT+Jr+4z5bZRS3QdeleFbku9UY8ku+d3tXrfxhuU0nTFtEYeXLzsx39a8o8ORGS+Vl5Rec4oA7HTY/Kkby87UXg0OGZ1OSWPNXmC2tkoLr5knJHpVWIZcHn2oAcp8maNz2PatC+1Q3Yy5YBRgLWZI43EHjnrUioG5H5igBwtmkh3oCWHPFViCHKldrHrV/Tbv7LOdy8NwKsanDHJtljGPXFAHO6lC37u8hX/Sbc/MP7611cFpbarpayQMF3jK4/hPoaxAh8woOcjvWZcX1zoU48gSIGOShBwfpQAniC9bTp44plUgcBh1BrpfCnjN2gNnIQFHcVw+qSzam9zc3ke1NuUz61m/DxpZvFtsoDMhbaR2I96APd7K5FxCfNnj552g8mqU960Urxi5jCHoBkk+wrdGj6TaFpZ4g/PQHFW7O00hXWe2ijBAOARnmgDyHxRr7RXnlIih1HQ1laPcHUZUd3PzNXOeLo7lPF10bkEeZNwSe2a6LUbGS1aBtMOUKDOPWgDsde1GGz0vyLZibiRfLVR/OuctLRLeKOML84+aRs/eNWNM0q5SA3lyrO5HftTlR/NCKrEt0wKAJbSJbi8SPzViDHq1dDrWLCzSO0CgHhpW6t9KpXnhvUYfDTX1rCJXDjzB3xx0qTxFOk1rpsik5SIBkP8JxQBmq9wFwXJUcjJqJXJl3Hoas4BhUrncRVFd7MVUc0AOuWXdlc56fWsXWLRpbOQupyvI4rrtKsbRJElvHzt52ZqPxV/pUkbRbRD0EQGBQB574a1IaPq8FwCQu4biOor6XtLpL3TDiQeXOgeJV6Zr5d1S3a3vH2jbzk17t8JdQj1bw81sz7p4FJjPcUAey2Ba68PeXIAfNtWQ49QDXwp4th+zeIr2Jc/LKwwfrX2z4L1AXGlRF2DBXaMr6HFfIHxftjZ+O9TQYXMrHj6mgDjGTuzfMD2po69Rx2pJODndxikDFlGc7vWgCld/8AHw+Pb+VQ1Nd8XDfh/KoaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAJrXPnrjrz/KrwJzkdfyqjaZ89cdef5VoMDkEjmgAIwMN096Xy13LkjNKqu0mWUkAY9qIwQzfKTQB9Xfs2ps8AX8igEswH4cda6HxKom8b6dGTnbCDx6YrnP2aJzL4F1KFSAyMpAA68itXxvfLZa5NeM+DDakKehJxQB4b8VtS+3+KLiJXeSKJiADziq/he38q1898qxPAIrCMr3urSzOC7zSE4P1rurSzdrJEKDzO1AAiee5Dc1YMG0jZkkelVV8yNtoUq69eKQyuineefrQBO9uW6Yz3zUyQELxwfaq8VyR8z8j2qc3mExGeTQAOmWUDg0+0m2OVk+ZR1FKhV0BXj1zUTx7eR39O9AG1o0VrdaigYdeQtbfiXT7W60XeI4yiNjleRXCxTvb3EcqEgqeDXYNq9vf+HbiLlJ4hkYH3jQB5Lr9y11dNbog2J8oUVteCHg0D95Faxy3B/5aOen0q9a+Fpr6ZZA/wC9l5wq9K6K0+G00VvJd3V0kcEYyzMcUAE3ih7m3eKeFA+c/KaZa+JUs1CCPJ9zXP3osUZo4ZGIBxv9agis7WRgGmcZ7mgDL+IktrqV5DdRQujj7wHc1reDbhLy3+zSczDpkVtweA5dStTPY3cc8S/eXPzD8Kuab4U/si7jLh42Iz8wxmgD0bRdLt5tEjjmiVpMYH1pq+DYbSx+1ahIkYjbf8g6j0qTRL02sLT3LIlsgwM9T9K4/wAdeM59WiWws2K2yHkr1NADtZ8Sfv2jsnCxA4wvQiuW1S7W9PEeHJ5xVKFc5JJFTblgKsFzu6+tAErriJVJwB0x1qnKAkqle/WrgdXUgfhmqsyYdmIJoAiYOysWY9aVpmdNkpyF+6aQcnnPHY0rosmSOPagDnvFVt5ka3MY4Aw3HSp/hX4hl0LxTaSqw8mRvLcN0wa2JIll02S2f7p5zjmvP5Uayv8AAbaUcFfagD6P0XXJ9L8czeH7S3Mlrcyec0oGdoPpXiPx4tmh8e3zYyjHIPqK7u01e5fxJpF5asdxjVZtozuFV/2ldLR5LPV7UZimjAO3nBxQB4IwIC4XFCbQpXvQqsIgxJx70hbK4A6UAZ9yxadievH8qiqa6GJ2H0/lUNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAE1rxOv4/yrS+9gkjis20OLhSff+VXyQGzx0oAlBJBUZx60I7MxJIGOMGmFxnDHBA+mKQFF5ZlzjOM/rQB9G/sx6hustVsdpY+WWCg88d65nx94lnubu9tZZCWQlQe+PSo/wBnC6lTxNLHHjbLEwO3vwa5fxw7HxVfAqRiVgfzoATw5CWmjdxnBzXZfaSr/u+D2rnfDAURGXA29BzW1gStwQT9aAJ7+Rpo42HDfxEVVEG7n9TV4m2W12MzHH86pg4LHdkds0AIEOcNwB1PrUsUIFgzsfmZsLUTlvLy3U8Crl6QIYIVxtUZP1oAaCyRgDj1NCTEnAbp1pj7vKAPT60xPl+YLknjmgCSTEgGMYBpPOe2tXEYJZzjFLgKAGXrzxV3TLT7XdwRZOC4oA9T8A6MV0mCacYZ1ySR0qn8YZJbHwhGbRyY5HxJjtXbXNmsOkW0EbFWEYzg1514n8QaZZW02m3d6by3k+/bqPun69KAPIdMnW5kcTg+Ui5LDrWVHq0N5ePDarJGQflY9/rXTxLoULzfZ/tUUbepz+HSqSW2hxMWRZCz9WAwcUAd38KJ7lJLididiLyM9TXpYiOv6dvuAPMAIVcYxXm/hjW9Ds9LGn2AaEZy7SnLOfrXbeG7qSLUkUybopR8vfAoA4bULyeOO4spWOYmIx7VyvzeYWZsc9a734i6eYNWeaNSFYdR3rhZBlxn/wDVQBKso27eCKjB3Fiw4HQ+tOAAjzwQKhJ/cljxzxQA9ZhEN38J4Ip+JYXDsMI44PrSMNtvk43Y/OlWRns1yNwU9+lADJYy5DKMn0qMSYGMYYHmpY5MDLD5euR2pZVWXJUA9xQBJbL52UTjPrXGeK7YxXJLqFwa6u3mkUELjg9Kr+MrI3OnJeKq8jDAdqAJfB8curaittbSmKZYcxN2zg1v6tqTaj4Zm0bW5YxfJnaW6Ej0rzjw7qr6be+ZE5jIG3I7UeKtSnvriFpJd5B+Vh3oA4u/t2huJIz0U4x61Ufb0Hp2ra19Yo5kKOS7D58VjuwJwBj6UAZ11kTtnjp/KoqluTmds+38qioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAns2ZLmNkxvXkZ9ccV6zq2u+GTp92LN7cXEUUl9bAQYLXFyHWSLOOkYaMjt+7OK8ktv8AXL+P8q0Ayg560Adl4X1bT4bDTILn7Hbzw3lw3mOhRwrQYVy+1uQ/3SQQCAcdTW/e6x4fe0nXT72ytpftAFszoWVZvMUm5dDD0IEgDA4wy/ICDjy/zFOAQSRQNuTnJH0oA95+GYiv/GGralYSoyeShLwg7d+xQ4U4GRkH5yBnk981yfjh7dtdtLyO5tZspDFNB8xdWX729cdPUgknNN+GHj/RvCOl30V3aXz3k6FEaFEKj65Yfyrk7rXLW51Y3LJPsLbiNoz/ADoA9w+2abFbysZFkTaSxRiTcA+biMfuhuUBoxjCYwOTt4wtQuZL6WESXTTCGNUDMc7mIBc/99EgeyiuftviBoAt0iurTUCFGMxomR/4/VB/GOi7j5MWojnjfGgP/odAHTeWQdr4waa6A4UYxXLnxrYLnMN2Qf8AZX/4qmnxtp38MF3n3Rf/AIqgDp7hCmM5IHSpJQXkjbnkdK5IeNdNZgDHeAZycKv/AMVU0njfSzMCIbzA/wBhf/iqAOqmACAgcdKSVNpjGevfNczJ460x0IWC84/2F/8AiqRvHGlsEKwXm7pyi/8AxVAHT7QWK5Ndz4B05ZtTtzxwc89a8gtvHGliXdPBelc9kTP/AKFXWWfxg0SxtT9isNR+0KuFJjQc/wDfdAHpnxX8bxafE2l6Wf8ASiNryZ6fSvE3lLjLfMzHLM3U1hX/AIyhvb2S5uY7hnkOSdq8frUMnieyZgViuv8Avlf8aAN9GySpbg0rbBjrmueXxLZbstDc+2FH+NB8UWbc+XcjHYqv+NAG9FIrMQcFu3rXo/w+8UCCT7FdAM+w+TI3UHHSvGE8S2QOTFcZH+yv+NSjxZao6yRR3SupyGCrwfzoA9wa7udWt7qS6LeZG5UAiuTuLdoLht/Q9jUNh8X9AWxgS90/UjdAYlMcce1vflxzWXq/xI8P3Tk29pqantvijH/s9AGkCMuNwH0pfKeSxLr/AAnn2rkj4009iWWC7P8AwBf/AIqtCz+IGkQW08cltfeY47IhH/oVAG27kQqvBb69qn0eEXcsyMeFXKgdM1xs/jbSyoCQXn12L/8AFVCfGVmqbYVu0U8nCrk/+PUAdYd0bMjL3wadC2xMjkZ5rll8Z2DxkSxXZkx97av/AMVUUfjSwAI8m6I9lX/4qgDsJYt2Co9+KjuJpJbGS0fBjPPPXNc4vjrTFxuhveOnyL/8VUb+NdOY48i7Pf7i/wDxVAGHdpJbXrqRx0BonuGMas3/ACz9Ki1bWbS4kd4Y5gTz84AP86ojUIjC6kOA3Xgf40AVLqfz52cZyeTUJyRk9+4oyNzf3cUE4AxggUAUboYnYfT+VQ1LcndMx+n8qioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAkt8+aNpAPOM/Su5+IHh+00CaxGnGcCRZI5fOzkyRkAkZA4O4cjKn+EnBrhoOJR+NX5pppQhmkkl2qFUuxbCjoBnoPagABKqDjk9aAGJwM0HmM/pRhhnBGKAI2Byemc1IeV+bAHQU3kA7tvXtSYxktnntQAv3cZJyaXJ3ZLZpQMqeR0pgGAeaAHAbehOf0pSQ4HIBNEZbPO7aKMDJPO386ABVzxnOaTlc+vvQSeGAHHeg9eee9AAccHPNIMhhk/LmgvucfyFSA/KQQRx1z1oAYxG47TjimqxyCKkXGcdRTehx2z2FAASWZc9aUcv8zUEAn5ec0jjqCcH6UALvG47sD+tNBIU7W6nmkZeQRzTxuAAHB5oAQ52jLc03cOgz7ilLNwOuKULtyc0ACth+BlaRlySUzQm4Nkjk+tLt25wc0AImMjPB9u9PPyjtk8U1DnJVenFIGKnpjPFACucKeM9uKTkqvr60u/jjBzxzQwIIJ/SgBNzAgn8KCehPU0mcsAMnvT8HDc8jv3oAQEBhxk470rFWO4nkdRTVXJHTvzRuxwMcHrQA/CsR7UmdrYBwR1pm4n3p3BIz+VABkEnrmlVcbjkn0Apme3PFPyu0AduetAFG5z5zZ68fyqKpLg5mbPNR0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAS23+uXPTn+VXlG0ZyCPSqNtnzlwMnn+VXcnngDigBrPwPl4p+dx+8T7YxSZYH3NDZ6cZoACAcj0pVOQRyVpBgZI644ozlM8n6UAL8o4xTcjIHBpQCCGDbgaQYbPynOc8UAA3ZB5Cg0qt1xnOaF+7g5/HpSbjuyBntQA5sFfnPTrSB8LgLQSCMnqeMUZAOD2oAan38gfUYpzOcjA4HY0qrlyc8YpWQHIGf8KAGrkZGOnPHFKSQSeCpoOQOn1NEYbBbHU0AICpHAwO9OYAjOeDVm0sZp5AEVsHnpXS6V4Qvb0jZbyMCepX5aAOPwQByd2aGxk88k9a9WHwo1d0BFnnPYGszUfh3q1kxWbTpVC9dozQB53jkgNyKeAcAN0rYv9AntJCCjq3o64rNktp0cjb+lAERK9e9NPIPzYOelOZGjAGD75HSmk7flOPXNADR0xkgmlZT/ABEE05VOCACe/ShlbdwDnHpQAxsMuDjil5Zc8jHvTlXBztppzkAdTQAo3KPlwB6mjg4Jz/jSMGDEEjikDbmOBg0AOK5Y46D1pNoxwfc8ULuzxz60Dqeo+tABsIfI/wAKQtjjAyfxpWGDjPIoIww4OfWgBQBtGOuOmKaEGCelLuGflJ9qAzrgAZoAo3BzMxqOpbj/AFzcYqKgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCW3/ANctXGHy5B2iqlqAZ1B/zxV18ZAC9O9ADDu79fWlKsuSQOacQSBgn86a5+pP50AOT7hBHOfwoZsqQOwpMltoJ4z6UHAPAOKAF2/KD2z3pQQcqOGNMIJRcdvelIwxw3agBoAyAxyfSlcHsBQDg8n8auWdjJdMAAQvrQBWgQluBvJ9K1rTRnkOX/IVv6fpEdrEJJNqoByxFSyszKPJRljY/KSME0AUYdIiDrlVB9TVv+yVaNlVFYe3enfZuRvl/CpApt2DGd1X1HagDEuNAJ5j49ulX/Dng6TUrtIXfaM87uAKvpdru/0oi5j/ALyfKy1p3Qk+wrc2N3vhHccOvsaAPUdD+HulaJaW9zO8MuSAd5H6V3D3uj2Ui6bpMFvdSsm7nG1PxrwTwr4imNytp4idriwAypZvmX6VT8Q+Jzc3TwaLCbW2J2/Ifmce5oA7vXvH8djq0mmuhhOcCdGBG7/Cuu8G+JXe2K66wlUn5LhcMCPQivny8sZGnty8eCeTuOfzq3Bf6noMomhaVY8/dzlG/CgD6D8VDw5e2dzMRHP5SZZAvIFeGatZ6XJc5sjtRuQPStDxB43GoaEsWmxJZXUo23DD+L6VleGdOW7mzNL+5RcuxPWgDPk0eOUFkHmL64qsmgq6bkjRQDyTVzWr+8juDb6YAkecDHJxTEhmNv8A6XNIzn+EdPxoAZJpFvCUDTxbj1xTHsY8HY0ZXtkdadJFHGAJFyT700RAoWjLELQBQvdHhfHyBD6jvXN31nLaTYf7vY13lrOYHWK5UNFJ0PWqusWCTIyAkhvu57e1AHBYIJGetNBDMMfpVi6gaGcxshyOOtR9OAv1FADQjZ+tLuOMBcEd6U4C57g8c0DPLA/rQArEHkfepuSx68ijemMc59KEwTwAR3oAaudxyBinEhcNjp0oxwQuMD2pykFsY7UAZ9wczMTUdSXHEzVHQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBNa/wCvXnHX+VXd3OPyqhb/AOuXFXgDuHTNACggZJHFIjEEhcY96VmbgHikwMDAxigAIYcH8xTckHJ5px3Fupz2pxjIOSeO9ADc7sg8euKVQuT1A9RSYwM4B5qe3jeWTZGM5OABQBY0rTpNQvI41UsOue1ei2Ghi1s/PlULbLwX/vH0FO8NaEbC2jWTAnlG5/VVq/4mvUnsBb28o8uIYVB/M0AcpfX5uZn6C3jOFX1qsbqUyAs547dhUJIEaAYxn86Bjg+/WgC41yGIJU7h3qCaZ3ADHg9BUTZJPJFAzgA80ALH8nIPNaejXKwXS7gWifhl9aywCFyT0qW3YggjqDkUAXvEFuE1ACN8RuMgE/dqCORBsjUgFeQfU1r+M40aw067SMB3Xa5HeuW0+BklzI3y54zQBtyvPM43nOO/pSXM0zWuyWX5U9adAxYsFQkj0qvM27zg68Dg0AVWg3R+arBgPSutgtRYaCLjzlYOuSoP864eWPy5IhbM2wkBvUV33i60Om6RYWzMuXjEhx/WgDM8P2/yvdyjMjn5c9hWpOA6/Mo2n2ptgAdPt8AYx2pZWIjJ/LNAGW8AlbaVyB3pixdY4xtHc1Ko25HRjzVq1iYSZZdo9+9AEB05ZLYoGO7GVB7GqNrIJEeGUESKcEmugjyXDdCTXOTKE1W4yeBzQBQ8QaQ0sPmxAmRPvACuObdG5D5HavYoLT7TpIv7QeZs4mQc8VyHi/QUVEvbMZtpB1H8J9DQBxG0lc45zSqp65H0pZo9jDg8daVsDAFAAybjyOnNKoRckDj0prbumeaU44z1xQAp5GQcYpOACTz9KQIcEnkUmF+6DgkUAU7j/XN+FRVLc589s9f/AK1RUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUATWv+vX8f5VbwCfYHqKp23+vXPv/Kr3CPzwKAEfJYMM49aTBXHoaUk/wngngUNjoMnPegBWADcdOmRSsx5pr8EAdh2oXPGT+dAEm05GRknivSfhx4aWZX1O9AW2gGRkfebtXMeCtCm1vVYbeJS25vToK938Y2dr4a8N2WmxBd+QTjqTQBxHiS/+xaXNKnFzcHGR2X0rj4knt9q3B/165Fem+IvCvk+BZNR1KRVv5SHghzyF9cVwN2qXtlDJAxMiLhgR0NAGOyYi+9gg9BSLgdD9asKoMZbBI6MB2qBkZDkjcvqKAGcl+tOBy2GpC2eVxSct1/SgBW+UetX9JgNxdRx9tpJqstuFUeZk5PAHJNdh4UsTbWuoXV5AyZjIikYcD2oAqeMbcp4Ps5sdJdo/OuUtAVyGHzEjBNeo67ZR3nwtik6zQyFse3rXllhuDsGzvxke9AHd/D+BJr+9MyAxxRFj+VctfSpJcTuoyrOcVu+D2vG1K5jtFLeZARJx2wa5uRWQSrjG2Q5/OgCnDNI93GFjwhkAJIr1LxtZm91HS7ZgA7WwC15dpcpl160iG9l8wZHrXr/jWFR4s0sMWRWjUZzjHFAHIaQ5ieTT7kFZ4GwFbjIqxfkgDoDW1468CXWnW51hNQ86U888YH171yUV+5hU3ygY/jWgC9bRBn3uMgdDVsLuIyOnrUUNxbSKDBMhU++KbPd20OWknQAehzQBbJEaM79FGa5CaZppZnQHdI2FxVy71Zr0NHArR2/djwWrQ8I6as1wb24+W2ThB6mgBfDl3P4T1YLdKZLS7jwyY4Oa1PBklvq2pXukXEf7m4J2K38NVPEt2uo3lnawYfyHzuUdPatPxLpraXLZ+I9EVzCu0TADlWoA4f4geCrzQb+SGaJvKz8kmOCK4SRSsiqw5WvtbSIdL+IPg5DPiZ2XEmRzG3rXzr8TPh7d+GryQvETbEkxygdR70AeaHByRkD3ppIyCckd6dKjLIQDxSEoF+bK0AN68kce1NAPQj6U9ADzn5AKBkZJ/KgCjcf65vw/lUVS3JzO3+e1RUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUASQf61augn1B9qp24zMv4/yq4iBiPXrQA9RjkjjoMmmsOAeg9qcw5GeR6elJuAwCM+goAQvuABx9BVm1tzPKgXJB9KrryTkEE16L8HPDg13xJCGUtDCd8nHHFAHrnwi8KJoGinVb1As7ruUEcgetJp9jN4x8d/aboA6dZfPt7EjpXd+JVjtdLWzibYrDLt6DpgVZ8B6PBYaQ1yy4Mx3HPGFFAHknxevna+2u2JZOFQfdROwrzW23xSBh/q2ODXdfFjUBca5KViUKz4Vh6Vz+kW9vd6LqSz4V413RnuaAKdnpsV1fyQ2zksy5UDoafpnhe+1UTjT+ZoTh4W/pVnSdOuLdbW9smJKfNj19q05tXbTdch1axYokxBlTptPcUAc5deHNctW2XGkyL7lSKifRtRitGuZrcwwIeSRzX1V4cvtH8XWNvdQyCRwoEkRAyretaOsaBpuo2ktldWkWxlwDjBz+FAHyLaSASJMgUyRnIzzXsGpXNvrXwre4t0VLmJgJdorE8VfCi+0pnu7ANJbFuV7rVjw5bNaeHtXtrohY2jyA3c80AZvhidb/whqVhKAQqbxk15lHCq3Z28AHGK63w7dm1S6jzgOpU1zG4C6YqP4jQBqaTqk+l3M09u4TehTB71nf65HeRQGYkmmTvun5AI6Yp0DkblYZxQAvh+zUeIbGRTtbzOn413fiq+e/8AFFvAASUZVWuH0Vv+J9bHBG05FdVpZNx4ygYKZSH3bR1PtQB1nxgvWRNN0lZDshiVpAO596830+xudZ1OOxsYGld+wHFdb41WbVNemmMEkbu23y26ivYfhr4Vt9D8PqXgzqV1hi2PuL7UAeTX/wAI9RWGOS0VjJj95Gw27aS5+GlloKQ3GvX2UdN4Uc5PpX0Tq11a6Tpz3mqSMlui4JPU+wr5q+I3jaTxTqaRqPJsYjtijHXFAHK3Fn9smcw7Yrcthc+lTXxFpp8cEE7bs4AU9KvXmjX11awSpE0MR4jU9W96oW9gLa+uI7sklUzxzzQBV08+VdwHJyHA619D+ArCC/s77RryHMVxHnDL37EV848mUgHAJ49a+m/hUXX+x5Z3Eoli2Bh9D1oA5/wxa3HgvWbizAYwB+VA/hz1r0LxVodr4h0mW1k8uSOWLfET64pPHlukep6ffBRjf5MxP8Q4HNa+lpH5DRRgCKI7owTzz2+lAHwp440OXRtbuLWRdpRjj6Vy7EEEH6V75+1FYQw65Fcxr5bSD5gteCyYyM49KAABVXbnFOYg4wD9aZh2bPBHYmg7gcDrQBQnGJWFR1LcjE7DOen8qioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAkg/1q1eUgDgEtVK2/wBcv4/yq6AS2AAcUAKU+92po7+lP5PHcetIAuCOjelADo8swPFfUX7Ouii20Sa/IbfKccDtXzHaRCSREBHLAGvtn4aWY03wRYxIdgdNx96AKurW733iGO3wZGkbGOyiuj8VTf2f4cm+zAbuIYV757n9ap+H4jL4huJyOIhgHrXLfGPxA1lGLK1kRZVXczf3aAPGPHe1dVWIyLJMq5kIPGfSsWO5kitjHGwRW+9jvULgXMrzSOWdjnJPWptPtTe3SRKCeecUAd/4WV20iGJkHByD3qTxL4aXV7Fp7EbLpfvKD9/3q9bwwadp8ck7eUsY5LNgVRHjDS7e4YQ3ac+gzQBy/g/xHf8Ag/XEd98YU4ceo96+pPD/AIh07xFpUN1DMC7YyB2NfPetDTNdtWaMoZSM7kPP41haTqGreFJt1rJIbc/XaaAPqTxDqo0u0l86NZMjCqec1ws1jbjTtRuL9Y282EvGoHCHBrg5/H41iW1neZhcRDaYz901qJ4ih1KwukdzENpwAeM0AeWFZfPl2AAEnr6Vzsnm290wk5UnjFb2pXLLLJhhlSefWsOSUyHLnJ7UAPRw5DEnk9acZBHIRnBqFSchugHakkcSZbAz70AX9JVpboTD5VXoa6rwk7W/iq3nGDsbJJri7SYoVCPtB64rqfD1xHHqUJdwccnPANAHr8EFtJ4vtzdgGO4YOM816ANf2arcKYXjt4F2iR+FVR6V5E2rw3N9YXaSpG9u/PoQO1UfiT8RJ9WWaz08kK52krQBV+Lnj6bxDqJsLDP2WM7QF/iPqag+H3ghZbpLzVmCAfMiNzurireePRSLiWL7Rd5zsPQfWtyz+KN1HdxxXdnCYsdVwCKAPYb+CB4m3AYjU4wOleDazI66teH5kDsR+Fejab490e/dlFz9ncjlJRkGuc8b2Ed2wvNPeOVGHJibNAHFZTIIOD05r1X4R+J3hurKylAEUcg2ua8sjCFMSIGZeD6itPw5ctaanFl/LTcDnFAH2D4jt1vdI1DCfOuJVP8AWq3h6aOW0gkcgvs259at+F7uLUdBi2yB/Og2HvnisjwzC0E8sQAbynPA7UAfOX7TGomfxD5IPyoMYrw4ptOSOfrXpHx6md/G14Dnhz1rzR+hA6ZoAcMnqTjsBQSDtVRzSKAuDzgdafkA5HGfWgCjdZ89s9eP5VDUtyd07GoqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAJbckTLjrV75g+SePaqNscTKT7/yq4vDcfkaAFALElzgUoC4BHWkJO7GMfSkwd3zc47UAa/hqBbvXbSOM8Fxx+NfcllGtl4esoH5dIAQPTivi/4Z2/2nxhpyADmRc469a+0PEkpt9LZY/kyixD34oAd4ab7Fol1dSjlyevevnb4mXb3GrTLI5LO2T7CvfdeJtfDdnp8ZbzJFy3rzXzT41gFtrMsPmFyDk5NAHPO2MgdPauu0uW10bT0uDiSZ+Qo61yc8eLcyHr296ntmZo08wknvntQA/wARX+patveRsL2QMcAVzMMUtvNmTCJ64zXUN1IHQ1QkRWcrjjPfpQAlpcNC6SQSMhHcHrXSW+q/bYTBeSA5Hy46Guee1Y4HA9qrzCW3kHBI9RQBYglSPUSrEqm7Ga0Li8kiaSBGz3yD1FVdM037aw80ZOcgiruuWBsIYpQCwzg5oAyEVrm6CMSB3zT7mLySBjgfmanuEC+XcQgBlwT7ithrAX1uk0S5DD8jQByzbmJB4FWrZUYBSnT171o3OkyxR5UfnU+jaZIXDvzz+VADLPS0kGwpsLdCaqyQSQXrIHDBO47V02p3UGn2xDLunIxGBXLlxb28zOxMjcmgCT7eyQzAuQFHFLot7bpbvLMCXHIz/EasaJpP26wEkikh6oaxpyWlzHFETz1BoArXMzT3Jlflj+lRXFmJwGZORyCOK1IoUVeBup7ZC84oA58WrRtvjYb+2RVmzutTR9yyEJ0wvSr7Rr5q46+1WAAgIGMHtQBSuZUTbJGCHb76+9TWEuy5jdjkBuQajvojIAy4BX9aUAIvPG4dqAPqz4V33kaZaQyFNrEMrA9j2rbtGFp40u7RW2+b84BH+fWvGvhtrjz+HJolcefZjzFOfmwK9QfVBf3Xh7WYtu2UeVKw9Qcc0AfO/wC0Xoj2vjO8m2kpLyrYrxcgFsY57ivtH9ozw4t7oJ1KJN0icEgdBXxpdoI5nzyymgCuxHqPpTsR5+fPrQSCpyCT601d3U4PpmgClcALKwHao6luOJmqKgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCW2GZlGM9f5VdwyD5eTVO1/wBevOPf8KubjuxnPvQAoJYKc4I4pSOmew796j27ecn14py5JycletAHpXwGthcfELTxs+UMCRX1X4sBe9toC48sz5/Wvmv9my3afx5E6KSI1J/SvozxcPLuraRm+85KgeuaAOO1XxO83ijVt2fItItqemcCvDNQuXutRmnkO55GPPpXq3j0W+kaZNvOLy6bLL3IryGMF5+MjHIoAfc4lCRdQnNKi4HBpiFjO7bge1TcntQApG0ZwNxqsqNvPFWGBDDFKuAD796AALhOaCqlSGAINIS4U4GR702JiwOSMZ9KALfh+6TTdRjE2fsrtjd/dNd34x0pLnw40tuqt/FlOcj1rzuVVKMj8qeldN4T8SfZoRp+otmEcKx9KAOQG6GLa46Doa3PCWoxQhoJZNoJyOKb47Fq/wA2nupzz8vWuEsNSf7YsYyMnGaAPZr2SzliAXLNjOBWYLpII2IAEgrmob64g+XOR9eaZPdSTNuJIFADdVu/OufMkJJqqqm8fYqnaeuK5/W9QcX3lrkqK6fw5OthEjXZ68g4oA9c8M2NhpfhuGa9j+VFLnPGeK8qv7x9S1i6vdgELOViHtWjrniW41aFLSJjHbD73+1WfCgXAUZUUAJjAJwRVaWXBKgj2pmo3PkRk7sEHoaXTykoaQ4ZiPyoAltwzZ3AZp4XDDB+tKR8vQjBp+MD6jrQA0orKVJ61FDH/ozgAb0PAp7YHOeKrLP5d2B2YYJPSgDf8G6kNO1ZWkz5Unytjrg179YrZ/2Itrasdinz42X1/wAmvmTd5U+EOCpyGr2v4balJqOjGPzAZYeqjqRQB65flfEPg+4tnTdJLCRj1I//AFV8H+LLF7LXbqHbgo5XntX3Z4Wlhn01djbSjFSfTjvXxv8AGmzFp471KNc48wkZ780AcEoYrtPGD2pdvOBQOACBhvajeUbJGc0AUrk5maoqmuv9e3GOn8qhoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAltv9cv4/yq50GPSqlp/r1/H+VXQQwAPr3oAarjdhhxjjHrT41yMg803HJz09RUiEhefw9aAPf/ANlSy/4nt3dE48uE/jwa9a8ZrLPr2lwxdXO4p+NeffspRKbLWJGxjZgn0613mvvjxZFIjDbBDuznr0oA8j+LGpC61g2/lbGh+UgnOa47S4wTNMxyqrip/E919r1q7nLfec4qOU/Z9NiRRzIck0AVY1VQcDJY5NSZH8P4UgBOe1KIyBleRQA4MBgqMnvRn0P4U4DPOeB2pq8qT39KAEXLZHY0GPBA/WnHdtBH5U45Bw3Ge9AEcjEjaccVm3KbmyrkevvWk6Ls5zzWbIMblweDmgCCefyF+UFmIxzWbpOnPJdieQbVDZroILaOQB3II9KvhoVxwuB2oAbAFeXbke1WpbcKhAK+uaoyywr904pUliZceZQBzviCx8qZZlXIY8mr1o5urVc8leMVqTww3KCNmAHtVeK1EAwjAj1oAjRygxjIpwuunlhgQeaYW52samgi+bpQAy5txdhhIM5/Sn2FmbRjs7Dj3q4AFXaevtS5IxgZNADCMgnknvTuQBn8hSDIbG7g9aeQAcmgCCQAgkioZ0XavGRmrLZJ4HJ9aRuQQQKAK92ixmN05Vhg+1dj8NdbGl63bI5Ajd9re4rk1QGF4X+qGq9tI0UgGcOhzxQB9OaDq1ppeq3tjeTrGJnDwqT97OK8B/aRt1Tx88iDaJFBwPxrsby8jubjw9qx+aRcIffFY/7S9g76hY6lt2rJGCT+FAHhSh/MyQB9aU/fB4PYikBLM3NImOp7/pQBSusGdsdP/rVFUtyczsR7fyqKgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCW15nXHv/Kr3fBI4qjb/wCuXn1/lVxVyu4HjPegAAAOTxmnqFwQzZPagcjjH09KYxZcjaOvWgD6W/ZNukS31eKQBv3RIz3xmneKPFscsmptGMTLmMCub/ZivDa61eArvV4mGO3Q1i+L58+Ir4JgL5hyoHvQBz0hMkozxlsmr7bpNqnoOgJqtCFeTJq19zr+tABkZBxxUpYYA28moGY7sLwDUyDj1oAcFJ7AL3oJ4x37U7IVRimPgtkYGKAAnjAA460jfOODilA+Uc0pxxQBGFyPQDtUUqIwf1x1qyRkn1PeoLrCxMcc0AUVbCBVOPemzSGKBmJywqaJcqpNFyivEVxyelAGTHK8r8nk9KeXaMlQw3DkjNRx2s6TFvLbA71CLCY3TTZY/wA6ANiwud2VONx/SrLSMqkR9ffvWfZQGNt0gKntV/IPTJoAbbgzMQVAOavbAqnIAqtbEI5PrVhh0LDigBwPzA4GPWlbAYfxE+nao1GGwRmndSe1ADvudfwpxbd0IBNMXkcnA75pVGM8fSgBrHHB6etMyepHXpU7qSoyBTQACNwJH6UARSjC/L25OKqzFBKrqDyMGrvVX/nWbdFkO0Z9RmgDqtNuy2nwW5JIhfePavRfiJbxeJ/h7DIhikliTI2EfrXmXg0ebqtush+To+eRiu08Vy2/hFgmn3H2m1uVy8JGMZ/lQB86SwlZWQjBTINRZBwOv9K6PxdbxpdG6t0KRzc49K51cNz/AA+ue9AFG5OZmqKpboYnYDp/9aoqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAJ7NS9zGo6scD61vNoGqooZ9PuAjSywBiuAZIhukX6qOT/8AWrnoBmUD1z/KvSNU8erd6de240/Y1xarGjCXPlztvE82Mf8ALQSyDHbj0oA5q38OaxcWVtdw6dO9tcMFikGMNndjPPA+VvmOB8p54pz+GNcjTzG0u6C+eLbGOfMztC469eM9M8ZrR0jX9N03SUtYrS+WWdZIr9hKgWdHR0+X5cqVVsqDkZyTnjGhaeM7OK7lu0025aZ5YWKNcLsVYcCN1+TPmBRjklSSTjtQB23wHtp9M1m9N5C0U0EZLJ1xkZByOCCCCCOCDWD4vZl1a6klBQzHzVz3U8g/jXcfCG7XVrrV9SFqwiaBEzIwLfIgXe2ABuO3OAAPyrhfG95a3N3GIIrhbqFUhYl1MbBQQCBjIPTqaAGafo2onzd1lMrxRrM6uNrBGXcDg+q5OOuAT2q4ulahM6gWcoPlCYAjGUJIU8+pBwOpxxVm08QGKFGltneaNITExl/5apCYtz5GSCGJxweOvJq3pPiBbN4HeB52ggiRAzoQ0kcjurtuVv72MjDDnB5oA55VGwnGc1NEm0deKahY4BYFh1OOtPBwDQA2UjcMAiow20knkU9mBI45poGOnTvQA5R8uQaTGWI6HvSqynJBx7Uo6exoANpwRuzVO6J+6T+VWpCqAjHJqoT5jdutADoo93A6DqauR26IASMmkjgx82KlbIUhTQAvoeMfSkZVCjCAGlGSoJUn3pFBJzjPtQA0xrMCGUYqnPbGPkE7e1XQfmxQ6h1AIzQBkJKjKduTzz7VcgbK7WbIqEW3kySYHDHNCHa3J4oAtFQF44NICBwOT60u5Wxz17UyU4ONvAoAXgnkc0nnbWClTyeT6UjnKAgc1Tm81j8hB9aANYBtuQPl9fWmuOR7dMVDaTOUCSjA7EVMcZyOhoAjLkfeP4CqV3GXy3PHSr5bOR0qIqM47etADND1B7O48xD8ymt/xdqbaq1tNIVJ27TjtXIKALtgByDVycu9pIucEL8pFAHPeKbzfLHbh1KxjpWACFOeMHtT5QzTMHOSSck1FuGcHPHSgClckGdiM496iqa6/wCPh/w/lUNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFADkYqwYdRU32p8YCoPoKKKAEe4Zzyq/lQLlxnAXn2oooA7Twn8T9Z8L6bcWWm2unNHOu1mljctj2w4H6VhXXie9ubgzSRW4YndhVbH86KKAHjxZfYx5Vtj/db/wCKpf8AhLb7AHk2vH+y3/xVFFAD/wDhML/H+otP++G/+KoPjHUCB+5tf++W/wDiqKKAEPjDUD/yxtP++W/+KpB4v1Af8srb/vlv/iqKKAD/AIS6/wCf3Nrz/st/8VTh4x1AY/c2vH+y3/xVFFADH8W37dYrb/vlv/iqbH4rvUIIhtSR6q3/AMVRRQBOfGmon/ljaf8AfLf/ABVIfGeon/ljaD/gLf8AxVFFAC/8JpqOMeTaf98t/wDFUf8ACZ6iDkQ2mf8Adb/4qiigA/4TTUc58i0z/uN/8VQfGmo/88bT/vhv/iqKKAGyeMdQkHzQ2v8A3y3/AMVUJ8U3pIJit+P9lv8AGiigBy+LL8f8srb/AL5b/Glfxbfv1jth9Fb/ABoooAQeLL8DHlW3/fLf40f8JXff88bX/vlv/iqKKAF/4S2//wCeNr/3y3/xVOHjDUB/yxtf++W/+KoooAD4w1AnJhtf++W/+Kpp8XX5/wCWVr/3y3/xVFFAEDeI7wyb9kAPsp/xqUeK74dYrY8Y5Vv8aKKAMma9klkZyqKWOcLnH86Z9pfnKqc98UUUAROxZiT1ptFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The retinal photograph depicts bullous retinal detachment in the left eye of a 1-year-old child with Coats disease simulating retinoblastoma. The magnetic resonance images confirm the diagnosis of retinal detachment and exclude retinoblastoma because of the absence of an intraocular mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard A Saunders, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38962=[""].join("\n");
var outline_f38_3_38962=null;
var title_f38_3_38963="Flurbiprofen (ophthalmic): Patient drug information";
var content_f38_3_38963=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Flurbiprofen (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/29/22995?source=see_link\">",
"     see \"Flurbiprofen (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/61/42962?source=see_link\">",
"     see \"Flurbiprofen (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8101431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ocufen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691299",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used during eye surgery.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702149",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to flurbiprofen or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4022144",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you had surgery on both eyes your doctor may order 2 eye drop bottles. One for each eye. Make sure you do not mix the 2 bottles up.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11686 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-DF771C1915-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38963=[""].join("\n");
var outline_f38_3_38963=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8101431\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031126\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031125\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031130\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031131\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031133\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031128\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031129\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031134\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031135\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/29/22995?source=related_link\">",
"      Flurbiprofen (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/61/42962?source=related_link\">",
"      Flurbiprofen (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/19/30008?source=related_link\">",
"      Flurbiprofen (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/35/36405?source=related_link\">",
"      Flurbiprofen (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/46/7911?source=related_link\">",
"      Flurbiprofen (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38964="Occult SUI flowchart";
var content_f38_3_38964=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 645px\">",
"   <div class=\"ttl\">",
"    Risk of developing postoperative stress urinary incontinence in women undergoing surgery for pelvic organ prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 625px; height: 772px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SUP: suburethral plication; TVT: tension-free vaginal tape; RPU: retropubic urethropexy; NS: needle suspension; PS: pubovaginal sling; %: percent.",
"     <br/>",
"     * Symptoms recorded per patient report.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Denotes abdominal procedures, all other procedures were performed vaginally.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38964=[""].join("\n");
var outline_f38_3_38964=null;
var title_f38_3_38965="Meningococcal polysaccharide vaccine: Drug information";
var content_f38_3_38965=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Meningococcal polysaccharide vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?11/38/11873?source=see_link\">",
"    see \"Meningococcal polysaccharide vaccine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/24/16773?source=see_link\">",
"    see \"Meningococcal polysaccharide vaccine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Menomune&reg;-A/C/Y/W-135",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F12592967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Menomune&reg;-A/C/Y/W-135",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F192543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Bacterial)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F192532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Immunization:",
"     </b>",
"     SubQ: 0.5 mL/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      ACIP recommendations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adults &le;55 years: 0.5 mL/dose; however, use is not generally recommended; meningococcal conjugate vaccine (MCV4) is preferred (CDC, 2011); If MCV4 is unavailable, meningococcal polysaccharide vaccine (MPSV4) is an acceptable alternative (CDC, 2005). Persons at prolonged increased risk for meningococcal disease should be revaccinated with MCV4 (CDC, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Adults &gt;55 years: 0.5 mL/dose (MPSV4 preferred in this population) (CDC, 2005)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F192539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/24/16773?source=see_link\">",
"      see \"Meningococcal polysaccharide vaccine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Immunization:",
"     </b>",
"     SubQ:",
"     <i>",
"      ACIP recommendations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Children &lt;2 years: Not usually recommended. Two doses (0.5 mL/dose), 3 months apart, may be considered in children 3-18 months to elicit short-term protection against serogroup A disease. A single dose may be considered in children 19-23 months (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;2 years: 0.5 mL/dose; however, use is not generally recommended; meningococcal conjugate vaccine (MCV4) is preferred (CDC, 2011); If MCV4 is unavailable, meningococcal polysaccharide vaccine (MPSV4) is an acceptable alternative (CDC, 2005) Persons at prolonged increased risk for meningococcal disease should be revaccinated with MCV4 (CDC, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F192533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16317920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16317921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F192514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution [MPSV4]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Menomune&reg;-A/C/Y/W-135: 50 mcg each of polysaccharide antigen groups A, C, Y, and W-135 per 0.5 mL dose [contains lactose 2.5-5 mg/0.5 mL, natural rubber/natural latex in packaging, thimerosal in diluent for multidose vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F192501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F192517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer by SubQ injection to the deltoid region; do not administer intradermally, I.M., or I.V.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &ge;1 vaccine on the same day at different anatomic sites. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC,  2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F192515\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Provide active immunity to meningococcal serogroups contained in the vaccine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for persons at increased risk for meningococcal disease. Meningococcal conjugate vaccine (MCV4) is preferred for persons aged 2-55 years; meningococcal polysaccharide vaccine (MPSV4) is preferred in adults &ge;56 years of age (CDC, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Persons at increased risk include:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Previously unvaccinated college freshmen living in dormitories",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Microbiologists routinely exposed to isolates of",
"     <i>",
"      N. meningitidis",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Military recruits",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Persons traveling to or who reside in countries where",
"     <i>",
"      N. meningitidis",
"     </i>",
"     is hyperendemic or epidemic, particularly if contact with local population will be prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Persons with persistent complement component deficiencies (eg, C5-C9, properidin, factor H, or factor D)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Persons with anatomic or functional asplenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     &bull; Persons with HIV infection",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Use is also recommended during meningococcal outbreaks caused by vaccine preventable serogroups.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F3343700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issue:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Menomune&reg; (MPSV4) should be administered by subcutaneous (SubQ) injection. Menactra&reg; (MCV4), also a meningococcal polysaccharide vaccine, is to be administered by intramuscular (I.M.) injection only.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F192541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"     In Canada, adverse reactions may be reported to local provincial/territorial health agencies or to the Vaccine Safety Section at Public Health Agency of Canada (1-866-844-0018).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (29% to 42%), fatigue (25% to 32%), malaise (17% to 22%), irritability (12%), drowsiness (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (10% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site: Pain (26% to 48%), redness (6% to 16%), induration (4% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (5% to 16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills (4% to 6%), fever (&le;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia (8% to 10%), vomiting (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site: Swelling (3% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Dizziness, Guillain-Barr&eacute; syndrome,  hypersensitivity (angioedema, dyspnea, pruritus,  rash, urticaria), myalgia, nausea, paresthesia, vasovagal syncope, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F192520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F192505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute illness: May consider deferring administration in patients with moderate or severe acute illness (with or without fever); may administer to patients with mild acute illness (with or without fever).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Meningococcal infections: Not to be used to treat meningococcal infections or to provide immunity against",
"     <i>",
"      N. meningitidis",
"     </i>",
"     serogroup B.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vaccines: In order to maximize vaccination rates, the ACIP recommends simultaneous administration of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single clinic visit, unless contraindications exist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered immunocompetence: Use with caution in severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy [including high-dose corticosteroids]); may have a reduced response to vaccination. In general, household and close contacts of persons with altered immunocompetence may receive all age appropriate vaccines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Packaging may contain natural latex rubber.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thimerosal: Some dosage forms contain thimerosal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F192509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F192511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F192523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. Inactivated bacterial vaccines have not been shown to cause increased risks to the fetus (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F192534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12602100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inactivated vaccines do not affect the safety of breast-feeding for the mother or the infant. Breast-feeding infants should be vaccinated according to the recommended schedules (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6871803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F192504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induces the formation of bactericidal antibodies to meningococcal antigens; the presence of these antibodies is strongly correlated with immunity to meningococcal disease caused by",
"     <i>",
"      Neisseria meningitidis",
"     </i>",
"     groups A, C, Y and W-135.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F192519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Antibody levels: 7-10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Antibodies against group A and C polysaccharides decline markedly (to prevaccination levels) over the first 3 years following a single dose of vaccine, especially in children &lt;4 years of age",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC), &ldquo;Report From the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years With Quadrivalent Meningococcal Conjugate Vaccine (MCV4),&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 57(17):462-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/18451758/pubmed\" id=\"18451758\" target=\"_blank\">",
"        18451758",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention,&ldquo;Prevention and Control of Meningococcal Disease Recommendations of the Advisory Committee on Immunization Practices (ACIP),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2005, 54(RR-7):1-21. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5407.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/pdf/rr/rr5407.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Syncope After Vaccination - United States, January 2005-July 2007,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 57(17):457-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/18451756/pubmed\" id=\"18451756\" target=\"_blank\">",
"        18451756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Updated Recommendations for Use of Meningococcal Conjugate Vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      . 2011, 60(3):72-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/21270745/pubmed\" id=\"21270745\" target=\"_blank\">",
"        21270745",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control, &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 55(RR-15):1-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/17136024/pubmed\" id=\"17136024\" target=\"_blank\">",
"        17136024",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2009, 58(37);1042-43. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5837a4.htm?s_cid=mm5837a4_e\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5837a4.htm?s_cid=mm5837a4_e",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38965/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9606 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-537ACF1ECA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38965=[""].join("\n");
var outline_f38_3_38965=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192529\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12592967\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192543\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192532\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192539\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192533\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317920\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317921\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192514\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192501\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192517\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192515\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3343700\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192541\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192520\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192505\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299663\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192509\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192511\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192523\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192534\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12602100\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6871803\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192504\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192519\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9606\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9606|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?11/38/11873?source=related_link\">",
"      Meningococcal polysaccharide vaccine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/24/16773?source=related_link\">",
"      Meningococcal polysaccharide vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38966="Supracristal VSD short axis 2D and color still frame";
var content_f38_3_38966=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    Supracristal VSD short axis 2D and color still frame",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Paired short axis images showing a moderately large supracristal VSD (arrow) located just proximal to the pulmonary valve and more distant from the tricuspid valve apparatus than is seen for membranous defects. The right hand panel shows the color flow jet exiting the left ventricular outflow tract and entering the right ventricle.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; TV: tricuspid valve; LVOT: left ventricular outflow tract; PV: pulmonary valve; RA: right atrium; LA: left atrium; arrow: VSD.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38966=[""].join("\n");
var outline_f38_3_38966=null;
var title_f38_3_38967="Azathioprine: Drug information";
var content_f38_3_38967=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Azathioprine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/31/28149?source=see_link\">",
"    see \"Azathioprine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/10/2216?source=see_link\">",
"    see \"Azathioprine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F138216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Azasan&reg;;",
"     </li>",
"     <li>",
"      Imuran&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F138217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Azathioprine&reg;;",
"     </li>",
"     <li>",
"      Imuran&reg;;",
"     </li>",
"     <li>",
"      Mylan-Azathioprine;",
"     </li>",
"     <li>",
"      Teva-Azathioprine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F138263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Immunosuppressant Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F138221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients with intermediate TPMT activity may be at risk for increased myelosuppression; those with low or absent TPMT activity receiving conventional azathioprine doses are at risk for developing severe, life-threatening myelotoxicity. Dosage reductions are recommended for patients with reduced TPMT activity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      I.V. dose is equivalent to oral dose",
"     </b>",
"     (dosing should be transitioned from I.V. to oral as soon as tolerated):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      Renal transplantation (treatment usually started the day of transplant, however, has been initiated [rarely] 1-3 days prior to transplant):",
"     </b>",
"     Oral, I.V.: Initial: 3-5 mg/kg/day usually given as a single daily dose, then 1-3 mg/kg/day maintenance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Rheumatoid arthritis:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Initial: 1 mg/kg/day (50-100 mg) given once daily or divided twice daily for 6-8 weeks; may increase by 0.5 mg/kg every 4 weeks until response or up to 2.5 mg/kg/day; an adequate trial should be a minimum of 12 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maintenance dose: Reduce dose by 0.5 mg/kg (~25 mg daily) every 4 weeks until lowest effective dose is reached; optimum duration of therapy not specified; may be discontinued abruptly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Crohn&rsquo;s disease, remission maintenance or reduction of steroid use (unlabeled use):",
"     </b>",
"     Oral: 2-3 mg/kg/day (Lichtenstein, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dermatomyositis/polymyositis, adjunctive management (unlabeled use):",
"     </b>",
"     Oral: 50 mg/day in conjunction with prednisone; increase by 50 mg/week to total dose of 2-3 mg/kg/day (Briemberg, 2003);",
"     <b>",
"      Note:",
"     </b>",
"     Onset of beneficial effects may take 3-6 months; however, may be preferred over methotrexate in patients with pulmonary or hepatic toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Immune (idiopathic) thrombocytopenic purpura, chronic refractory (unlabeled use):",
"     </b>",
"     Oral: Maintenance: 100-200 mg/day (Boruchov, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lupus nephritis, maintenance (unlabeled use):",
"     </b>",
"     Oral: Initial: 2 mg/kg/day; may reduce to 1.5 mg/kg/day after 1 month (if proteinuria &lt;1 g/day and serum creatinine stable) (Moroni, 2006)",
"     <b>",
"      or",
"     </b>",
"     target dose: 2 mg/kg/day (Hahn, 2012; Houssiau, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ulcerative colitis, remission maintenance or reduction of steroid use (unlabeled use):",
"     </b>",
"     Oral: 1.5-2.5 mg/kg/day (Kornbluth, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for concomitant use with allopurinol:",
"     </b>",
"     Reduce azathioprine dose to one-third or one-fourth the usual dose when used concurrently with allopurinol. Patients with low or absent TPMT activity may require further dose reductions or discontinuation.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F138222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F138223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; however, the following adjustments have been recommended (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No adjustment recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer 75% of normal dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer 50% of normal dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hemodialysis (dialyzable; ~45% removed in 8 hours): Administer 50% of normal dose; supplement: 0.25 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     CRRT: Administer 75% of normal dose",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15673236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F6730683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rapid WBC count decrease, persistently low WBC count, or serious infection: Reduce dose or temporarily withhold treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Severe toxicity in renal transplantation: May require discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease): Permanently discontinue.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F138195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Azasan&reg;: 75 mg, 100 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Imuran&reg;: 50 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F138180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F138198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Azathioprine can be administered IVP over 5 minutes at a concentration not to exceed 10 mg/mL",
"     <b>",
"      or",
"     </b>",
"     diluted and given as an intermittent infusion usually over 30-60 minutes or as an extended infusion over up to 8 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Administering tablets after meals or in divided doses may decrease adverse GI events.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F138269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS. Stable in neutral or acid solutions, but is hydrolyzed to mercaptopurine in alkaline solutions.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F138197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive therapy in prevention of rejection of kidney transplants; management of active rheumatoid arthritis (RA)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F138260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct in prevention of rejection of solid organ (nonrenal) transplants; remission maintenance or reduction of steroid use in Crohn&rsquo;s disease (CD) and in ulcerative colitis (UC); dermatomyositis/polymyositis; erythema multiforme; pemphigus vulgaris, lupus nephritis (maintenance), chronic refractory immune (idiopathic) thrombocytopenic purpura, relapsed/remitting multiple sclerosis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F138271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       AzaTHIOprine may be confused with azaCITIDine, azidothymidine, azithromycin, Azulfidine&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Imuran&reg; may be confused with Elmiron&reg;, Enduron, Imdur&reg;, Inderal&reg;, Tenormin&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Azathioprine is metabolized to mercaptopurine; concurrent use of these commercially-available products has resulted in profound myelosuppression.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F138261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined; dependent upon dose, duration, indication, and concomitant therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Fever, malaise",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Nausea/vomiting (RA 12%), diarrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Leukopenia (renal transplant &gt;50%; RA 28%), thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hepatic: Alkaline phosphatase increased, bilirubin increased, hepatotoxicity, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Infection (renal transplant 20%; RA &lt;1%; includes bacterial, fungal, protozoal, viral), neoplasia (renal transplant 3% [other than lymphoma], 0.5% [lymphoma])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Postmarketing and/or case reports: Abdominal pain, alopecia, anemia, arthralgia, bleeding, bone marrow suppression, fever, hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease), hepatosplenic T-cell lymphoma, hypersensitivity, hypotension, interstitial pneumonitis, lymphoma, macrocytic anemia, negative nitrogen balance, pancreatitis, pancytopenia, rash, skin cancer, steatorrhea, Sweet&rsquo;s syndrome (acute febrile neutrophilic dermatosis)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F138202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to azathioprine or any component of the formulation; pregnancy (in patients with rheumatoid arthritis); patients with rheumatoid arthritis and a history of treatment with alkylating agents (eg, cyclophosphamide, chlorambucil, melphalan) may have a prohibitive risk of neoplasia with azathioprine treatment",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F138184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal toxicity: Severe nausea, vomiting, diarrhea, rash, fever, malaise, myalgia, hypotension, and liver enzyme abnormalities may occur within the first several weeks of treatment and are generally reversible upon discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic toxicity: Dose-related hematologic toxicities (leukopenia, thrombocytopenia, and anemias, including macrocytic anemia or pancytopenia) may occur; delayed toxicities may also occur. May be more severe with renal transplants undergoing rejection and in patients with thiopurine methyltransferase (TPMT) deficiency; monitor hematologic function closely. May require dosage modification.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: Hepatotoxicity (transaminase, bilirubin, and alkaline phosphatase elevations) may occur, usually in renal transplant patients. Usually occurs within 6 months of transplant and is normally reversible with discontinuation. Monitor liver function periodically. Rarely, hepatic sinusoidal obstruction syndrome (SOS; formerly called veno-occlusive disease [VOD]) has been reported; discontinue if hepatic SOS is suspected.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infections: Chronic immunosuppression increases the risk of  serious infections; may require dosage reduction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Malignancy:",
"     <b>",
"      [U.S. Boxed Warning]: Immunosuppressive agents, including azathioprine, are associated with the development of lymphoma and other malignancies,",
"     </b>",
"     especially of the skin. Hepatosplenic T-Cell Lymphoma (HSTCL), a rare white blood cell cancer that is usually fatal, has predominantly occurred in adolescents and young adults treated for Crohn's disease or ulcerative colitis and receiving TNF blockers (eg, adalimumab, certolizumab pegol, etanercept, golimumab), azathioprine, and/or mercaptopurine. Most cases have occurred in patients treated with a combination of immunosuppressant agents, although there have been reports of HSTCL in patients receiving azathioprine or mercaptopurine monotherapy. Renal transplant patients are also at increased risk for malignancy (eg, skin cancer, lymphoma); limit sun and ultraviolet light exposure and use appropriate sun protection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dosage reductions may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; TPMT deficiency: Patients with genetic deficiency of TPMT may be sensitive to myelosuppressive effects. Patients with intermediate TPMT activity may be at risk for increased myelosuppression; those with low or absent TPMT activity are at risk for developing severe and life-threatening hematologic toxicity. TPMT genotyping or phenotyping may assist in identifying patients at risk for developing toxicity. Consider TPMT testing in patients with abnormally low CBC unresponsive to dose reduction. TPMT testing does not substitute for CBC monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mercaptopurine: Azathioprine is metabolized to mercaptopurine; concomitant use may result in profound myelosuppression and should be avoided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; TPMT or xanthine oxidase inhibitors: Patients on concurrent therapy with drugs which may inhibit TPMT (eg, olsalazine) or xanthine oxidase (eg, allopurinol) may be sensitive to myelosuppressive effects. Dose adjustment of azathioprine may be recommended when used concurrently with allopurinol; patients with low or absent TPMT activity may require further dose reductions or discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vaccines: Immune response to vaccines may be diminished.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Special handling:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician:",
"     <b>",
"      [U.S. Boxed Warning]: Should be prescribed by physicians familiar with the risks, including hematologic toxicities and mutagenic potential.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F138189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     5-ASA Derivatives: May decrease the metabolism of Thiopurine Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: May enhance the myelosuppressive effect of AzaTHIOprine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: May decrease the metabolism of AzaTHIOprine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Febuxostat: May increase the serum concentration of AzaTHIOprine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mercaptopurine: AzaTHIOprine may enhance the myelosuppressive effect of Mercaptopurine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ribavirin: May increase serum concentrations of the active metabolite(s) of AzaTHIOprine. Specifically, concentrations of potentially myelotoxic methylated metabolites may be increased, while concentrations of active 6-thioguanine nucleotides may be decreased. Management: Consider using alternative agent(s) when possible.  When these drugs are used in combination, monitor patients extra closely for signs/symptoms of myelosuppression.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfamethoxazole: May enhance the myelosuppressive effect of AzaTHIOprine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: May enhance the myelosuppressive effect of AzaTHIOprine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): AzaTHIOprine may enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): AzaTHIOprine may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F138213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herb/Nutraceutical: Avoid cat's claw, echinacea (have immunostimulant properties).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F138191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1620142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Azathioprine was found to be teratogenic in animal studies; temporary depression in spermatogenesis and reduction in sperm viability and sperm count were also reported in mice. Azathioprine crosses the placenta in humans; congenital anomalies, immunosuppression, hematologic toxicities (lymphopenia, pancytopenia), and intrauterine growth retardation have been reported. There are no adequate and well-controlled studies in pregnant women. Azathioprine should not be used to treat rheumatoid arthritis during pregnancy. The potential benefit to the mother versus possible risk to the fetus should be considered when treating other disease states. Women of childbearing potential should avoid becoming pregnant during treatment.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The National Transplantation Pregnancy Registry (NTPR, Temple University) is a registry for pregnant women taking immunosuppressants following any solid organ transplant. The NTPR encourages reporting of all immunosuppressant exposures during pregnancy in transplant recipients at 877-955-6877.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F138227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F1620144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to risk of immunosuppression and serious adverse effects in the nursing infant, breast-feeding is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F138205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F138204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (AzaTHIOprine Sodium Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (1): $246.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Azasan Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 mg (100): $498.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $667.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (AzaTHIOprine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $131.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Imuran Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $757.64",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F138193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential and platelets (weekly during first month, twice monthly for months 2 and 3, then monthly; monitor more frequently with dosage modifications), total bilirubin, liver function tests, creatinine clearance, TPMT genotyping or phenotyping (consider TPMT testing in patients with abnormally low CBC unresponsive to dose reduction); monitor for symptoms of infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     For use as immunomodulatory therapy in CD or UC, monitor CBC with differential weekly for 1 month, then biweekly for 1 month, followed by monitoring every 1-2 months throughout the course of therapy; monitor more frequently if symptomatic. LFTs should be assessed every 3 months. Monitor for signs/symptoms of malignancy (eg, splenomegaly, hepatomegaly, abdominal pain, persistent fever, night sweats, weight loss).",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F138206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aza-Q (DE);",
"     </li>",
"     <li>",
"      Azadus (TH);",
"     </li>",
"     <li>",
"      Azafalk (DE);",
"     </li>",
"     <li>",
"      Azamun (AU, MY, NZ, TW);",
"     </li>",
"     <li>",
"      Azamune (GB);",
"     </li>",
"     <li>",
"      Azanin (JP);",
"     </li>",
"     <li>",
"      Azapin (AU);",
"     </li>",
"     <li>",
"      Azapress (ZA);",
"     </li>",
"     <li>",
"      Azaprine (KP);",
"     </li>",
"     <li>",
"      Azarekhexal (EE);",
"     </li>",
"     <li>",
"      Azarex (DE);",
"     </li>",
"     <li>",
"      Azathiodura (DE);",
"     </li>",
"     <li>",
"      Azatioprina (PE);",
"     </li>",
"     <li>",
"      Azatioprina Wellcome (IT);",
"     </li>",
"     <li>",
"      Azatrilem (MX);",
"     </li>",
"     <li>",
"      Azopi (IL);",
"     </li>",
"     <li>",
"      Azoran (IN);",
"     </li>",
"     <li>",
"      Colinsan (DE);",
"     </li>",
"     <li>",
"      Imunen (BR);",
"     </li>",
"     <li>",
"      Imuprin (AE, BB, BF, BH, BJ, BM, BS, BZ, CI, CY, EG, ET, FI, GH, GM, GN, GY, HK, IQ, IR, JM, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, PR, QA, SA, SC, SD, SL, SN, SR, SY, TH, TN, TT, TW, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Imuprine (NZ);",
"     </li>",
"     <li>",
"      Imuran (AE, AR, AU, BB, BD, BE, BF, BG, BH, BJ, BM, BR, BS, BZ, CI, CL, CN, CO, CY, CZ, EC, EE, EG, ET, GB, GH, GM, GN, GR, GY, HK, HN, HR, HU, ID, IE, IL, IN, IQ, IR, JM, JO, JP, KE, KP, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, NZ, OM, PH, PK, PL, PT, PY, QA, RU, SA, SC, SD, SG, SL, SN, SR, SY, TH, TN, TR, TT, TW, TZ, UG, UY, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Imurek (AT, CH, DE);",
"     </li>",
"     <li>",
"      Imurel (DK, ES, FI, FR, NO, SE);",
"     </li>",
"     <li>",
"      Thioprine (AU);",
"     </li>",
"     <li>",
"      Transimune (IN);",
"     </li>",
"     <li>",
"      Zaprine (ZA);",
"     </li>",
"     <li>",
"      Zytrim (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F138183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Azathioprine is an imidazolyl derivative of mercaptopurine; antagonizes purine metabolism and may inhibit synthesis of DNA, RNA, and proteins; may also interfere with cellular metabolism and inhibit mitosis. The 6-thioguanine nucleotides appear to mediate the majority of azathioprine&rsquo;s immunosuppressive and toxic effects.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F138201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses placenta",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: ~30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, to 6-mercaptopurine, possibly by glutathione S-transferase (GST). Further metabolism of 6-mercaptopurine (in the liver and GI tract), via three major pathways: Hypoxanthine guanine phosphoribosyltransferase (to active metabolites: 6-thioguanine-nucleotides, or 6-TGNs), xanthine oxidase (to inactive metabolite: 6-thiouric acid), and thiopurine methyltransferase (TPMT) (to inactive metabolite: 6-methylmercaptopurine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Parent drug: 12 minutes; mercaptopurine: 0.7-3 hours; End-stage renal disease: Slightly prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Oral: 1-2 hours (including metabolites)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (primarily as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Rheumatology Ad Hoc Committee on Clinical Guidelines, &ldquo;Guidelines for Monitoring Drug Therapy in Rheumatoid Arthritis,&rdquo;",
"      <i>",
"       Arthritis Rheum",
"      </i>",
"      , 1996, 39(5):723-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/8639168/pubmed\" id=\"8639168\" target=\"_blank\">",
"        8639168",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anstey AV, Wakelin S, and Reynolds NJ, &ldquo;Guidelines for Prescribing Azathioprine in Dermatology,&rdquo;",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 2004, 151(6):1123-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/15606506/pubmed\" id=\"15606506\" target=\"_blank\">",
"        15606506",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Arnold DM, Nazi I, Santos A, et al, &ldquo;Combination Immunosuppressant Therapy for Patients With Chronic Refractory Immune Thrombocytopenic Purpura,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2010, 115(1):29-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/19897578/pubmed\" id=\"19897578\" target=\"_blank\">",
"        19897578",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 97, 177.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baum D, Bernstein D, Starnes VA, et al, &ldquo;Pediatric Heart Transplantation at Stanford: Results of a 15-Year Experience,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1991, 88(2):203-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/1861916/pubmed\" id=\"1861916\" target=\"_blank\">",
"        1861916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Beissert S, Werfel T, Frieling U, et al, \"A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus,\"",
"      <i>",
"       Arch Dermatol",
"      </i>",
"      , 2006, 142(11):1447-54.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/17116835/pubmed\" id=\"17116835\" target=\"_blank\">",
"        17116835",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boruchov DM, Gururangan S, Driscoll MC, et al, &ldquo;Multiagent Induction and Maintenance Therapy for Patients With Refractory Immune Thrombocytopenic Purpura (ITP),&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2007, 110(10):3526-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/17698634/pubmed\" id=\"17698634\" target=\"_blank\">",
"        17698634",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Briemberg HR and Amato AA, &ldquo;Dermatomyositis and Polymyositis,&rdquo;",
"      <i>",
"       Curr Treat Options Neurol",
"      </i>",
"      , 2003, 5(5):349-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/12895397/pubmed\" id=\"12895397\" target=\"_blank\">",
"        12895397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brookes MJ and Green JR, &ldquo;Maintenance of Remission in Crohn's Disease: Current and Emerging Therapeutic Options,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 2004, 64(10):1069-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/15139787/pubmed\" id=\"15139787\" target=\"_blank\">",
"        15139787",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cheble JM, Gaburri PD, De Souza AF, et al, &ldquo;Long-Term Results With Azathioprine Therapy in Patients With Corticosteroid-Dependent Crohn's Disease: Open-Label Prospective Study,&rdquo;",
"      <i>",
"       J Gastroenterol Hepatol",
"      </i>",
"      , 2007, 22(2):268-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/17295882/pubmed\" id=\"17295882\" target=\"_blank\">",
"        17295882",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hahn BH, McMahon MA, Wilkinson A, et al, \"American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis,\"",
"      <i>",
"       Arthritis Care Res (Hoboken)",
"      </i>",
"      , 2012, 64(6):797-808.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/22556106/pubmed\" id=\"22556106\" target=\"_blank\">",
"        22556106",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Houssiau FA, D'Cruz D, Sangle S, &ldquo;Azathioprine versus Mycophenolate Mofetil for Long-Term Immunosuppression in Lupus Nephritis: Results from the MAINTAIN Nephritis Trial,&rdquo;",
"      <i>",
"       Ann Rheum Dis",
"      </i>",
"      , 2010, 69(12):2083-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/20833738/pubmed\" id=\"20833738\" target=\"_blank\">",
"        20833738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Johnson CA and Porter WA, &ldquo;Compatibility of Azathioprine Sodium With Intravenous Fluids,&rdquo;",
"      <i>",
"       Am J Hosp Pharm",
"      </i>",
"      , 1981, 38(6):871-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/7246562/pubmed\" id=\"7246562\" target=\"_blank\">",
"        7246562",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jones RR, \"Azathioprine Therapy in the Management of Persistent Erythema Multiforme,\"",
"      <i>",
"       Br J Dermatol",
"      </i>",
"      , 1981, 105(4):465-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/7295560/pubmed\" id=\"7295560\" target=\"_blank\">",
"        7295560",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kornbluth A and Sachar DB, &ldquo;Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2010, 105(3):501-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/20068560/pubmed\" id=\"20068560\" target=\"_blank\">",
"        20068560",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lichtenstein GR, Abreu MT, Cohen R, et al, &ldquo;American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      ,  2006, 130(3):935-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/16530531/pubmed\" id=\"16530531\" target=\"_blank\">",
"        16530531",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lichtenstein GR, Hanauer SB, and Sandborn WJ, &ldquo;Management of Crohn's Disease in Adults,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2009, 104(2):465-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/19174807/pubmed\" id=\"19174807\" target=\"_blank\">",
"        19174807",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Matalon ST, Ornoy A, and Lishner M, et al, &ldquo;Review of the \Potential Effects of Three Commonly Used Antineoplastic and Immunosuppressive Drugs (Cyclophosphamide, Azathioprine, Doxorubicin on the Embryo and Placenta),&rdquo;",
"      <i>",
"       Reprod Toxicol",
"      </i>",
"      , 2004,  18(2):219-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/15019720/pubmed\" id=\"15019720\" target=\"_blank\">",
"        15019720",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moroni G, Doria A, Mosca M, et al, &ldquo;A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis Over Four Years,&rdquo;",
"      <i>",
"       Clin J Am Soc Nephrol",
"      </i>",
"      , 2006, 1(5):925-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/17699309/pubmed\" id=\"17699309\" target=\"_blank\">",
"        17699309",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Parakkal D, Sifuentes H, Semer R, et al, &ldquo;Hepatosplenic T-Cell Lymphoma in Patients Receiving TNF-&alpha; Inhibitor Therapy: Expanding the Groups at Risk,&rdquo;",
"      <i>",
"       Eur J Gastroenterol Hepatol",
"      </i>",
"      , 2011, 23(12):1150-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/21941193/pubmed\" id=\"21941193\" target=\"_blank\">",
"        21941193",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Petri M, &ldquo;Immunosuppressive Drug Use in Pregnancy,&rdquo;",
"      <i>",
"       Autoimmunity",
"      </i>",
"      , 2003, 36(1):51-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/12765471/pubmed\" id=\"12765471\" target=\"_blank\">",
"        12765471",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sandborn WJ, &ldquo;A Review of Immune Modifier Therapy for Inflammatory Bowel Disease: Azathioprine, 6-mercaptopurine, Cyclosporine, and Methotrexate,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 1996, 91(3):423-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/8633486/pubmed\" id=\"8633486\" target=\"_blank\">",
"        8633486",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simon L, Lipman AG, Jacox A, et al, &ldquo;Guideline for the Management of Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis Pain,&rdquo; 2nd ed, Glenview IL, American Pain Society, 2002.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wiendl H, Toyka KV, Rieckmann P, et al, &ldquo;Basic and Escalating Immunomodulatory Treatments in Multiple Sclerosis: Current Therapeutic Recommendations,&rdquo;",
"      <i>",
"       J Neurol",
"      </i>",
"      , 2008, 255(10):1449-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/3/38967/abstract-text/19005625/pubmed\" id=\"19005625\" target=\"_blank\">",
"        19005625",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9026 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-9E6425AB09-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38967=[""].join("\n");
var outline_f38_3_38967=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708623\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138216\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138217\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138263\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138221\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138222\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138223\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15673236\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6730683\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138195\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138180\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138198\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138269\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138197\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138260\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138271\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138261\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138202\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138184\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298801\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138189\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138213\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138191\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1620142\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138227\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1620144\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138205\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138204\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138193\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138206\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138183\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138201\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9026\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9026|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/31/28149?source=related_link\">",
"      Azathioprine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/10/2216?source=related_link\">",
"      Azathioprine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38968="Viral encephalitis in adults";
var content_f38_3_38968=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Viral encephalitis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     R Paul Johnson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Stephen J Gluckman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38968/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/3/38968/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral infections of the central nervous system (CNS) result in the clinical syndromes of aseptic meningitis or encephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The true incidence of these infections is difficult to determine because the diagnosis may not be considered, many cases are unreported, or a specific viral etiology is never confirmed. However, these disorders occur with sufficient frequency that physicians should be familiar with the clinical manifestations, diagnostic techniques, and therapeutic options [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, the clinical syndromes and results of routine laboratory tests are typically nonspecific. Thus, other infectious and noninfectious causes must be entertained when evaluating such patients, particularly those disorders that are treatable.",
"   </p>",
"   <p>",
"    The major distinguishing features of aseptic meningitis and viral encephalitis will be reviewed here. The clinical manifestations, diagnosis, and pathogens associated with aseptic meningitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Detailed information regarding various pathogens that cause encephalitis, like herpes simplex virus, is found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=see_link\">",
"     \"Herpes simplex virus type 1 encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/1/25622?source=see_link\">",
"     \"Nipah and Hendra viral encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=see_link\">",
"     \"St. Louis encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5208?source=see_link\">",
"     \"Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link\">",
"     \"Arthropod-borne encephalitides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MENINGITIS VERSUS ENCEPHALITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence or absence of normal brain function is the important distinguishing feature between encephalitis and meningitis. Patients with meningitis may be uncomfortable, lethargic, or distracted by headache, but their cerebral function remains normal. In encephalitis, however, abnormalities in brain function are expected, including altered mental status, motor or sensory deficits, altered behavior and personality changes, and speech or movement disorders. Seizures and postictal states can be seen with meningitis alone and should not be construed as definitive evidence of encephalitis. Other neurologic manifestations of encephalitis may include hemiparesis, flaccid paralysis, and paresthesias.",
"   </p>",
"   <p>",
"    However, the distinction between the two entities is frequently blurred since some patients may have both a parenchymal and meningeal process with clinical features of both. The patient is usually labeled as having meningitis or encephalitis based upon which features predominate in the illness although meningoencephalitis is also a common term that recognizes the overlap. The importance of distinguishing between encephalitis and aseptic meningitis relates to the fact that the likely cause of each syndrome is different. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     VIRAL VERSUS POSTINFECTIOUS ENCEPHALITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral encephalitis can be either primary or postinfectious [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/5\">",
"     5",
"    </a>",
"    ]. Primary infection is characterized by viral invasion of the CNS. Neuronal involvement can be identified on histologic examination, which may also show inclusion bodies on light microscopy or viral particles on electron microscopy. The virus can often be cultured from brain tissue.",
"   </p>",
"   <p>",
"    By contrast, in postinfectious encephalitis (also called acute disseminated encephalomyelitis or ADEM), a virus cannot be detected or recovered and the neurons are spared [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/5\">",
"     5",
"    </a>",
"    ]. However, perivascular inflammation and demyelination are prominent in this entity. The inability to recover a virus and the type of histologic abnormalities observed suggest that postinfectious encephalitis is an immune-mediated disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the differences in pathogenesis and histologic findings, these two disorders are typically difficult to differentiate on clinical grounds. A number of viral infections, like measles, varicella, or rubella, can also produce either syndrome. The pace of the illness and associated symptoms provide the major clinical clues. Postinfectious encephalitis, in contrast to primary viral encephalitis, typically occurs either as the initial infection is resolving or may appear following a subclinical illness that was not appreciated by the patient. Magnetic resonance imaging during postinfectious encephalitis may demonstrate multifocal lesions mainly involving supratentorial white matter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/11/43192?source=see_link\">",
"     \"Clinical presentation and diagnosis of measles\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H4\">",
"     'Viral pathogens'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     VIRAL PATHOGENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide variety of different viruses can infect the CNS. Most viruses are capable of causing either meningitis or encephalitis, although in general, a given virus is more likely to cause one syndrome than the other. A subset of these viruses, including mumps, measles, varicella-zoster virus (VZV), rubella, and influenza have also been associated with postinfectious encephalitis.",
"   </p>",
"   <p>",
"    A common cause of sporadic encephalitis is herpes simplex virus type 1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/7\">",
"     7",
"    </a>",
"    ]. Other diagnostic considerations will depend on geographic location (eg, St. Louis encephalitis in North America and Japanese encephalitis in Asia) and epidemiologic clues such as exposure history (eg, bat exposure or dog bite and rabies), regional outbreaks (eg, enterovirus type 71 in Denver, Colorado) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/8\">",
"     8",
"    </a>",
"    ], and clinical clues such as profound weakness and rash with West Nile. Uncommon causes include varicella-zoster virus, Epstein-Barr virus, HIV, and human herpes virus-6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=see_link\">",
"     \"Herpes simplex virus type 1 encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=see_link\">",
"     \"St. Louis encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link\">",
"     \"Arthropod-borne encephalitides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Historical clues",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of viral encephalitis is apparent in some cases because of an unusual exposure history or a characteristic clinical presentation. In the absence of these findings, epidemiologic information such as seasonal occurrence or exposures may be helpful in establishing a specific diagnosis (",
"    <a class=\"graphic graphic_table graphicRef57784 \" href=\"mobipreview.htm?28/5/28763\">",
"     table 1",
"    </a>",
"    ). Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arboviruses (eastern equine, western equine, St. Louis, Venezuelan equine encephalitis, and West Nile virus) cause disease when mosquitoes are active, whereas herpes simplex virus can occur at any time. In contrast, walking in woods or marshy areas with high tick populations might suggest other viral encephalitides, such as Colorado tick fever (western United States) or non-viral etiologies, such as Lyme disease or Rocky Mountain spotted fever. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16088?source=see_link\">",
"       \"Epidemiology and pathogenesis of West Nile virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=see_link\">",
"       \"St. Louis encephalitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link\">",
"       \"Arthropod-borne encephalitides\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prior to the appearance of West Nile virus in 1999, arboviral infections were relatively infrequent in the United States. Since then WNV encephalitis has been by far the most commonly diagnosed arboviral infection of the CNS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/12\">",
"       12",
"      </a>",
"      ]. The incidence of arthropod-borne viruses (arboviruses) varies significantly based upon geographic region. St. Louis encephalitis virus infection occurs in North America, predominantly throughout the Midwest and South in the United States whereas West Nile virus infection occurs in multiple continents including Asia, Africa, Europe, and North America. In patients with the appropriate travel history, other non-viral mosquito-borne illnesses, such as cerebral malaria, may also be a consideration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=see_link\">",
"       \"St. Louis encephalitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=see_link\">",
"       \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5543?source=see_link\">",
"       \"Clinical manifestations of malaria\"",
"      </a>",
"      .) For the past several years, West Nile virus has been by far the most common cause of proven viral encephalitis in the United States [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Both geography and animal exposure can broaden the diagnostic considerations of etiologic agents. Nipah virus encephalitis, which appeared in Malaysia and Singapore, and is now present in Bangladesh, may be associated with exposure to pigs or bats [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/14-16\">",
"       14-16",
"      </a>",
"      ]. Avian influenza infection was associated with encephalitis in two patients from Vietnam; the source of exposure was unclear but both children swam in a canal that was frequented by ducks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/17\">",
"       17",
"      </a>",
"      ]. Lymphocytic choriomeningitis virus (LCMV) is a human acquired zoonosis caused by a rodent-borne arenavirus, which can be transmitted through exposure to secretions of mice, rats and hamsters. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/1/25622?source=see_link\">",
"       \"Nipah and Hendra viral encephalitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14090?source=see_link\">",
"       \"Epidemiology, transmission, and pathogenesis of avian influenza\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=see_link\">",
"       \"Aseptic meningitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prior history of an animal exposure or bite may also suggest the possibility of rabies encephalitis; however the absence of such a history does not eliminate the diagnostic possibility of rabies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rabies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with encephalitis have an altered mental status ranging from subtle deficits to complete unresponsiveness. Symptoms and signs of meningeal irritation (photophobia and nuchal rigidity) are usually absent with a pure encephalitis but often accompany a meningoencephalitis. Seizures are common with encephalitis, and focal neurologic abnormalities can occur, including hemiparesis, cranial nerve palsies, and exaggerated deep tendon",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pathologic reflexes. Patients may appear confused, agitated, or obtunded.",
"   </p>",
"   <p>",
"    The clinical presentation of aseptic meningitis is generally nonspecific, with fever, headache, nausea and vomiting, occasionally accompanied by photophobia and a stiff neck. Physical examination typically reveals signs of nuchal rigidity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clues on physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are usually no pathognomonic findings on the initial patient encounter, certain physical examination features may suggest a particular diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parotitis strongly suggests the diagnosis of mumps encephalitis in an unvaccinated patient with mental status changes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8154?source=see_link\">",
"       \"Epidemiology, clinical manifestations, diagnosis and management of mumps\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Flaccid paralysis that evolves into an encephalitis strongly suggests the possibility of West Nile virus infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/18\">",
"       18",
"      </a>",
"      ]. In fact, it has been misdiagnosed as Guillain-Barr&eacute; syndrome. A maculopapular rash is also seen in approximately half of patients with this infection and is not expected in other viral encephalitides.",
"     </li>",
"     <li>",
"      Tremors of the eyelids, tongue, lips, and extremities may suggest the possibility of St. Louis encephalitis or WN encephalitis in the appropriate geographic location or travel history.",
"     </li>",
"     <li>",
"      Findings of hydrophobia, aerophobia, pharyngeal spasms, and hyperactivity suggest encephalitic rabies. Atypical presentations of rabies include seizures, cranial nerve palsies, and myoclonus.",
"     </li>",
"     <li>",
"      Grouped vesicles in a dermatomal pattern may suggest varicella-zoster virus, which can occasionally cause encephalitis; however the absence of rash does not eliminate VZV from consideration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=see_link\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=see_link\">",
"     \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8154?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis and management of mumps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Results of imaging in patients with encephalitis may or may not demonstrate abnormal radiographic findings on CT or MRI modalities. CT scanning is useful to rule space-occupying lesions or brain abscess. MRI is sensitive for detecting demyelination, which may be seen in other clinical states presenting with mental status changes (eg. progressive multifocal leukoencephalopathy). If present, the location of abnormal signal can sometimes be suggestive of specific etiologies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Temporal lobe involvement is strongly suggestive of HSV encephalitis, although other herpes viruses (eg, VZV, EBV, human herpesvirus 6) can also produce this clinical picture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Involvement of the thalamus or basal ganglia may be observed in the setting of encephalitis due to respiratory viral infection, Creutzfeld-Jacob disease, arbovirus, and tuberculosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/22-24\">",
"       22-24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 17 patients with confirmed West Nile infection, MRI imaging demonstrated a variety of abnormalities in the basal ganglia, thalami, mesial temporal structures, brainstem and cerebellum in eight patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/25\">",
"       25",
"      </a>",
"      ]. Three patients with muscle weakness also had abnormalities noted in the spinal cord and cauda equina.",
"     </li>",
"     <li>",
"      The presence of hydrocephalus may suggest nonviral etiologies, such as bacteria, fungal, or parasitic agents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Electroencephalography is often abnormal in acute encephalitis. Focality in the temporal lobe region is suggestive of HSV encephalitis, as noted above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the cerebrospinal fluid (CSF), although not diagnostic, will usually confirm the presence of inflammatory disease of the CNS. The findings with aseptic meningitis and meningoencephalitis are generally indistinguishable (although rarely there may be few, if any, CSF abnormalities with a pure encephalitis).",
"   </p>",
"   <p>",
"    The following findings are characteristic of viral CNS infections (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased white blood cell (WBC) count, but usually less than",
"      <span class=\"nowrap\">",
"       250/mm3.",
"      </span>",
"      The differential shows a predominance of lymphocytes, although early infection may reveal a predominance of neutrophils. In the latter setting, a repeat CSF cell count eight hours later will generally show a shift from neutrophils to lymphocytes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Elevated protein concentration, but usually less than 150",
"      <span class=\"nowrap\">",
"       mg/dL.",
"      </span>",
"     </li>",
"     <li>",
"      Usually normal glucose concentration (&gt;50 percent of blood value), but moderately reduced values are occasionally seen with HSV, mumps, or some enteroviruses.",
"     </li>",
"     <li>",
"      Red cells are usually absent (in a nontraumatic tap); their presence in the appropriate clinical setting suggests HSV-1 infection or other necrotizing encephalitides [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings are generally quite different from those associated with bacterial meningitis, which include a higher WBC count in the CSF",
"    <span class=\"nowrap\">",
"     (&gt;2000/mm3)",
"    </span>",
"    with neutrophil predominance, a higher protein concentration (&gt;200",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    and usually hypoglycorrhachia (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, exclusion of bacterial meningitis based only upon individual CSF parameters can be difficult, since the spectrum of CSF values in bacterial meningitis is so wide that the absence of one of more of these findings is of little value (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"mobipreview.htm?13/55/14204\">",
"     table 2",
"    </a>",
"    ). This was illustrated in a review of 296 episodes of community-acquired bacterial meningitis; 50 percent had a CSF glucose above 40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    44 percent had a CSF protein below 200",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and 13 percent had a CSF white cell count below",
"    <span class=\"nowrap\">",
"     100/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\", section on 'CSF analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the California Encephalitis Project, more than 1500 patients with encephalitis were enrolled from 1998 through 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/21\">",
"     21",
"    </a>",
"    ]. A confirmed or probable etiologic agent was identified for only 16 percent of cases. Although the vast majority of patients did not have an established diagnosis, those presenting with diffuse cerebral edema or intractable seizures had a poor neurologic recovery and increased risk of mortality. In contrast, those with self-limited seizure activity had a rapid recovery. These data suggest that future studies, which group disorders by clinical profile, may help better estimate prognosis, even if the etiologic agent is unknown.",
"   </p>",
"   <p>",
"    Even with prompt initiation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    therapy, HSV encephalitis is associated with significant morbidity and mortality. An analysis of 236 patients with confirmed HSV-1 encephalitis in Sweden has demonstrated a one-year mortality of 14 percent, with epilepsy and neuropsychiatric sequelae occurring in 24 percent and 22 percent of surviving patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important initial diagnostic step in the patient with suspected viral encephalitis is analysis of the CSF. The opening CSF pressure should be noted and CSF should be analyzed for cell count, glucose, and protein. Specific diagnostic tests to consider include: polymerase chain reaction (PCR) tests for viruses, culture for bacteria, fungi and mycobacteria and serology for the arboviruses. However, even with use of polymerase chain reaction testing, the etiology in most cases remains undefined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most important viral etiology to rule out in a patient with encephalitis is HSV, since this clinical entity is usually fatal if untreated. HSV should be considered particularly if there is temporal lobe focality suggested by symptoms, signs or imaging studies. Diagnosis is most readily made by detecting HSV DNA by polymerase chain reaction on CSF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/31\">",
"     31",
"    </a>",
"    ]. While awaiting confirmation, empiric therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    should be initiated. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Empiric therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Enteroviruses are more commonly associated with viral meningitis, but infrequently they may cause encephalitis as well. PCR testing on the CSF sample is the diagnostic test of choice. The pathogen can also be cultured from the stool and throat; however, a positive stool or throat culture is not necessarily diagnostic of disease, especially in summer months.",
"   </p>",
"   <p>",
"    In summary, the battery of diagnostic tests often includes cerebrospinal fluid culture, polymerase chain reaction, and serology for the suspected pathogens. As noted below, other diagnostic etiologies for non-viral infectious and non-infectious etiologies should also be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral culture has been routinely ordered by most physicians after obtaining CSF samples. However, one review demonstrated that viruses were recovered from only 6 percent of 22,394 viral cultures of CSF samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/32\">",
"     32",
"    </a>",
"    ]. Furthermore, in a subset analysis by suspected etiology, 1290 CSF samples were evaluated for HSV by PCR and culture. Of these, only nine samples were positive for HSV and all were identified only by PCR testing.",
"   </p>",
"   <p>",
"    In most circumstances, PCR testing has replaced viral culture in the work-up of the CSF. Culture may still be important when rare causes of encephalitis are being considered (eg, influenza, parainfluenza, measles, mumps) for which PCR testing is unavailable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the advent of PCR technology, significant advances have been made in the ability to diagnose viral infections of the CNS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/33\">",
"     33",
"    </a>",
"    ]. CSF PCR should be performed for HSV-1, HSV-2, and enteroviruses. Identification of HSV-1 in the CSF is a rapid, sensitive, and specific diagnostic test for HSV-1 encephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/34\">",
"     34",
"    </a>",
"    ]. Likewise, identification of HSV-2 in CSF is a rapid diagnostic test for HSV-2 meningitis. PCR testing can also be requested for VZV and CMV in the appropriate settings. PCR testing for other viruses will depend on the clinical situation, epidemiology, and availability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=see_link\">",
"     \"PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is most important for patients who are not improving and who do not have a diagnosis based upon CSF analysis, culture, and PCR. Most viral etiologies require paired sera for diagnosis; thus it is prudent to save serum in the setting of acute illness that can later be used if necessary. Convalescent serology should be obtained no sooner than three weeks after the onset of the clinical illness. As an example, the presence of IgM antibodies in a single serum provides presumptive evidence of St. Louis encephalitis; however, a significant rise or fall between appropriately timed acute-convalescent or early-late convalescent sera is diagnostic.",
"   </p>",
"   <p>",
"    West Nile has emerged as the most common cause of viral encephalitis in the United States. A single specimen looking for IgM antibodies on the serum or CSF is sufficient for diagnosis. A single serum specimen can also be used to diagnose mumps. Serology may also be helpful in obtaining evidence for primary EBV infection, a rare cause of meningoencephalitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=see_link\">",
"     \"St. Louis encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=see_link\">",
"     \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Brain biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a last resort, brain biopsy can be considered in the patient if the etiology of encephalitis is still unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Definitive diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of identification of a specific agent in patients with aseptic meningitis and encephalitis has been variable and depends upon the population studied and the mode of testing. The following illustrates the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 432 high-risk patients who underwent brain biopsy of presumptive herpes simplex encephalitis, 45 percent had the diagnosis confirmed, 9 percent had another virus detected, and 9 percent had another treatable cause [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/28\">",
"       28",
"      </a>",
"      ]. This underscores the point that the clinical diagnosis of HSV encephalitis is often incorrect and needs to be confirmed by PCR testing.",
"     </li>",
"     <li>",
"      Among 334 patients with a case definition of encephalitis in the California Encephalitis Project, a confirmed or probable viral cause was present in 9 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/35\">",
"       35",
"      </a>",
"      ]. A possible cause was identified in 12 percent, a noninfectious etiology in 10 percent, and a bacterial cause in 3 percent. Despite extensive testing, 62 percent of cases were unexplained.",
"     </li>",
"     <li>",
"      In a series from the New York State Department of Health of 106 patients with presumed viral CNS infection seen in 1997 and 1998, polymerase chain reaction (PCR) testing revealed a viral cause in 38 (36 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/36\">",
"       36",
"      </a>",
"      ]. The rate of detection in earlier time periods before PCR testing was much lower (about 10 percent) employing cell culture and serologic testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a later, larger series of almost 3500 patients from the same laboratory, PCR identified a viral etiology in CSF or brain tissue in only 14 percent (498 patients); selection bias may have accounted for much of the difference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/37\">",
"     37",
"    </a>",
"    ]. The most common viral causes were enterovirus (72 percent), Herpes simplex (15 percent), varicella-zoster virus (6 percent), and West Nile virus (4 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of noninfectious etiologies can mimic CNS infections. These include intracranial tumors, collagen vascular disorders, vasculitis, neoplastic diseases, and adverse effects of medications (",
"    <a class=\"graphic graphic_table graphicRef77933 \" href=\"mobipreview.htm?16/7/16508\">",
"     table 3",
"    </a>",
"    ). Other non-viral infectious etiologies to consider in the patient with suspected CNS infection include brain abscess, syphilis, tuberculous meningitis, and fungal meningitis (eg, coccidioides), which can affect the sensorium. Knowledge of the patient's underlying immune status is critical since the differential diagnosis is even broader in immunocompromised hosts (eg, Toxoplasma encephalitis and cryptococcal meningitis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=see_link\">",
"     \"Toxoplasmosis in immunocompetent hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     EMPIRIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific therapies for most CNS viral infections. However, some important exceptions apply:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Empiric treatment for HSV-1 infection with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"       acyclovir",
"      </a>",
"      (10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV Q8h) should always be initiated as soon as possible if the patient has encephalitis without apparent explanation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/38\">",
"       38",
"      </a>",
"      ]. Early therapy is vital because it is associated with a significant decrease in mortality and morbidity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=see_link\">",
"       \"Herpes simplex virus type 1 encephalitis\"",
"      </a>",
"      .) Acyclovir should also be considered if VZV encephalitis is likely.",
"     </li>",
"     <li>",
"      Since a number of other treatable illnesses may present in a similar manner to viral CNS infections, consideration of alternative diagnoses, such as tuberculosis and drug-induced delirium, is essential (",
"      <a class=\"graphic graphic_table graphicRef77933 \" href=\"mobipreview.htm?16/7/16508\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A list of the major pathogens that produce the clinical syndrome of encephalitis along with suggested initial treatment appears in the table (",
"    <a class=\"graphic graphic_table graphicRef69990 \" href=\"mobipreview.htm?41/16/42253\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27776766\">",
"    <span class=\"h1\">",
"     INCREASED INTRACRANIAL PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms and signs of increased intracranial pressure include headache, vomiting, and a decreased level of consciousness. Information on the incidence or management of raised CSF pressure in patients with viral encephalitis is limited.",
"   </p>",
"   <p>",
"    All of the &ldquo;standard&rdquo; therapeutic interventions for lowering CSF pressure (eg, steroids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    ) have been used in this setting, but none have been shown to be of well-established benefit. Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    has been shown to reduce brain edema and improve neurologic outcomes in patients with pneumococcal meningitis, there are only limited retrospective data on the use of steroids in viral encephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/41\">",
"     41",
"    </a>",
"    ]; extrapolating these data to patients with viral encephalitis may not be valid. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/34/23080?source=see_link\">",
"     \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, serial intracranial pressure (ICP) monitoring should be part of the management of a patient with encephalitis with documented elevated ICP since this parameter has been associated with a negative prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/42\">",
"     42",
"    </a>",
"    ]. Relieving elevated ICP may decrease secondary brain injury while the patient is responding to anti-infective therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/43\">",
"     43",
"    </a>",
"    ]. Whether any of these interventions may have a positive impact on outcome has not been determined in prospective clinical trials.",
"   </p>",
"   <p>",
"    Various strategies to reduce intracranial pressure are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33402?source=see_link&amp;anchor=H19#H19\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\", section on 'General management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8547895\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies of viral encephalitis are focused on short-term outcomes.",
"   </p>",
"   <p>",
"    One prospective study in France examined 167 surviving patients with a history of encephalitis three years after enrollment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38968/abstract/44\">",
"     44",
"    </a>",
"    ]. Sixty-one percent survived without sequelae, while 18 percent were mildly impaired, 14 percent were severely impaired, and 1 percent remained in a vegetative state. The most frequent sequelae included difficulties in concentration, behavioral and speech disorders, and memory loss. One-quarter of those who were previously employed had not returned to work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/50/18209?source=see_link\">",
"       \"Patient information: Encephalitis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     General recommendations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with aseptic meningitis most commonly present with fever and headache with meningismus on examination. Patients may be lethargic but have a normal sensorium. By contrast, patients with encephalitis present with mental status changes. Patients with features of both may be considered to have a meningoencephalitis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Meningitis versus encephalitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viral encephalitis can be either primary or postinfectious, which are difficult to differentiate on clinical grounds. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Viral versus postinfectious encephalitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elicit a detailed sexual, travel, and exposure history (to both insects and animals). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Viral pathogens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carefully examine the patient for generalized rashes and focal neurologic findings. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obtain neuroimaging to assess the possibility of a localized process, such as an abscess, and to look for focality, which may suggest a specific etiology of encephalitis (eg, temporal lobe involvement and HSV-1). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CSF examination of patients with suspected meningitis or encephalitis is essential for diagnosis. A lymphocytic predominance is suggestive of a viral etiology; red blood cells in the absence of a traumatic tap is suggestive of HSV or other necrotizing viral encephalitides. The most important diagnostic consideration in patients with encephalitis is HSV since delay in treatment can impact morbidity and mortality. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cerebrospinal fluid findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Patients with suspected encephalitis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the patient with clinical encephalitis, we recommend diagnostic CSF PCR for HSV-1 and IgM antibody on CSF and serum for West Nile virus. Testing for other viral pathogens will depend on travel or exposure history to insects and animals. Serologic testing for West Nile virus, mumps, and Epstein-Barr virus can also be considered in the appropriate clinical setting. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the patient with encephalitis, we recommend rapid initiation of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/7/31856?source=see_link\">",
"       acyclovir",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      three times daily intravenously due to the high mortality associated with HSV encephalitis when treatment is delayed (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Empiric therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/1\">",
"      Whitley RJ. Viral encephalitis. N Engl J Med 1990; 323:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/2\">",
"      Connolly KJ, Hammer SM. The acute aseptic meningitis syndrome. Infect Dis Clin North Am 1990; 4:599.",
"     </a>",
"    </li>",
"    <li>",
"     Gluckman SJ, DiNubile MJ. Acute viral infections of the central nervous system. In: Emergent and Urgent Neurology, Weiner WJ (Ed), Lippincott, Philadelphia 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/4\">",
"      Tyler KL. Emerging viral infections of the central nervous system: part 1. Arch Neurol 2009; 66:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/5\">",
"      Johnson RT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987; 155:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/6\">",
"      Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J Infect 2009; 58:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/7\">",
"      Mailles A, Stahl JP, Steering Committee and Investigators Group. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis 2009; 49:1838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/8\">",
"      P&eacute;rez-V&eacute;lez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007; 45:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/9\">",
"      Torre D, Mancuso R, Ferrante P. Pathogenic mechanisms of meningitis/encephalitis caused by human herpesvirus-6 in immunocompetent adult patients. Clin Infect Dis 2005; 41:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/10\">",
"      Isaacson E, Glaser CA, Forghani B, et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005; 40:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/11\">",
"      Weinberg A, Li S, Palmer M, Tyler KL. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol 2002; 52:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/12\">",
"      Reimann CA, Hayes EB, DiGuiseppi C, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg 2008; 79:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/13\">",
"      McNabb SJ, Jajosky RA, Hall-Baker PA, et al. Summary of notifiable diseases--United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/14\">",
"      Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999; 354:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/15\">",
"      Paton NI, Leo YS, Zaki SR, et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 1999; 354:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/16\">",
"      Hsu VP, Hossain MJ, Parashar UD, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004; 10:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/17\">",
"      de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/18\">",
"      Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/19\">",
"      Koskiniemi M, Piiparinen H, Rantalaiho T, et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002; 25:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/20\">",
"      Wasay M, Mekan SF, Khelaeni B, et al. Extra temporal involvement in herpes simplex encephalitis. Eur J Neurol 2005; 12:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/21\">",
"      Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/22\">",
"      Lury KM, Castillo M. Eastern equine encephalitis: CT and MRI findings in one case. Emerg Radiol 2004; 11:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/23\">",
"      Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997; 336:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/24\">",
"      Beattie GC, Glaser CA, Sheriff H, et al. Encephalitis with thalamic and Basal Ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 2013; 56:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/25\">",
"      Petropoulou KA, Gordon SM, Prayson RA, Ruggierri PM. West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol 2005; 26:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/26\">",
"      Misra UK, Kalita J. Neurophysiological studies in herpes simplex encephalitis. Electromyogr Clin Neurophysiol 1998; 38:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/27\">",
"      Feigin RD, Shackelford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973; 289:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/28\">",
"      Whitley RJ, Cobbs CG, Alford CA Jr, et al. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA 1989; 262:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/29\">",
"      Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/30\">",
"      Hjalmarsson A, Blomqvist P, Sk&ouml;ldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 2007; 45:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/31\">",
"      Kupila L, Vuorinen T, Vainionp&auml;&auml; R, et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006; 66:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/32\">",
"      Polage CR, Petti CA. Assessment of the utility of viral culture of cerebrospinal fluid. Clin Infect Dis 2006; 43:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/33\">",
"      Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002; 359:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/34\">",
"      Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995; 171:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/35\">",
"      Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003; 36:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/36\">",
"      Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system. N Engl J Med 1999; 340:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/37\">",
"      Huang C, Morse D, Slater B, et al. Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses. Clin Infect Dis 2004; 39:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/38\">",
"      Benson PC, Swadron SP. Empiric acyclovir is infrequently initiated in the emergency department to patients ultimately diagnosed with encephalitis. Ann Emerg Med 2006; 47:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/39\">",
"      Marinac JS. Drug- and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother 1992; 26:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/40\">",
"      Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/41\">",
"      Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005; 76:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/42\">",
"      Kumar G, Kalita J, Misra UK. Raised intracranial pressure in acute viral encephalitis. Clin Neurol Neurosurg 2009; 111:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/43\">",
"      Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Treat Options Neurol 2008; 10:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38968/abstract/44\">",
"      Mailles A, De Broucker T, Costanzo P, et al. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis 2012; 54:1455.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1284 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38968=[""].join("\n");
var outline_f38_3_38968=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MENINGITIS VERSUS ENCEPHALITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      VIRAL VERSUS POSTINFECTIOUS ENCEPHALITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      VIRAL PATHOGENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Historical clues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clues on physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cerebrospinal fluid findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Brain biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Definitive diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      EMPIRIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27776766\">",
"      INCREASED INTRACRANIAL PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8547895\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      General recommendations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Patients with suspected encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/1284\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1284|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/5/28763\" title=\"table 1\">",
"      Seasons of viral CNS infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/55/14204\" title=\"table 2\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/7/16508\" title=\"table 3\">",
"      Differential diagnosis of viral CNS infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/16/42253\" title=\"table 4\">",
"      Therapy for agents that cause encephalitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=related_link\">",
"      Arthropod-borne encephalitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=related_link\">",
"      Aseptic meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=related_link\">",
"      Clinical manifestations and diagnosis of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5543?source=related_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/11/43192?source=related_link\">",
"      Clinical presentation and diagnosis of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/34/23080?source=related_link\">",
"      Dexamethasone to prevent neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16088?source=related_link\">",
"      Epidemiology and pathogenesis of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8154?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis and management of mumps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/48/14090?source=related_link\">",
"      Epidemiology, transmission, and pathogenesis of avian influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/39/33402?source=related_link\">",
"      Evaluation and management of elevated intracranial pressure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=related_link\">",
"      Herpes simplex virus type 1 encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5208?source=related_link\">",
"      Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/1/25622?source=related_link\">",
"      Nipah and Hendra viral encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=related_link\">",
"      PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/50/18209?source=related_link\">",
"      Patient information: Encephalitis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38023?source=related_link\">",
"      St. Louis encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/38/16999?source=related_link\">",
"      Toxoplasmosis in immunocompetent hosts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38969="Diagnosis of autism spectrum disorders";
var content_f38_3_38969=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of autism spectrum disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Marilyn Augustyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38969/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/3/38969/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autism spectrum disorders (ASD) are a group of biologically based neurodevelopmental disorders characterized by impairments in three major domains: socialization, communication, and behavior. These disorders include autistic disorder (classic autism, sometimes called early infantile autism, childhood autism, or Kanner's autism), Rett disorder, childhood disintegrative disorder, pervasive developmental disorder-not otherwise specified (PDD-NOS), and Asperger disorder (also known as Asperger syndrome) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=see_link\">",
"     \"Asperger disorder: Clinical features and diagnosis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41801?source=see_link\">",
"     \"Asperger disorder: Management and prognosis in children and adolescents\"",
"    </a>",
"    ). Rett disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=see_link\">",
"     \"Rett syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of ASD will be reviewed here. Surveillance and screening for ASD and the terminology, epidemiology, pathogenesis, clinical features, and management of ASD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=see_link\">",
"     \"Surveillance and screening for autism spectrum disorders in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"     \"Clinical features of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=see_link\">",
"     \"Autism spectrum disorders in children and adolescents: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPREHENSIVE EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for autism spectrum disorders (ASD) should include a comprehensive assessment, preferably by a team that has expertise in the diagnosis and management of ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. The evaluation should include a complete history, physical examination, neurologic examination, and direct assessment of the child's social, language, and cognitive development. Sufficient time should be set aside for standardized parent interviews regarding current concerns and behavioral history, as well as structured observation of social and communicative behavior and play. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The comprehensive evaluation has several objectives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,7,8\">",
"     4,7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Definitive diagnosis of ASD (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Exclusion of conditions that may produce symptoms suggestive of ASD (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Identification of comorbid conditions that have implications for treatment or genetic counseling (see",
"      <a class=\"local\" href=\"#H26\">",
"       'Additional evaluation'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Determination of the child's level of functioning and profile of strengths and weaknesses (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Ancillary testing'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Role of primary care provider",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important thing the primary care clinician can do is to listen to the parents and take their concerns seriously. Although primary care clinicians typically feel comfortable conducting the etiologic search (eg, identifying associated disorders, performing the medical history and examination, and coordinating genetic, metabolic, and neurologic evaluations as necessary), they usually seek the help of ASD specialists in making the definitive diagnosis of ASD.",
"   </p>",
"   <p>",
"    Ideally, children identified by primary care providers to be at risk for ASD should be referred for a comprehensive specialty evaluation. In some cases, this may result in a significant delay in making the diagnosis. Thus, primary care clinicians should be familiar with the components of the comprehensive evaluation. Based on those pieces of the evaluation able to be competently completed in primary care (eg, review of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM-IV] diagnostic criteria, use of a diagnostic instrument), children may receive a provisional diagnosis while awaiting a comprehensive evaluation or a definitive diagnosis if the primary care provider feels that a thorough evaluation has been accomplished. In addition, primary care providers who have significant concerns about a potential delay in any of the key areas &mdash; communication, behavior, or socialization &mdash; should simultaneously refer the child to the appropriate servicing agency (ie, either Early Intervention or the department of education of the public school system).",
"   </p>",
"   <p>",
"    The primary care provider can suggest",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    refer the child for several other interventions that the family can provide while awaiting the comprehensive specialty evaluation. The interventions vary depending upon the parents' concerns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the child whose parents are concerned about a difficult temperament, the provider can discuss the concept of temperament, administer a temperament scale (eg, the Carey Temperament Scales) to the child and parent, and discuss \"goodness of fit\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For the child whose parents are concerned about delays in socialization, referrals can be made to a supervised community play group (in addition to a referral for developmental services, which should be made for all children in whom ASD is suspected).",
"     </li>",
"     <li>",
"      For the child whose parents are concerned about language, the provider can suggest that the parents use picture books to foster joint attention, name objects, and tell stories. Parents can also be encouraged to provide an ongoing description of their activities for the child.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The above are suggested interventions, applicable for all children (especially those with communication delays), that may support the family while they wait for a more definitive evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history for children who screen positive for ASD should include the following information [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4,7,8\">",
"     2,4,7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Review of the developmental history, with particular attention to early social-emotional and language milestones, play skills, behavior, and any regression",
"     </li>",
"     <li>",
"      Parental concerns regarding hearing, vision, and",
"      <span class=\"nowrap\">",
"       speech/language",
"      </span>",
"     </li>",
"     <li>",
"      Specific information regarding early communicative behaviors, such as pointing, use of eye contact, and response to name",
"     </li>",
"     <li>",
"      History of repetitive, ritualized, or stereotyped behaviors, such as hand flapping",
"     </li>",
"     <li>",
"      Unusual visual behavior, or preoccupation with parts of toys",
"     </li>",
"     <li>",
"      Frequent tantrums and trouble tolerating change or transition",
"     </li>",
"     <li>",
"      History of possible seizures",
"     </li>",
"     <li>",
"      Self-injury",
"     </li>",
"     <li>",
"      Significant disturbance in eating (including pica) or sleep",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Autistic disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A three-generation family history should be reviewed thoroughly, since ASD have a strong genetic component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,13\">",
"     4,13",
"    </a>",
"    ]. The following disorders should be asked about specifically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Autism and other pervasive developmental disorders",
"     </li>",
"     <li>",
"      Language delay",
"     </li>",
"     <li>",
"      Intellectual disability (mental retardation)",
"     </li>",
"     <li>",
"      Fragile X syndrome, Rett disorder, Angelman syndrome, Prader-Willi syndrome, Smith-Lemli-Opitz syndrome",
"     </li>",
"     <li>",
"      Tuberous sclerosis complex",
"     </li>",
"     <li>",
"      Learning and attentional disorders",
"     </li>",
"     <li>",
"      Anxiety",
"     </li>",
"     <li>",
"      Obsessive-compulsive disorders",
"     </li>",
"     <li>",
"      Extreme shyness, social phobia, or mutism",
"     </li>",
"     <li>",
"      Mood disorders",
"     </li>",
"     <li>",
"      Schizophrenia",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"     <li>",
"      Tic disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H11#H11\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Associated conditions'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The psychosocial history should include information regarding the family supports and stresses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extra time should be allotted for the examination because the communication deficits and behavioral symptoms may limit cooperation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7\">",
"     7",
"    </a>",
"    ]. Important aspects of the examination include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measurements of growth parameters, including head circumference. Approximately one-fourth of children with isolated ASD have head circumference greater than the 97",
"      <sup>",
"       th",
"      </sup>",
"      percentile [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,15\">",
"       2,15",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"       \"Clinical features of autism spectrum disorders\"",
"      </a>",
"      ). It is important to review the trajectory of head growth if previous measurements are available. Children with ASD have early acceleration of head growth, followed by stabilization [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/16\">",
"       16",
"      </a>",
"      ]. In addition, individuals with ASD and macrocephaly may have mutations in the",
"      <em>",
"       PTEN",
"      </em>",
"      gene, placing them at risk for hamartomatous tumor syndromes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/17\">",
"       17",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29530?source=see_link&amp;anchor=H462460064#H462460064\">",
"       \"PTEN hamartoma tumor syndrome, including Cowden syndrome\", section on 'Autism spectrum disorders and macrocephaly'",
"      </a>",
"      ). Although microcephaly is present in approximately 15 percent of patients with ASD, it usually occurs in patients with associated conditions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/18\">",
"       18",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Height and weight measurements are necessary in children who are being evaluated for ASD, since dietary obsessions and compulsions can result in poor weight gain or obesity. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link\">",
"       \"Clinical features of autism spectrum disorders\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Examination of the skin with a Wood lamp may demonstrate the hypopigmented macules of tuberous sclerosis complex (",
"      <a class=\"graphic graphic_picture graphicRef61601 \" href=\"mobipreview.htm?26/39/27263\">",
"       picture 1",
"      </a>",
"      ), an associated condition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4,7\">",
"       2,4,7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/38/34410?source=see_link\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Examination for dysmorphic features.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Features consistent with fragile X syndrome include long face, large ears, and large testes (postpubertally). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/4/34889?source=see_link\">",
"       \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Features consistent with Angelman syndrome include an ataxic gait, broad mouth, persistent smile, language delay, and seizures.",
"     </li>",
"     <li>",
"      Features consistent with Smith-Lemli-Opitz syndrome include microcephaly; soft cleft",
"      <span class=\"nowrap\">",
"       palate/bifid",
"      </span>",
"      uvula; micrognathia; low-set, posteriorly rotated ears; failure to thrive; syndactyly of the second and third toes; abnormal genitalia; intellectual disability; hypotonia; and autistic features [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/19,20\">",
"       19,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Examination of muscle tone and reflexes. Children with ASD can have mild hypotonia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7\">",
"       7",
"      </a>",
"      ]. Focal neurologic findings, such as asymmetry in tone or reflexes, require further neurologic evaluation and possible neuroimaging.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ancillary testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancillary testing may be necessary to exclude conditions that may produce symptoms suggestive of ASD, to identify potentially treatable conditions associated with ASD, and to define the child's particular pattern of strengths and weaknesses for education planning.",
"   </p>",
"   <p>",
"    Ancillary testing should include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,3,8\">",
"     2,3,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vision and hearing assessment",
"     </li>",
"     <li>",
"      Speech, language, and communication assessments",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Developmental/intelligence",
"      </span>",
"      testing with separate estimates for verbal and nonverbal skills; overall levels of function determine eligibility for services in many states",
"     </li>",
"     <li>",
"      Assessment of adaptive skills to document the presence of associated intellectual disability and to help establish priorities for treatment planning",
"     </li>",
"     <li>",
"      Neuropsychologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      achievement testing",
"     </li>",
"     <li>",
"      Sensorimotor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      occupational therapy evaluation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ancillary testing may also include specific tests for certain conditions associated with ASD as indicated by the initial clinical evaluation. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Additional evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Reevaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reevaluation is suggested within one year of initial diagnosis to address behavioral, environmental, and other developmental concerns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2\">",
"     2",
"    </a>",
"    ]. Although extensive diagnostic testing is not necessary, reassessment of developmental skills may be helpful, since relatively small changes in developmental level may affect the impact of autism in young children. The primary care clinician should continue to reevaluate every 6 to 12 months, since long-term support is critical for children with autism and their families.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of autism is a clinical diagnosis. It should be suspected in children with abnormalities in social interaction, communication, and behavior (",
"    <a class=\"graphic graphic_table graphicRef72403 \" href=\"mobipreview.htm?29/6/29804\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Autistic disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Accurate and appropriate diagnosis usually requires a clinician who is experienced in the diagnosis and treatment of autism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4,7,21,22\">",
"     2,4,7,21,22",
"    </a>",
"    ]. Clinicians must rely on their clinical judgment, aided by guides to diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. At a minimum, the diagnostic evaluation should include documentation of whether the child's symptoms meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for autism (",
"    <a class=\"graphic graphic_table graphicRef72403 \" href=\"mobipreview.htm?29/6/29804\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic evaluation also should include the use of a diagnostic instrument with at least moderate sensitivity and high specificity for autism spectrum disorders (ASD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4,8\">",
"     2,4,8",
"    </a>",
"    ]. Unfortunately, there is currently no \"meta\" policy statement that addresses a minimum standard. Among others, the diagnostic instruments recommended by the American Academy of Child and Adolescent Psychiatry, the American Academy of Neurology, and the American Academy of Pediatrics include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4,8\">",
"     2,4,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measures relying on parent report &ndash; The Autism Behavior Checklist (ABC), Gilliam Autism Rating Scale, 2",
"      <sup>",
"       nd",
"      </sup>",
"      edition (GARS-2), and the Autism Diagnostic Interview-Revised (ADI-R). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnostic tools'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Measures using direct observation &ndash; The Childhood Autism Rating Scale (CARS) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnostic tools'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Autistic disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the DSM-IV-TR criteria, a diagnosis of autistic disorder requires delays or abnormal functioning in at least one of the following areas, with onset before three years of age (",
"    <a class=\"graphic graphic_table graphicRef72403 \" href=\"mobipreview.htm?29/6/29804\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Social interaction",
"     </li>",
"     <li>",
"      Language as used in social communication",
"     </li>",
"     <li>",
"      Symbolic and imaginative play (ie, behavior)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, two rare pervasive developmental disorders, Rett disorder and childhood disintegrative disorder, must be excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Rett disorder'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H22\">",
"     'Childhood disintegrative disorder'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The clinical features of ASD, including examples of delays and abnormal functioning in each of these domains, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Autistic disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Asperger disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;The DSM-IV-TR criteria for Asperger disorder are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef60599 \" href=\"mobipreview.htm?12/57/13212\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=see_link\">",
"     \"Asperger disorder: Clinical features and diagnosis in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     PDD-NOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term \"pervasive developmental disorder-not otherwise specified\" (PDD-NOS) is used to describe individuals who meet some, but not all, of the DSM-IV-TR criteria for autistic disorder (ie, atypical autism) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/23\">",
"     23",
"    </a>",
"    ]. Individuals may fall into this category because of late age of presentation, atypical symptoms, or subthreshold symptoms. Clinicians may give PDD-NOS as a provisional diagnosis because of the child's young age, atypical presentation, or while awaiting a more complete evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Pervasive developmental disorder-not otherwise specified'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnostic tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several diagnostic tools are available. However, many of them have not been widely studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24\">",
"     24",
"    </a>",
"    ]. In addition, protocols in published studies generally follow rigid administration standards that may be obtainable only in a research setting. Thus, the clinician must consider the source of the testing, as well as the tool that was administered, when interpreting results.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autism Behavior Checklist &ndash; The Autism Behavior Checklist (ABC) is a list of 57 questions to be completed by a parent or teacher [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/25\">",
"       25",
"      </a>",
"      ]. The questions are divided into five categories: sensory, relating, body and object use, language, and social and self-help. It was designed primarily to identify children with autism from a population of school-age children with severe disabilities. However, it has been used with children as young as three years. The reported sensitivity and specificity of the ABC in referral samples range from 38 to 58 percent and 76 to 97 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gilliam Autism Rating Scale &ndash; The Gilliam Autism Rating Scale (GARS) consists of a checklist of 42 items for parents based on DSM-IV criteria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/26\">",
"       26",
"      </a>",
"      ]. Thus, items are grouped into categories addressing social development, communication, and stereotypic behaviors. The GARS was designed for use in children older than three years and has been revised (GARS-2) to be used for children and adolescents up to 22 years. The GARS-2 was standardized on a representative sample of 1107 persons with autism from 48 states within the United States [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/27\">",
"       27",
"      </a>",
"      ]. The reported sensitivity of the GARS in referral populations is low (average of 53 percent in a systematic review) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24,28,29\">",
"       24,28,29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autism Diagnostic Interview-Revised &ndash; The Autism Diagnostic Interview-Revised (ADI-R) is a two- to three-hour clinical interview that probes for autistic symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7,30\">",
"       7,30",
"      </a>",
"      ]. It has excellent psychometric properties (average sensitivity of 82 percent in children &lt;3 years and 91 percent in children &gt;3 years in a systematic review) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24\">",
"       24",
"      </a>",
"      ]. The ADI-R is typically used in research settings, often combined with the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) as the gold-standard diagnostic instrument [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7,24\">",
"       7,24",
"      </a>",
"      ]. However, the ADI-R is not practical for use in clinical settings because of the time required for administration.",
"     </li>",
"     <li>",
"      Childhood Autism Rating Scale &ndash; The Childhood Autism Rating Scale (CARS) is a 15-item direct-observation instrument designed to facilitate the diagnosis of autism in children two years of age and older [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7,31\">",
"       7,31",
"      </a>",
"      ]. Each of the items is scored on a seven-point rating scale. The CARS is well correlated with the DSM-IV criteria and discriminates ASD from other developmental disorders better than the ABC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/32\">",
"       32",
"      </a>",
"      ]. The CARS is intended for use by a trained clinician and takes approximately 20 to 30 minutes to administer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/31\">",
"       31",
"      </a>",
"      ]. In a systematic review, the average sensitivity and specificity were 89 and 82 percent, respectively, for autism and 82 and 80 percent, respectively, for ASD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autism Diagnostic Observation Schedule &ndash; The Autism Diagnostic Observation Schedule (ADOS) is the gold standard for diagnosis of autism in children &ge;30 months of age in research studies and many clinical settings [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24,33\">",
"       24,33",
"      </a>",
"      ]. The second edition (ADOS-2) was published in 2012 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/34\">",
"       34",
"      </a>",
"      ]. The ADOS is meant to be used as one facet of an evaluation, with results to be considered in conjunction with other clinical information and the examiner's clinical expertise.",
"      <br/>",
"      <br/>",
"      The ADOS is a semistructured assessment of social interaction, play, communication, and imaginative use of materials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7\">",
"       7",
"      </a>",
"      ]. It provides an overall score and scores for social interaction and communication. There are four modules based upon the child's expressive language abilities. It takes 40 to 60 minutes to administer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/34\">",
"       34",
"      </a>",
"      ]. Substantial training is required for administration and scoring.",
"      <br/>",
"      <br/>",
"      In a systematic review, the average sensitivity and specificity of the first edition of the generic ADOS were 87 and 73 percent, respectively, for autism, and 87 and 78 percent, respectively, for ASD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24\">",
"       24",
"      </a>",
"      ]. The ADOS discriminates autism and PDD-NOS from non-ASD. However, it is less accurate in discriminating autism from PDD-NOS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/35\">",
"       35",
"      </a>",
"      ]. The sensitivity of the first edition of the generic ADOS for distinguishing autism and PDD-NOS from non-ASD ranged from 90 to 97 percent across the four modules; specificity ranged from 87 to 94 percent. Information regarding the sensitivity and specificity of the ADOS-2 has not been published.",
"     </li>",
"     <li>",
"      Autism Diagnostic Observation Schedule-Toddler Module &ndash; The Autism Diagnostic Observation Schedule-Toddler Module (ADOS-Toddler Module, Module T) is a standardized research tool for use in children aged 12 to 30 months (or until phrase speech is acquired) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/36\">",
"       36",
"      </a>",
"      ]. It targets communication, reciprocal social interaction, emerging object use, and play skills. The Toddler Module classifies children as ASD or nonspectrum. Similar to the ADOS-2, results must be considered in conjunction with other clinical information and the examiner's clinical expertise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of autism spectrum disorders (ASD) includes the following disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,6,8,14\">",
"     4,6,8,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Global developmental",
"      <span class=\"nowrap\">",
"       delay/intellectual",
"      </span>",
"      disability",
"     </li>",
"     <li>",
"      Developmental language disorder",
"     </li>",
"     <li>",
"      Language-based learning disability",
"     </li>",
"     <li>",
"      Hearing impairment",
"     </li>",
"     <li>",
"      Landau-Kleffner syndrome",
"     </li>",
"     <li>",
"      Rett disorder",
"     </li>",
"     <li>",
"      Childhood disintegrative disorder",
"     </li>",
"     <li>",
"      Severe early",
"      <span class=\"nowrap\">",
"       deprivation/reactive",
"      </span>",
"      attachment disorder",
"     </li>",
"     <li>",
"      Anxiety disorder",
"     </li>",
"     <li>",
"      Obsessive-compulsive disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comprehensive history is the best tool for distinguishing these disorders from ASD, although sometimes ancillary tests are necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"     8",
"    </a>",
"    ]. The history is usually obtained from the parents, but teachers and therapists can provide useful information. It may be difficult to distinguish some of these disorders from ASD in young children (who may need to be followed over time before a definitive diagnosis can be made) or in older children when information about early development is not available. Sometimes in the very young child, or a child who is awaiting a more comprehensive assessment, a provisional diagnosis is given so that the child may receive the intensity of intervention necessary to help children on the spectrum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Global delay/intellectual disability (mental retardation)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Global developmental delay or intellectual disability (mental retardation) may be difficult to distinguish from ASD. Cognitive deficits are difficult to assess in the young, nonverbal child, and severe deficits may be associated with repetitive behaviors and mixed",
"    <span class=\"nowrap\">",
"     expressive/receptive",
"    </span>",
"    language delay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. In addition, a high percentage of individuals with ASD have cognitive deficits. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/10/26793?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Cognitive skills'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain aspects related to communication and social interaction may help to differentiate children with ASD and global developmental",
"    <span class=\"nowrap\">",
"     delay/intellectual",
"    </span>",
"    disability from those with global developmental",
"    <span class=\"nowrap\">",
"     delay/intellectual",
"    </span>",
"    disability without ASD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The social responsiveness and communication efforts of children with isolated global developmental",
"      <span class=\"nowrap\">",
"       delay/intellectual",
"      </span>",
"      disability are usually appropriate for their developmental level, whereas those of children with ASD are aberrant for their developmental level [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,8\">",
"       4,8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children with isolated global developmental",
"      <span class=\"nowrap\">",
"       delay/intellectual",
"      </span>",
"      disability usually can understand language at a higher level than they can express it, whereas in children with ASD, receptive language is usually more affected than expressive language [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Developmental language disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to children with ASD, children with developmental language disorder have normal reciprocal social interactions, normal desire and intent to communicate, and appropriate imaginative play [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8,14,37\">",
"     8,14,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=see_link&amp;anchor=H17#H17\">",
"     \"Etiology of speech and language disorders in children\", section on 'Developmental language impairment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Language-based learning disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to children with ASD, children with language-based learning disorders have normal reciprocal social interactions, normal desire and intent to communicate, and appropriate imaginative play. Children with language-based learning disorder have difficulty or delay in processing content, but their pragmatics (ie, ability to initiate and sustain a conversation) are more typical than those of children with ASD. In addition, the intent to communicate in children with language-based learning disorder is present, even though the competency may be lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hearing impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to children with ASD, children with hearing impairment usually have normal reciprocal social interactions, imaginative play, normal eye-to-eye gaze, and facial expressions indicative of their intention to communicate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4,14,37\">",
"     4,14,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Landau-Kleffner",
"    </span>",
"    &nbsp;&mdash;&nbsp;Landau-Kleffner syndrome (LKS, also called acquired epileptic aphasia) is characterized by the loss of previously established language milestones, inability to comprehend the spoken word, and seizures or an epileptiform electroencephalogram (EEG). Children with LKS usually develop normally until approximately three to six years of age (in contrast to autism, which, by definition, must manifest before three years of age). LKS typically begins with the children behaving as if they were deaf (auditory verbal agnosia). Difficulties with expressive language also occur with time, but cognitive function usually remains normal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33769?source=see_link&amp;anchor=H10#H10\">",
"     \"Epilepsy syndromes in children\", section on 'Landau-Kleffner syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Rett disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rett disorder is a neurodevelopmental disorder that occurs almost exclusively in females. Affected patients initially develop normally, then gradually lose speech and purposeful hand use sometime after 18 months of age. Most cases of Rett disorder result from mutations in the",
"    <em>",
"     MECP2",
"    </em>",
"    gene. Characteristic features of Rett disorder include deceleration of head growth (in contrast to acceleration of head growth, which occurs in ASD), stereotypic hand movements, and dementia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=see_link&amp;anchor=H7#H7\">",
"     \"Rett syndrome\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Childhood disintegrative disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;The essential feature of childhood disintegrative disorder (CDD), which is extremely rare, is a marked regression in multiple areas of functioning following a period of at least two years of apparently normal development. Apparently normal development is reflected in age-appropriate verbal and nonverbal communication, social relationships, play, and adaptive behavior. After the first two years of life (but before age 10 years), the child has a clinically significant loss of previously acquired skills in at least two of the following areas: expressive or receptive language, social skills or adaptive behavior, bowel or bladder control, play, or motor skills. Symptoms in children with CDD are essentially identical to children with autistic disorder, save a history of normal development. CDD is often associated with an identified organic condition (eg, seizures, metabolic disorder, etc).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Attachment disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to children with ASD, children with severe early deprivation or reactive attachment disorder may have abnormalities in social interaction, communication, and behavior. However, there usually is a history of severe neglect or mental health issues in the caretaker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"     8",
"    </a>",
"    ]. In addition, the social deficits of children with attachment disorder tend to improve in response to an appropriate caregiving environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Anxiety disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anxiety disorder has behavioral features that overlap with ASD. To the extent that it can be determined, individuals with anxiety disorder find their symptoms distressing, whereas individuals with ASD typically do not want to change their preoccupations or mannerisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/14\">",
"     14",
"    </a>",
"    ]. However, children with ASD frequently experience anxiety symptoms that they find distressing. In contrast to children with ASD, children with primary anxiety disorders usually have normal communication skills and reciprocal social interactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Obsessive-compulsive disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obsessive-compulsive disorder (OCD) has behavioral features that overlap with ASD. To the extent that it can be determined, individuals with OCD find their symptoms distressing, whereas individuals with ASD typically do not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/14\">",
"     14",
"    </a>",
"    ]. However, children with ASD may have symptoms of OCD that they find distressing. In addition, children with OCD typically have normal social and",
"    <span class=\"nowrap\">",
"     communication/language",
"    </span>",
"    skills [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ADDITIONAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of autism spectrum disorder (ASD) is confirmed, additional medical testing may be indicated. Additional evaluation may be necessary to identify comorbid conditions that have important implications for treatment or genetic counseling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to definitively exclude some conditions in the differential diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. A recognizable disorder is found in a minority of cases, usually in patients with comorbid global developmental delay or intellectual disability. The most common of these disorders include tuberous sclerosis complex, fragile X syndrome, and Angelman syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H11#H11\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Associated conditions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the relative infrequency of these associated conditions, establishing a potential etiology may provide emotional relief for the parents and can be crucial to the therapeutic alliance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/38\">",
"     38",
"    </a>",
"    ]. Establishing an etiology also may help in predicting the prognosis, providing accurate genetic counseling for future pregnancies, organizing appropriate laboratory testing, and initiating treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation for associated conditions must include genetic testing and may include metabolic testing, neuroimaging,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electroencephalography (EEG). These evaluations should be obtained as indicated based upon the history and clinical presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,7,8,14\">",
"     2,7,8,14",
"    </a>",
"    ]. The yield of such testing in the absence of clinical indications is low, as illustrated by the following study:",
"   </p>",
"   <p>",
"    In a prospective study, 85 children with ASD (diagnosed by the Autism Diagnostic Interview-Revised [ADI-R] and Autism Diagnostic Observation Schedule-Generic [ADOS-G] with clinical confirmation based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM-IV] symptoms) underwent extensive etiologic evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/38\">",
"     38",
"    </a>",
"    ]. The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An associated condition was detected in 14 patients (16.5 percent).",
"     </li>",
"     <li>",
"      Detailed history and examination by a clinical geneticist was informative in nine patients (10 percent).",
"     </li>",
"     <li>",
"      High-resolution banding karyotype was diagnostic in one patient.",
"     </li>",
"     <li>",
"      Molecular fragile X testing was diagnostic in one patient.",
"     </li>",
"     <li>",
"      Comparative genomic hybridization microarray did not detect any 15q11-q13 microduplications.",
"     </li>",
"     <li>",
"      Two children with macrocephaly but no neurologic features had abnormalities on brain magnetic resonance imaging (MRI) (focal band heterotopia at the level of the right lateral ventricle in one; partial agenesis of the corpus callosum with right cerebellar hypoplasia in the second).",
"     </li>",
"     <li>",
"      EEG identified one child with Landau-Kleffner syndrome.",
"     </li>",
"     <li>",
"      Audiometry and brainstem auditory evoked response (BAERS) identified bilateral sensorineural hearing loss in one child.",
"     </li>",
"     <li>",
"      Metabolic evaluation was normal in all subjects.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that all children diagnosed with ASD receive chromosomal microarray (CMA) and DNA analysis for fragile X [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Karyotype is warranted if a balanced translocation is suspected (eg, history of &ge;2 miscarriages) because CMA does not detect balanced translocations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/40\">",
"     40",
"    </a>",
"    ]. However, truly balanced de novo translocations are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interpretation of microarray data is complicated by the presence of both novel and recurrent copy-number variants of unknown significance. Nonetheless, CMA has the highest detection rate among clinically available genetic tests for patients with ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. In a cohort of 933 patients who underwent genetic testing for a diagnosis of ASD, karyotype was abnormal in 2 percent, fragile X testing was abnormal in 0.5 percent, and array-CGH identified abnormal deletions or duplications in 7 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional genetic testing (beyond CMA, fragile X, and possibly karyotype) is indicated only for individuals with dysmorphic features, microcephaly, macrocephaly, cognitive impairment, suspicious medical or family history, or in cases where prenatal genetic counseling is desired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/13,46-49\">",
"     13,46-49",
"    </a>",
"    ]. Specific testing should be guided by the patient's individual clinical profile. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing for the X-linked",
"      <em>",
"       MECP2",
"      </em>",
"      Rett mutation may be warranted for patients, particularly girls, with a history of significant developmental regression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,50\">",
"       2,50",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=see_link\">",
"       \"Rett syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Testing for mutations in the",
"      <em>",
"       PTEN",
"      </em>",
"      gene should be completed for patients with autism and macrocephaly (greater than 2.5 SD above the mean for age and sex) to rule out hamartomatous tumor syndromes, such as Bannayan-Riley Ruvalcaba, Proteus, and Cowden syndromes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29530?source=see_link&amp;anchor=H462460064#H462460064\">",
"       \"PTEN hamartoma tumor syndrome, including Cowden syndrome\", section on 'Autism spectrum disorders and macrocephaly'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Metabolic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders of amino acid, carbohydrate, purine, peptide, and mitochondrial metabolism account for less than 5 percent of cases of ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,51\">",
"     2,51",
"    </a>",
"    ]. Although metabolic testing is not necessary in the routine evaluation of all children with ASD, it may be indicated if there are symptoms or signs of a metabolic disorder. These include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,38,51,52\">",
"     2,38,51,52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lethargy, limited endurance",
"     </li>",
"     <li>",
"      Hypotonia",
"     </li>",
"     <li>",
"      Recurrent vomiting and dehydration",
"     </li>",
"     <li>",
"      Early seizure",
"     </li>",
"     <li>",
"      Dysmorphic or coarse features",
"     </li>",
"     <li>",
"      Intellectual disability (or if intellectual disability cannot be excluded)",
"     </li>",
"     <li>",
"      Developmental regression",
"     </li>",
"     <li>",
"      Hearing impairment",
"     </li>",
"     <li>",
"      Vision impairment",
"     </li>",
"     <li>",
"      Unusual odors",
"     </li>",
"     <li>",
"      Specific food intolerance (eg, protein)",
"     </li>",
"     <li>",
"      Inadequate or questionable adequate newborn screen",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the absence of signs or symptoms of metabolic disease, metabolic screening has very low yield [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,38,53\">",
"     2,38,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=see_link\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/0/10250?source=see_link\">",
"     \"Inborn errors of metabolism: Metabolic emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine use of MRI is not indicated, particularly in light of the need for sedation. Neither the AAP nor the AAN guidelines recommend routine neuroimaging for patients with ASD and isolated macrocephaly without focal neurologic signs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Electroencephalogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine electroencephalography (EEG) is not indicated in the evaluation of all children with ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Sleep-deprived EEG is indicated when there is a history of unusual spells or behaviors frankly suggestive of seizures and to exclude Landau-Kleffner syndrome (acquired epileptic aphasia) in patients with a significant regression in language skills [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33769?source=see_link&amp;anchor=H10#H10\">",
"     \"Epilepsy syndromes in children\", section on 'Landau-Kleffner syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tests for yeast metabolites, gut permeability, heavy metals (other than lead), trace elements, micronutrients, and immune abnormalities are NOT indicated, since there are no empiric data to support such analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lead testing may be indicated by the clinical history.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/37/38481?source=see_link\">",
"       \"Patient information: Autism (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/46/41699?source=see_link\">",
"       \"Patient information: Autism spectrum disorders (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation for autism spectrum disorders (ASD) should include a comprehensive evaluation, preferably by a team that has expertise in the diagnosis and management of ASD. The most important thing the primary care clinician can do is listen to the parents and take their concerns seriously and refer appropriately. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The comprehensive evaluation has several objectives, including (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Definitive diagnosis of ASD",
"     </li>",
"     <li>",
"      Exclusion of conditions that have symptoms suggestive of ASD",
"     </li>",
"     <li>",
"      Detection of comorbid conditions with implications for treatment or genetic counseling",
"     </li>",
"     <li>",
"      Determination of the child's profile of strengths and weaknesses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation should include a thorough history, including family history and psychosocial history. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation should include examination with particular attention to growth parameters, neurocutaneous manifestations, dysmorphic features, and neurologic findings. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ancillary testing should include assessment of vision, hearing, speech, language, communication, and adaptive skills; developmental",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intelligence testing; neuropsychologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      achievement testing; and sensorimotor and occupational therapy evaluation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ancillary testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of autism is a clinical diagnosis. It should be suspected in children with abnormalities in social interaction, communication, and behavior. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical features of autism spectrum disorders\", section on 'Autistic disorder'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnostic evaluation should include documentation of whether the child's symptoms meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for autism (",
"      <a class=\"graphic graphic_table graphicRef72403 \" href=\"mobipreview.htm?29/6/29804\">",
"       table 1",
"      </a>",
"      ) or Asperger disorder (",
"      <a class=\"graphic graphic_table graphicRef60599 \" href=\"mobipreview.htm?12/57/13212\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic evaluation also should include the use of a diagnostic instrument with at least moderate sensitivity and high specificity for ASD. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Further evaluation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Once the diagnosis of ASD is confirmed, additional medical testing may be indicated to identify disorders associated with ASD that may have important implications for treatment",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      genetic counseling. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Additional evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that all children diagnosed with ASD receive chromosomal microarray testing and DNA analysis for fragile X. Karyotype is indicated if balanced translocation is suspected. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Genetic testing'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=see_link&amp;anchor=H20#H20\">",
"       \"Surveillance and screening for autism spectrum disorders in primary care\", section on 'Genetic counseling'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest metabolic testing, as indicated, in children with signs or symptoms of metabolic disease, including lethargy, hypotonia, recurrent vomiting and dehydration, early seizures, dysmorphic or coarse features, or intellectual disability (or if intellectual disability cannot be excluded, developmental regression, hearing impairment, vision impairment, unusual odors, specific food intolerance, inadequate or questionable newborn screen). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/0/10250?source=see_link\">",
"       \"Inborn errors of metabolism: Metabolic emergencies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest not obtaining neuroimaging in children with ASD and isolated macrocephaly. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest sleep-deprived electroencephalography in children with clinical or suspicion of subclinical seizures, and a history of regression at any age, but especially in toddlers and preschoolers. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Electroencephalogram'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/4/14409?source=see_link\">",
"       \"Clinical and laboratory diagnosis of seizures in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33769?source=see_link&amp;anchor=H10#H10\">",
"       \"Epilepsy syndromes in children\", section on 'Landau-Kleffner syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/1\">",
"      Schopler E. On confusion in the diagnosis of autism. J Autism Child Schizophr 1978; 8:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/2\">",
"      Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000; 55:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/3\">",
"      Dover CJ, Le Couteur A. How to diagnose autism. Arch Dis Child 2007; 92:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/4\">",
"      Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120:1183.",
"     </a>",
"    </li>",
"    <li>",
"     Scottish Intercollegiate Guideline Network. Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders, a national clinical guideline, number 98. July 2007. www.sign.ac.uk/pdf/sign98.pdf (Accessed on February 08, 2011).",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Autism. Recognition, referral and diagnosis of children and young people on the autism spectrum file://www.nice.org.uk/nicemedia/live/13572/56428/56428.pdf (Accessed on January 12, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/7\">",
"      Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999; 29:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/8\">",
"      Volkmar F, Cook EH Jr, Pomeroy J, et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry 1999; 38:32S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/9\">",
"      Caronna EB, Augustyn M, Zuckerman B. Revisiting parental concerns in the age of autism spectrum disorders: the need to help parents in the face of uncertainty. Arch Pediatr Adolesc Med 2007; 161:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/10\">",
"      Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009; 123:1383.",
"     </a>",
"    </li>",
"    <li>",
"     Carey Temperament Scale. Harcourt Assessment. (harcourtassessment.com/haiweb/cultures/en-us/productdetail.htm?pid=015-8040-015).",
"    </li>",
"    <li>",
"     Chess S, Thomas A. Temperament in Clinical Practice, Guilford Press, New York 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/13\">",
"      Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113:e472.",
"     </a>",
"    </li>",
"    <li>",
"     Teplin SW. Autism and related disorders. In: Developmental Behavioral Pediatrics, 3rd ed, Levine MD, Carey WB, Crocker AC (Eds), WB Saunders, Philadelphia 1999. p.589.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/15\">",
"      Lainhart JE, Piven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997; 36:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/16\">",
"      Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290:337.",
"     </a>",
"    </li>",
"    <li>",
"     GeneReviews. PTEN hamartoma tumor syndrome (PHTS). Available at: ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=phts (Accessed on April 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/18\">",
"      Fombonne E, Rog&eacute; B, Claverie J, et al. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999; 29:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/19\">",
"      Sikora DM, Pettit-Kekel K, Penfield J, et al. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A 2006; 140:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/20\">",
"      Bukelis I, Porter FD, Zimmerman AW, Tierney E. Smith-Lemli-Opitz syndrome and autism spectrum disorder. Am J Psychiatry 2007; 164:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/21\">",
"      Stone WL, Lee EB, Ashford L, et al. Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry 1999; 40:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/22\">",
"      Volkmar FR, Klin A, Siegel B, et al. Field trial for autistic disorder in DSM-IV. Am J Psychiatry 1994; 151:1361.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Pervasive Developmental Disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR&reg;)., American Psychiatric Association, Washington, DC  p.70.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/24\">",
"      Falkmer T, Anderson K, Falkmer M, Horlin C. Diagnostic procedures in autism spectrum disorders: a systematic literature review. Eur Child Adolesc Psychiatry 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/25\">",
"      Krug DA, Arick J, Almond P. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry 1980; 21:221.",
"     </a>",
"    </li>",
"    <li>",
"     Gilliam JE. Gilliam Autism Rating Scale (GARS). Pro-Ed, Austin, TX 1995.",
"    </li>",
"    <li>",
"     Gilliam Autism Rating Scale-Second Edition (GARS-2). Pro-ed. Available at: www.proedinc.com/Customer/productView.aspx?ID=3754. (Accessed on September 14, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/28\">",
"      South M, Williams BJ, McMahon WM, et al. Utility of the Gilliam Autism Rating Scale in research and clinical populations. J Autism Dev Disord 2002; 32:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/29\">",
"      Lecavalier L. An evaluation of the Gilliam Autism Rating Scale. J Autism Dev Disord 2005; 35:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/30\">",
"      Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24:659.",
"     </a>",
"    </li>",
"    <li>",
"     New York State Department of Health Early Intervention Program. Clinical practice guideline: The guideline technical report: Autism/Pervasive developmental disorders assessment and intervention for young children (age 0-3 years). Publication No. 4217, Albany, NY 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/32\">",
"      Rellini E, Tortolani D, Trillo S, et al. Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 2004; 34:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/33\">",
"      Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30:205.",
"     </a>",
"    </li>",
"    <li>",
"     Autism Diagnostic Observation Schedule, Second Edition (ADOS-2). https://www.pearsonclinical.com.au/productdetails/502 (Accessed on February 06, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/35\">",
"      Chawarska K, Klin A, Paul R, Volkmar F. Autism spectrum disorder in the second year: stability and change in syndrome expression. J Child Psychol Psychiatry 2007; 48:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/36\">",
"      Luyster R, Gotham K, Guthrie W, et al. The Autism Diagnostic Observation Schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord 2009; 39:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/37\">",
"      Stone WL, Lemanek KL, Fishel PT, et al. Play and imitation skills in the diagnosis of autism in young children. Pediatrics 1990; 86:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/38\">",
"      Battaglia A, Carey JC. Etiologic yield of autistic spectrum disorders: a prospective study. Am J Med Genet C Semin Med Genet 2006; 142C:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/39\">",
"      Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012; 366:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/40\">",
"      Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/41\">",
"      Manning M, Hudgins L, Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/42\">",
"      Beaudet AL. The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Dev 2013; 84:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/43\">",
"      Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010; 125:e727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/44\">",
"      Bar-Shira A, Rosner G, Rosner S, et al. Array-based comparative genome hybridization in clinical genetics. Pediatr Res 2006; 60:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/45\">",
"      Schaefer GB, Starr L, Pickering D, et al. Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J Child Neurol 2010; 25:1498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/46\">",
"      Chudley AE, Gutierrez E, Jocelyn LJ, Chodirker BN. Outcomes of genetic evaluation in children with pervasive developmental disorder. J Dev Behav Pediatr 1998; 19:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/47\">",
"      Skjeldal OH, Sponheim E, Ganes T, et al. Childhood autism: the need for physical investigations. Brain Dev 1998; 20:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/48\">",
"      Simonoff E. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord 1998; 28:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/49\">",
"      Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 2008; 10:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/50\">",
"      Sanmann JN, Schaefer GB, Buehler BA, Sanger WG. Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with neurodevelopmental disabilities. J Child Neurol 2012; 27:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/51\">",
"      Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol 2008; 23:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/52\">",
"      Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 2008; 3:e3815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38969/abstract/53\">",
"      Schiff M, Benoist JF, A&iuml;ssaoui S, et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One 2011; 6:e21932.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 628 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-76F9A528C7-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38969=[""].join("\n");
var outline_f38_3_38969=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPREHENSIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Role of primary care provider",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ancillary testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Reevaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Autistic disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Asperger disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - PDD-NOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Global delay/intellectual disability (mental retardation)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Developmental language disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Language-based learning disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hearing impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Landau-Kleffner",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Rett disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Childhood disintegrative disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Attachment disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ADDITIONAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Genetic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Metabolic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Electroencephalogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Further evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/628\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/628|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/39/27263\" title=\"picture 1\">",
"      TSC hypomelanotic macules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/628|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/6/29804\" title=\"table 1\">",
"      DSM IV criteria autism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/57/13212\" title=\"table 2\">",
"      DSM IV criteria Asperger disorder",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/20/15689?source=related_link\">",
"      Asperger disorder: Clinical features and diagnosis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41801?source=related_link\">",
"      Asperger disorder: Management and prognosis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/54/872?source=related_link\">",
"      Autism spectrum disorders in children and adolescents: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/4/14409?source=related_link\">",
"      Clinical and laboratory diagnosis of seizures in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/4/34889?source=related_link\">",
"      Clinical features and diagnosis of fragile X syndrome in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33769?source=related_link\">",
"      Epilepsy syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29530?source=related_link\">",
"      PTEN hamartoma tumor syndrome, including Cowden syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/37/38481?source=related_link\">",
"      Patient information: Autism (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/46/41699?source=related_link\">",
"      Patient information: Autism spectrum disorders (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/29/32218?source=related_link\">",
"      Rett syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=related_link\">",
"      Surveillance and screening for autism spectrum disorders in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=related_link\">",
"      Terminology, epidemiology, and pathogenesis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38970="Clinical features and diagnosis of community-acquired pneumonia in children";
var content_f38_3_38970=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"8\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of community-acquired pneumonia in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     William J Barson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/3/38970/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/3/38970/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Community-acquired pneumonia (CAP) is defined as signs and symptoms of an acute infection of the pulmonary parenchyma in a previously healthy patient who acquired the infection in the community, as distinguished from hospital-acquired (nosocomial) pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. CAP is a common and potentially serious illness with considerable morbidity.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of CAP in children will be reviewed here. The epidemiology, pathogenesis, and treatment of pneumonia in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link\">",
"     \"Outpatient treatment of community-acquired pneumonia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link\">",
"     \"Inpatient treatment of pneumonia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of childhood pneumonia varies depending upon the responsible pathogen, the particular host, and the severity. The presenting signs and symptoms are nonspecific; no single symptom or sign is pathognomonic for pneumonia in children.",
"   </p>",
"   <p>",
"    Symptoms and signs of pneumonia may be subtle, particularly in infants and young children. The combination of fever and cough is suggestive of pneumonia; other respiratory findings (eg, tachypnea, increased work of breathing) may precede cough. Cough may not be a feature initially since the alveoli have few cough receptors. Cough begins when the products of infection irritate cough receptors in the airways. The longer fever, cough, and respiratory findings are present, the greater the likelihood of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonates and young infants may present with difficulty feeding, restlessness, or fussiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. Young children (ie, &lt;5 to 10 years of age) may present with fever and leukocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Older children may complain of pleuritic chest pain (pain with respiration), but this is an inconsistent finding. Occasionally, the predominant manifestation may be abdominal pain (because of referred pain from the lower lobes) or nuchal rigidity (because of referred pain from the upper lobes). \"Walking pneumonia\" is a term that is sometimes used to describe pneumonia in which the respiratory symptoms do not interfere with normal activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of the child with cough and potential lower respiratory tract disease has two goals: the identification of the clinical syndrome (eg, pneumonia, bronchiolitis, asthma) and an assessment of the severity of the illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. The severity of illness determines the need for additional evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the history for children with possible community-acquire pneumonia are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef52510 \" href=\"mobipreview.htm?8/59/9149\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,6,7\">",
"     4,6,7",
"    </a>",
"    ]. Historical features can be helpful in determining the etiologic agent, the likelihood of infection with an organism that is resistant to antibiotics, and the severity of illness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link&amp;anchor=H14#H14\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'Etiologic agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the examination are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef65313 \" href=\"mobipreview.htm?5/57/6045\">",
"     table 2",
"    </a>",
"    ) and discussed in greater detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     General appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the young infant, assessment of general appearance includes the ability to attend to the environment, to feed, to vocalize, and to be consoled. The state of awareness and presence of cyanosis should be assessed in all children, although children may be hypoxemic without cyanosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/8\">",
"     8",
"    </a>",
"    ]. Most children with radiographically confirmed pneumonia appear ill [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is a common manifestation of pneumonia in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/10\">",
"     10",
"    </a>",
"    ]. However, it is nonspecific and variably present. Young infants may have afebrile pneumonia related to",
"    <em>",
"     Chlamydia trachomatis",
"    </em>",
"    or other pathogens. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27992?source=see_link&amp;anchor=H7#H7\">",
"     \"Chlamydia trachomatis infections in the newborn\", section on 'Pneumonia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link&amp;anchor=H18#H18\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'In infants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fever may be the only sign of occult pneumonia in highly febrile young children. In one report, 26 percent of 146 children (&lt;5 years) with fever &ge;39&ordm;C, no clinical evidence of pneumonia or other localizing signs, and peripheral white blood cell count",
"    <span class=\"nowrap\">",
"     &ge;20,000/microL",
"    </span>",
"    had radiographic evidence of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Tachypnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tachypnea is the most sensitive and specific sign of radiographically confirmed pneumonia in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,11-13\">",
"     4,11-13",
"    </a>",
"    ]. In a systematic review of studies evaluating the correlation between clinical examination findings and radiographic pneumonia, tachypnea was twice as frequent in children with than without radiographic pneumonia, and the absence of tachypnea was the single most valuable sign for excluding pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. Tachypnea in infants with pneumonia (respiratory rate &gt;70",
"    <span class=\"nowrap\">",
"     breaths/min)",
"    </span>",
"    also has been associated with hypoxemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/14\">",
"     14",
"    </a>",
"    ]. Tachypnea may be less useful early in the course of illness (eg, less than three days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The World Health Organization age-related definitions of tachypnea are as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Younger than two months: &gt;60",
"      <span class=\"nowrap\">",
"       breaths/min",
"      </span>",
"     </li>",
"     <li>",
"      Two to 12 months: &gt;50",
"      <span class=\"nowrap\">",
"       breaths/min",
"      </span>",
"     </li>",
"     <li>",
"      One to 5 years: &gt;40",
"      <span class=\"nowrap\">",
"       breaths/min",
"      </span>",
"     </li>",
"     <li>",
"      &ge;5 years: &gt;20",
"      <span class=\"nowrap\">",
"       breaths/min",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The respiratory rate varies with activity in infants and young children, and in these patients is best assessed by counting for a full 60 seconds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,17-19\">",
"     4,17-19",
"    </a>",
"    ]. Observation of chest wall movements is preferable to auscultation because auscultation may stimulate the child, falsely elevating the rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. The respiratory rate may increase by as many as 10 breaths per minute per degree (Celsius) of fever in children without pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/20\">",
"     20",
"    </a>",
"    ]; the effect of fever on respiratory rate in children with pneumonia has not been investigated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Respiratory distress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs of respiratory distress include tachypnea, hypoxemia (peripheral arterial oxygen saturation [SpO",
"    <sub>",
"     2",
"    </sub>",
"    ] &lt;90 percent on room air at sea level), increased work of breathing (intercostal, subcostal, or suprasternal retractions; nasal flaring; grunting; use of accessory muscles), apnea, and altered mental status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oxygen saturation should be measured in any child with increased work of breathing, particularly if he or she has a decreased level of activity or agitation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2,21\">",
"     1,2,21",
"    </a>",
"    ]. Infants and children with hypoxemia may not appear cyanotic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/8\">",
"     8",
"    </a>",
"    ]. Hypoxemia is a sign of severe disease and an indication for admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs of respiratory distress are more specific than fever or cough for lower respiratory tract infection. In a review of 192 febrile infants younger than three months of age, the specificity of at least one sign of respiratory distress for radiographic pneumonia (respiratory rate &gt;60",
"    <span class=\"nowrap\">",
"     breaths/min,",
"    </span>",
"    retractions, flaring, rales, grunting, apnea, or cyanosis) was 93 percent, but the sensitivity was only 59 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Signs of respiratory distress that are predictive of pneumonia include hypoxemia (defined differently in different studies, usually oxygen saturation &lt;94 to 96 percent in room air), retractions, head bobbing, and nasal flaring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7,9,12,23\">",
"     7,9,12,23",
"    </a>",
"    ]. Unlike tachypnea, the absence of these findings does not exclude a diagnosis of pneumonia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of children 2 to 59 months of age, oxygen saturation &le;96 percent in room air was 2.8 times more frequent among children with pneumonia than without [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In a systematic review, retractions were 2.5 times more frequent in infants with pneumonia than without [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Nasal flaring is approximately three times more frequent in children &lt;5 years with pneumonia than without [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"       4",
"      </a>",
"      ], and five times more frequent in infants 2 to 12 months with pneumonia than without [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Grunting, when present, is a sign of severe disease and impending respiratory failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Lung examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the lungs may provide clues to the diagnosis of pneumonia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    potential complications.",
"   </p>",
"   <p>",
"    Auscultation is an important component of the examination of the child who presents with findings indicative of pneumonia. However, auscultatory findings have less interobserver agreement than observable findings, such as retractions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. Auscultation of all lung fields should be performed.",
"   </p>",
"   <p>",
"    Examination findings consistent with radiographically confirmed pneumonia include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Crackles, also called rales or crepitations; in a systematic review, crackles were 3.5 times more frequent in infants with radiographic pneumonia than without [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Findings consistent with consolidated lung parenchyma, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Decreased breath sounds",
"     </li>",
"     <li>",
"      Bronchial breath sounds (louder than normal, with short inspiratory and long expiratory phases, and higher-pitched during expiration), egophony (E to A change)",
"     </li>",
"     <li>",
"      Bronchophony (the distinct transmission of sounds such as the syllables of &ldquo;ninety-nine&rdquo;)",
"     </li>",
"     <li>",
"      Whispered pectoriloquy (transmission of whispered syllables)",
"     </li>",
"     <li>",
"      Tactile fremitus (eg, when the patient says &ldquo;ninety-nine&rdquo;)",
"     </li>",
"     <li>",
"      Dullness to percussion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wheezing is more common in pneumonia caused by atypical bacteria and viruses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/25\">",
"       25",
"      </a>",
"      ] than bacteria (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Clues to etiology'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Findings suggestive of pleural effusion include chest pain with splinting, dullness to percussion, distant breath sounds, and a pleural friction rub (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/34/9770?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Severity assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assessment of pneumonia severity is necessary to determine the need for laboratory and imaging studies and the appropriate treatment setting. The severity of pneumonia is assessed by the child's overall clinical appearance and behavior, including an assessment of his or her degree of awareness and willingness to eat or drink (",
"    <a class=\"graphic graphic_table graphicRef72015 \" href=\"mobipreview.htm?28/35/29244\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clues to etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features classically taught to be characteristic of bacterial pneumonia, atypical bacterial pneumonia, or viral pneumonia are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef52021 \" href=\"mobipreview.htm?22/2/22573\">",
"     table 4",
"    </a>",
"    ). However, the features frequently overlap and cannot be used reliably to distinguish between the various etiologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In addition, as many as 50 percent of infections may be mixed",
"    <span class=\"nowrap\">",
"     bacterial/viral",
"    </span>",
"    infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link&amp;anchor=H15#H15\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'Community-acquired pneumonia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Bacterial",
"      </strong>",
"      &ndash; Classically, bacterial (\"typical\") pneumonia, usually resulting from",
"      <em>",
"       Streptococcus pneumoniae",
"      </em>",
"      and less commonly from",
"      <em>",
"       Staphylococcus aureus",
"      </em>",
"      and group A",
"      <em>",
"       streptococcus",
"      </em>",
"      , which may follow days of upper respiratory tract infection symptoms, is considered abrupt in onset, with the febrile patient appearing ill and sometimes toxic. Respiratory distress is moderate to severe; auscultatory findings may be few and focal, limited to the involved anatomic segment. Signs and symptoms of sepsis and localized chest pain (signifying pleural irritation) are more suggestive of bacterial etiology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/10\">",
"       10",
"      </a>",
"      ], as they are rarely present in nonbacterial pneumonia. Complications, discussed below, also are more suggestive of bacterial etiology (see",
"      <a class=\"local\" href=\"#H2294532\">",
"       'Complications'",
"      </a>",
"      below) On the other hand, primary bacterial pneumonia is unlikely in children older than five years if wheezing is present [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/28\">",
"       28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Pneumococcal pneumonia is the most common typical bacterial pneumonia in children of all ages. In one retrospective review of 254 children and young adults (age &lt;1 month to 26 years) with pneumococcal pneumonia, the most common signs and symptoms and their approximate frequencies are listed below [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/29\">",
"       29",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fever: 90 percent",
"     </li>",
"     <li>",
"      Cough: 70 percent; productive cough: 10 percent",
"     </li>",
"     <li>",
"      Tachypnea: 50 percent",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Malaise/lethargy:",
"      </span>",
"      45 percent",
"     </li>",
"     <li>",
"      Emesis: 43 percent",
"     </li>",
"     <li>",
"      Hypoxemia (oxygen saturation &le;95 percent): 50 percent",
"     </li>",
"     <li>",
"      Decreased breath sounds: 55 percent",
"     </li>",
"     <li>",
"      Crackles: 40 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pneumococcal pneumonia in children is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35001?source=see_link\">",
"     \"Pneumococcal pneumonia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Atypical bacterial",
"      </strong>",
"      &ndash; \"Atypical\" bacterial pneumonia resulting from",
"      <em>",
"       Mycoplasma pneumoniae",
"      </em>",
"      or",
"      <em>",
"       Chlamydophila",
"      </em>",
"      (formerly",
"      <em>",
"       Chlamydia",
"      </em>",
"      )",
"      <em>",
"       pneumoniae",
"      </em>",
"      usually presents abruptly with constitutional findings of fever, malaise and myalgia, headache, photophobia, sore throat, and gradually worsening nonproductive cough despite improvement of other symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/25,28\">",
"       25,28",
"      </a>",
"      ]. Although hoarseness may be seen in disease caused by both agents, it is more frequently seen with",
"      <em>",
"       C. pneumoniae",
"      </em>",
"      infection. Wheezing is a frequent finding in atypical bacterial and viral pneumonias [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33062?source=see_link\">",
"       \"Pneumonia caused by Chlamydophila (Chlamydia) species in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=see_link&amp;anchor=H5#H5\">",
"       \"Mycoplasma pneumoniae infection in children\", section on 'Clinical features'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      may be associated with a variety of extrapulmonary manifestations. Dermatologic manifestations may range from a mild erythematous maculopapular rash or urticaria to the Stevens-Johnson syndrome. Other extrapulmonary manifestations include hemolytic anemia, polyarthritis, pancreatitis, hepatitis, pericarditis, myocarditis, and neurologic complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=see_link&amp;anchor=H5#H5\">",
"       \"Mycoplasma pneumoniae infection in children\", section on 'Clinical features'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Infants younger than one year of age may develop \"afebrile pneumonia of infancy\". Afebrile pneumonia of infancy is a syndrome generally seen between two weeks and three to four months of life. It is classically caused by",
"      <em>",
"       C. trachomatis",
"      </em>",
"      , but other agents, such as cytomegalovirus,",
"      <em>",
"       M. hominis",
"      </em>",
"      , and",
"      <em>",
"       Ureaplasma urealyticum",
"      </em>",
"      , also are implicated. The clinical presentation is one of insidious onset of rhinorrhea and tachypnea followed by a staccato cough pattern (individual coughs separated by inspirations). Physical examination typically reveals diffuse inspiratory crackles. Conjunctivitis may be present, or there may have been a past history of conjunctivitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/31\">",
"       31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27992?source=see_link&amp;anchor=H7#H7\">",
"       \"Chlamydia trachomatis infections in the newborn\", section on 'Pneumonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Viral",
"      </strong>",
"      &ndash; The onset of viral pneumonia is gradual and associated with preceding upper airway symptoms (eg, rhinorrhea, congestion). The child does not appear toxic. Auscultatory findings are usually diffuse and bilateral. In one study of 98 ambulatory children with pneumonia, wheezing was more frequent in patients with viral than bacterial pneumonia (43 versus 16 percent), but other clinical features often associated with viral illness, such as rhinorrhea, myalgia, and ill contacts, were not [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Some viral causes of pneumonia are associated with characteristic dermatologic findings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Measles (",
"      <a class=\"graphic graphic_picture graphicRef57803 graphicRef57093 \" href=\"mobipreview.htm?40/5/41041\">",
"       picture 1A-B",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/11/43192?source=see_link\">",
"       \"Clinical presentation and diagnosis of measles\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Varicella (",
"      <a class=\"graphic graphic_picture graphicRef55533 \" href=\"mobipreview.htm?36/3/36927\">",
"       picture 2",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33480?source=see_link\">",
"       \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Herpes simplex virus (",
"      <a class=\"graphic graphic_picture graphicRef62720 graphicRef73975 \" href=\"mobipreview.htm?33/33/34327\">",
"       picture 3A-B",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=see_link&amp;anchor=H23#H23\">",
"       \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\", section on 'Respiratory tract infections'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/31/35321?source=see_link&amp;anchor=H9#H9\">",
"       \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Disseminated disease'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of an infiltrate on chest radiograph is often used to define pneumonia, particularly in clinical research [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/23,33\">",
"     23,33",
"    </a>",
"    ]. The radiographic definition is necessary because of the difficulty in obtaining appropriate specimens from the lower respiratory tract for culture or microbiologic evaluation. This peculiarity makes it difficult to assess the degree to which chest radiographs are actually needed to diagnose pneumonia in the clinical setting, as the likelihood ratio of a standard cannot be measured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine chest radiographs are not necessary to confirm the diagnosis of suspected community-acquired pneumonia (CAP) in children with mild, uncomplicated lower respiratory tract infection who are well enough to be treated as outpatients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2,7\">",
"     1,2,7",
"    </a>",
"    ]. Indications for radiographs in children with clinical evidence of pneumonia include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2,7\">",
"     1,2,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe disease (",
"      <a class=\"graphic graphic_table graphicRef72015 \" href=\"mobipreview.htm?28/35/29244\">",
"       table 3",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Severity assessment'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Confirmation of the diagnosis when clinical findings are inconclusive",
"     </li>",
"     <li>",
"      Hospitalization (to document the presence, size, and character of parenchymal infiltrates and evaluate potential complications)",
"     </li>",
"     <li>",
"      Exclusion of alternate explanations for respiratory distress (eg, foreign body aspiration, heart failure), particularly in patients with underlying cardiopulmonary or medical conditions (see",
"      <a class=\"local\" href=\"#H33\">",
"       'Differential diagnosis'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Assessment of complications, particularly in children whose pneumonia is prolonged and unresponsive to antimicrobial therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7\">",
"       7",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H13#H13\">",
"       \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Treatment failure'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H2294532\">",
"       'Complications'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Exclusion of pneumonia in young children (3 to 36 months) with fever &gt;39&ordm;C and leukocytosis (&ge;20,000 white blood cell",
"      <span class=\"nowrap\">",
"       [WBC]/microL)",
"      </span>",
"      and older children (&lt;10 years) with fever &gt;38&ordm;C, cough, and leukocytosis (&ge;15,000",
"      <span class=\"nowrap\">",
"       WBC/microL)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/3,5\">",
"       3,5",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/14/22762?source=see_link\">",
"       \"Fever without a source in children 3 to 36 months of age\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of caveats to consider when deciding whether to obtain radiographs and whether radiographs will alter management. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiographic findings are poor indicators of the etiologic diagnosis and must be used in conjunction with other clinical features to make therapeutic decisions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2,34-37\">",
"       2,34-37",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H13#H13\">",
"       \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Treatment failure'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Radiographic findings may lag behind the clinical findings [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Patients who are hypovolemic may have normal-appearing chest radiography before volume repletion",
"     </li>",
"     <li>",
"      There is variation in intraobserver and interobserver agreement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2,39\">",
"       2,39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Radiographic interpretation may be influenced by the clinical information that is provided to the radiologist [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Obtaining outpatient chest radiographs does not affect outcome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Views",
"    </span>",
"    &nbsp;&mdash;&nbsp;When radiographs are indicated, the recommended views depend upon the age of the child [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/42\">",
"     42",
"    </a>",
"    ]. In children older than four years, the frontal posteroanterior (PA) upright chest view is usually obtained to minimize the cardiac shadow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/43\">",
"     43",
"    </a>",
"    ]. In younger children, position does not affect the size of the cardiothoracic shadow, and the anteroposterior (AP) supine view is preferred because immobilization is easier and the likelihood of a better inspiration is improved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a lack of consensus regarding the need for lateral radiographs to demonstrate infiltrates behind the dome of the diaphragm or the cardiac shadow that may not be visualized on AP or PA views [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44\">",
"     44",
"    </a>",
"    ]. In a review of chest radiographs in 201 children with pneumonia, the lateral film was abnormal in 91 percent of 109 children with definite pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/45\">",
"     45",
"    </a>",
"    ]. However, it was the sole basis for the diagnosis in only three cases.",
"    <br/>",
"    <br/>",
"    We suggest that a lateral view be obtained in settings where the radiographs are interpreted by nonradiologists. The Pediatric Infectious Diseases Society and Infectious Diseases Society of America suggest PA and lateral views for all children who are hospitalized for management of CAP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"     1",
"    </a>",
"    ]. The British Thoracic Society guidelines recommend against lateral radiographs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A lateral decubitus radiograph (with the affected side down) may be needed to identify the presence of a pleural effusion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/34/9770?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children\", section on 'Radiologic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High-resolution computed tomography and ultrasonography are available for patients who require more extensive imaging or clarification of plain radiographic findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Etiologic clues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain radiographic features that are more often associated with bacterial, atypical bacterial, or viral etiologies are listed below. However, none can reliably differentiate between a bacterial, atypical bacterial, and viral pneumonia (",
"    <a class=\"graphic graphic_table graphicRef52021 \" href=\"mobipreview.htm?22/2/22573\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/26,47-49\">",
"     26,47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Segmental consolidation is reasonably specific for bacterial pneumonia but lacks sensitivity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/36,50\">",
"       36,50",
"      </a>",
"      ]. Radiologic features of segmental consolidation are not always easy to distinguish from segmental collapse (atelectasis), which is apparent in about 25 percent of children with bronchiolitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/51,52\">",
"       51,52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In clinical practice it is common to consider alveolar infiltrates to be caused by bacteria and bilateral diffuse interstitial infiltrates to be caused by atypical bacterial or viral infections. However, this is not supported in the literature. In a study of 254 children with radiographically defined pneumonia, the etiology was determined in 215 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/35\">",
"       35",
"      </a>",
"      ]. The sensitivity and specificity of alveolar infiltrate for bacterial pneumonia were 72 and 51 percent, respectively; the sensitivity and specificity of interstitial infiltrates for viral pneumonia were 49 and 72 percent, respectively. A lobar infiltrate is reasonably specific for a bacterial pneumonia but lacks sensitivity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/29,53\">",
"       29,53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pulmonary consolidation in young children sometimes appears to be spherical (ie, \"round pneumonia\") [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. Round pneumonias tend to be &gt;3 cm, solitary, and posteriorly located [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. The most common bacterial etiology for round pneumonia is",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      ; additional bacterial causes include other streptococci,",
"      <em>",
"       Haemophilus influenzae",
"      </em>",
"      ,",
"      <em>",
"       S. aureus",
"      </em>",
"      , and",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/36,57\">",
"       36,57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pneumatoceles, cavitations, large pleural effusions (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86360 graphicRef86361 \" href=\"mobipreview.htm?38/31/39414\">",
"       image 1A-B",
"      </a>",
"      ), and necrotizing processes (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86362 \" href=\"mobipreview.htm?19/30/19941\">",
"       image 2",
"      </a>",
"      ) are supportive of a bacterial etiology.",
"     </li>",
"     <li>",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      and viruses are most likely to spread diffusely along the branches of the bronchial tree, resulting in a bronchopneumonic pattern (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86363 \" href=\"mobipreview.htm?1/6/1121\">",
"       image 3",
"      </a>",
"      ). However,",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      have been associated with a similar radiographic pattern in children. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35001?source=see_link&amp;anchor=H6#H6\">",
"       \"Pneumococcal pneumonia in children\", section on 'Radiographic features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In young infants, hyperinflation with an interstitial process is characteristic of afebrile pneumonia of infancy, typically caused by",
"      <em>",
"       C. trachomatis",
"      </em>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27992?source=see_link&amp;anchor=H7#H7\">",
"       \"Chlamydia trachomatis infections in the newborn\", section on 'Pneumonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Significant",
"      <span class=\"nowrap\">",
"       mediastinal/hilar",
"      </span>",
"      adenopathy suggests a mycobacterial or fungal etiology.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation of the child with community-acquired pneumonia (CAP) depends on the clinical scenario, including the age of the child, severity of illness, presence of potential complications, and whether the child requires hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"     1",
"    </a>",
"    ]. More aggressive evaluation is required when it is necessary to determine a microbiologic etiology (eg, in children with severe disease, potential complications, and who require hospital admission) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2\">",
"     2",
"    </a>",
"    ]. An etiologic diagnosis in such children helps to direct pathogen-specific therapy and permits cohorting of children if necessary to prevent the spread of nosocomial infection.",
"   </p>",
"   <p>",
"    Young infants in whom pneumonia is suspected, particularly those who are febrile and toxic appearing, require a full evaluation for sepsis and other serious bacterial infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete blood count (CBC) with differential and acute phase reactants may provide supportive evidence for bacterial or viral pneumonia, but should not be used as the only criteria in determining the need for antimicrobial therapy. Serum electrolytes may be useful in assessing the degree of dehydration and the presence of hyponatremia, which may indicate the syndrome of inappropriate antidiuretic hormone secretion (SIADH). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7913?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\", section on 'Pulmonary disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count &ndash; CBC usually is not necessary for children with mild lower respiratory tract infection who will be treated as outpatients, unless the CBC will determine the need for antibiotic therapy. CBC typically is performed in infants and children who require hospital admission. Certain CBC findings, described below, are more characteristic of bacterial, atypical bacterial, or viral pneumonias. However, the findings overlap and cannot reliably differentiate between the etiologic agents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      White blood cell (WBC) count",
"      <span class=\"nowrap\">",
"       &lt;15,000/microL",
"      </span>",
"      suggests a nonbacterial etiology, except in the severely ill patient, who also may be neutropenic and have a predominance of immature cells.",
"     </li>",
"     <li>",
"      WBC count",
"      <span class=\"nowrap\">",
"       &gt;15,000/microL",
"      </span>",
"      is suggestive of pyogenic bacterial disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/58\">",
"       58",
"      </a>",
"      ]. However, children with",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      , influenza, or adenovirus pneumonia also may have WBC count",
"      <span class=\"nowrap\">",
"       &gt;15,000/microL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/59-61\">",
"       59-61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Peripheral eosinophilia may be present in infants with afebrile pneumonia of infancy, typically caused by",
"      <em>",
"       C. trachomatis",
"      </em>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27992?source=see_link&amp;anchor=H7#H7\">",
"       \"Chlamydia trachomatis infections in the newborn\", section on 'Pneumonia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute phase reactants &ndash; Acute phase reactants, such as the erythrocyte sedimentation rate, C-reactive protein (CRP), and serum procalcitonin (PCT), need not be routinely measured in fully immunized children with CAP managed as outpatients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"       1",
"      </a>",
"      ]. However, for those with more serious disease requiring hospitalization, measurement of acute phase reactants may provide useful information to assist clinical management.",
"      <br/>",
"      <br/>",
"      Measurement of serum CRP may be helpful in distinguishing bacterial from viral pneumonia. A meta-analysis of eight studies including 1230 patients suggested that children with bacterial pneumonia were more likely to have serum CRP concentrations greater than 35 to 60",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      (3.5 to 6",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      than children with nonbacterial pneumonia (odds ratio 2.6, 95% CI 1.2-5.6) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/62\">",
"       62",
"      </a>",
"      ]. Given a 41 percent prevalence of bacterial pneumonia, the positive predictive value for CRP values of 40 to 60",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      (4 to 6",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      was 64 percent. An elevated serum PCT concentration may be as sensitive as but more specific than an increased CRP level for differentiating a bacterial from a viral process [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/26,63,64\">",
"       26,63,64",
"      </a>",
"      ]. However, predictable utility has not been documented [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,65,66\">",
"       1,65,66",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Acute phase reactants should not be used as the sole determinant to distinguish between viral and bacterial etiologies of CAP but may be helpful in following the disease course, response to therapy, and in determining when therapy can be discontinued [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,65,67,68\">",
"       1,65,67,68",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H26#H26\">",
"       \"Inpatient treatment of pneumonia in children\", section on 'Duration of treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum electrolytes &ndash; Measurement of serum electrolytes may be helpful in assessing the degree of dehydration in children with limited fluid intake and whether hyponatremia is present (as pneumonia may be complicated by SIADH). (See",
"      <a class=\"local\" href=\"#H2294532\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H254167804\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;If possible, a microbiologic diagnosis should be established in children with severe disease (",
"    <a class=\"graphic graphic_table graphicRef72015 \" href=\"mobipreview.htm?28/35/29244\">",
"     table 3",
"    </a>",
"    ), potential complications, and those who require hospitalization. Accurate and rapid diagnosis of the responsible pathogen helps to determine the appropriate antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H13#H13\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A microbiologic diagnosis also should be established if there appears to be a community outbreak [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/69\">",
"     69",
"    </a>",
"    ] or if an unusual pathogen is suspected, particularly if it requires treatment that differs from standard empiric regimens (eg, S",
"    <em>",
"     . aureus",
"    </em>",
"    including methicillin-resistant strains,",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    ). (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Critical microbes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children with mild disease who are treated as outpatients usually can be treated empirically, based on age and other epidemiologic features, without establishing a microbiologic etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2,70\">",
"     2,70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H3#H3\">",
"     \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Microbiologic diagnosis can be established with culture, rapid diagnostic testing (enzyme immunoassay, immunofluorescence, polymerase chain reaction [PCR]), or serology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Cultures",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood cultures &ndash; We suggest that blood cultures be performed in children with CAP who require admission to the hospital and in children with parapneumonic effusion or other complication [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2,71\">",
"       1,2,71",
"      </a>",
"      ]. Although blood cultures are positive in at most 10 to 12 percent of children with pneumonia, when positive they help to confirm the etiologic diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/72-74\">",
"       72-74",
"      </a>",
"      ]. The yield of blood cultures increases to 30 to 40 percent in patients with a parapneumonic effusion or empyema [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/74-76\">",
"       74-76",
"      </a>",
"      ]. The utility of blood culture is limited when antibiotics are administered before obtaining the specimen. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=see_link\">",
"       \"Blood cultures for the detection of bacteremia\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Blood cultures are not necessary in children with CAP who will be treated as outpatients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,7,72,77\">",
"       1,7,72,77",
"      </a>",
"      ]. In the outpatient setting, the likelihood of a positive blood culture in children with CAP is less than 3 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/72,73\">",
"       72,73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nasopharyngeal cultures &ndash; We do not suggest obtaining nasopharyngeal (NP) cultures for etiologic diagnosis in children with pneumonia. Bacterial organisms recovered from the nasopharynx do not accurately predict the etiology of pneumonia because bacteria that cause pneumonia also may be normal upper respiratory flora. The results of NP cultures for viruses and atypical bacterial although helpful may not be available soon enough to assist with management decisions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7\">",
"       7",
"      </a>",
"      ]. Rapid diagnostic tests for viruses and atypical bacteria are discussed below. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Rapid diagnostic tests'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Sputum cultures &ndash; We suggest that sputum samples for Gram stain and culture be obtained in children who require hospital admission if they are able to produce sputum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"       1",
"      </a>",
"      ]. Children younger than five years usually swallow sputum, so it is rarely available for examination. Good-quality sputum samples can be obtained by sputum induction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/78\">",
"       78",
"      </a>",
"      ]. However, sputum induction is unpleasant and not routinely necessary because most children respond to empiric antimicrobial therapy. It may be beneficial in children who require intensive-care therapy, have a pleural effusion, or fail to respond to empiric therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/78,79\">",
"       78,79",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H12#H12\">",
"       \"Inpatient treatment of pneumonia in children\", section on 'Empiric therapy'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      As a general guide, an appropriate sputum specimen for examination is one with &le;10 epithelial cells and &ge;25 polymorphonuclear leukocytes (PMN) under low power (x100) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/80\">",
"       80",
"      </a>",
"      ]. A predominant microorganism",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intracellular organisms suggest the etiologic agent. When the following criteria are used, the specificity of the Gram stain for identifying pneumococci has been shown to be 85 percent, with a sensitivity of 62 percent: predominant flora or more than 10 Gram-positive, lancet-shaped diplococci per oil immersion field (x1000) (",
"      <a class=\"graphic graphic_picture graphicRef75924 \" href=\"mobipreview.htm?21/0/21507\">",
"       picture 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pleural fluid cultures &ndash; Diagnostic (and possibly therapeutic) thoracentesis generally is warranted for children with more than minimal pleural effusion. Specimens for culture of pleural fluid ideally should be obtained before administration of antibiotics. The evaluation of pleural fluid is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/34/9770?source=see_link&amp;anchor=H16#H16\">",
"       \"Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children\", section on 'Pleural fluid analysis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Rapid diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid diagnostic tests, such as molecular testing using PCR techniques and immunofluorescence, on NP specimens can be helpful in the management of infants and children who are admitted to the hospital with probable viral or atypical bacterial CAP. The results of rapid diagnostic tests can be used to make decisions about treatment and cohorting of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"     1",
"    </a>",
"    ]. The rapid diagnostic tests that are available for the following pathogens are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory syncytial virus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7050?source=see_link&amp;anchor=H25#H25\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Influenza viruses (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24346?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Parainfluenza viruses (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36808?source=see_link&amp;anchor=H11#H11\">",
"       \"Parainfluenza viruses in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Adenovirus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/40/37513?source=see_link&amp;anchor=H13#H13\">",
"       \"Diagnosis and treatment of adenovirus infection\", section on 'Pneumonia'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <em>",
"       M. pneumoniae",
"      </em>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=see_link&amp;anchor=H15#H15\">",
"       \"Mycoplasma pneumoniae infection in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <em>",
"       Chlamydophila",
"      </em>",
"      spp (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33062?source=see_link&amp;anchor=H7#H7\">",
"       \"Pneumonia caused by Chlamydophila (Chlamydia) species in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Human metapneumovirus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/33/33304?source=see_link&amp;anchor=H14#H14\">",
"       \"Human metapneumovirus infections\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest routine serologic testing for specific pathogens (eg,",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    ,",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    ,",
"    <em>",
"     C. pneumoniae",
"    </em>",
"    ) because the results usually do not influence management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7,82,83\">",
"     7,82,83",
"    </a>",
"    ]. Serologic diagnosis of viral pathogens is not practical because acute and convalescent specimens are needed.",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    has too many potential infecting serotypes to make antibody determinations practical. Serologic tests for",
"    <em>",
"     Chlamydophila",
"    </em>",
"    spp are not readily available.",
"   </p>",
"   <p>",
"    Although most older children with atypical pneumonia can be treated empirically for",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    , serologic and PCR testing can be helpful in evaluating the younger child. These tests also may be helpful in establishing the diagnosis of",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    in patients with extrapulmonary manifestations, particularly central nervous system manifestations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=see_link&amp;anchor=H5#H5\">",
"     \"Mycoplasma pneumoniae infection in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other tests that may be helpful in establishing less common microbiologic etiologies of CAP in children include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tuberculin skin and interferon gamma release assay if pulmonary tuberculosis is a consideration; additional diagnostic testing for tuberculosis in children is discussed separately (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"       \"Tuberculosis disease in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Urine antigen testing for legionellosis due to serogroup 1 (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical manifestations and diagnosis of Legionella infection\", section on 'Urinary antigen testing'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Serum and urine antigen testing for histoplasmosis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21881?source=see_link&amp;anchor=H6#H6\">",
"       \"Diagnosis and treatment of pulmonary histoplasmosis\", section on 'Antigen detection'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Urine antigen testing for",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      in children should not be performed because of false positive reactions, some of which may merely indicate colonization with",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Invasive studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive procedures may be necessary to obtain lower respiratory tract specimens for culture and other studies in children in whom an etiologic diagnosis is necessary and has not been established by other means [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,84-87\">",
"     1,84-87",
"    </a>",
"    ]. These procedures are typically reserved for seriously ill patients whose condition is worsening despite empiric therapy, or individuals with significant comorbidities (eg, immune compromise). They include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,84-86\">",
"     1,84-86",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchoscopy with bronchoalveolar lavage (BAL). Because the accurate identification of bacterial pathogens via bronchoscopy is hampered by specimen contamination with upper airway normal flora, quantitative culture techniques are utilized in many centers to differentiate true infection from upper airway contamination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/88-90\">",
"       88-90",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Percutaneous needle aspiration of the affected lung tissue guided by computed tomography or ultrasonography. A small study from Finland found that needle aspiration determined an infectious etiology (21 bacteria and 2 viruses) in 20 of 34 patients (59 percent) studied and in 18 of 26 (69 percent) of those in whom an adequate specimen was obtained [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/84\">",
"       84",
"      </a>",
"      ]. Six patients developed a pneumothorax, which spontaneously resolved over two to three days without intervention.",
"     </li>",
"     <li>",
"      Lung biopsy either by a thoracoscopic or thoracotomy approach. Open biopsy yields diagnostic information that may affect medical management in up to 90 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/86\">",
"       86",
"      </a>",
"      ]. In one retrospective review, an infectious etiology was determined by open lung biopsy in 10 of 33 patients with respiratory failure, eight of whom had a prior nondiagnostic BAL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/85\">",
"       85",
"      </a>",
"      ]. In another retrospective review, lung biopsy provided a definitive diagnosis in 25 of 50 immunocompromised patients, nine of whom had a prior nondiagnostic BAL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Critical microbes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some microbes are critical to detect because they require treatment that differs from standard empiric regimens or have public health implications. Diagnostic testing for these pathogens is discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Influenza A and B (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24346?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Community-associated methicillin-resistant",
"      <em>",
"       S. aureus",
"      </em>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29802?source=see_link&amp;anchor=H17#H17\">",
"       \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Pneumonia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30042?source=see_link&amp;anchor=H12#H12\">",
"       \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'Epidemiology and risk factors'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <em>",
"       M. tuberculosis",
"      </em>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=see_link\">",
"       \"Tuberculosis disease in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fungal etiologies (",
"      <em>",
"       Coccidioides immitis",
"      </em>",
"      ,",
"      <em>",
"       Blastomyces dermatitidis",
"      </em>",
"      ,",
"      <em>",
"       Histoplasma capsulatum",
"      </em>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/425?source=see_link\">",
"       \"Primary coccidioidal infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/79?source=see_link\">",
"       \"Mycology, pathogenesis, and epidemiology of blastomycosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29912?source=see_link\">",
"       \"Treatment of blastomycosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21881?source=see_link\">",
"       \"Diagnosis and treatment of pulmonary histoplasmosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <em>",
"       Legionella",
"      </em>",
"      species (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical manifestations and diagnosis of Legionella infection\", section on 'Specific laboratory diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Avian influenza (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22599?source=see_link&amp;anchor=H13#H13\">",
"       \"Clinical manifestations and diagnosis of avian influenza\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hantavirus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/14/38119?source=see_link\">",
"       \"Hantavirus cardiopulmonary syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Agents of bioterrorism (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=see_link\">",
"       \"Identifying and managing casualties of biological terrorism\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of pneumonia requires historical or physical examination evidence of an acute infectious process with signs or symptoms of respiratory distress or radiologic evidence of an acute pulmonary infiltrate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7,30\">",
"     7,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic approach depends, to some extent, upon the setting and the severity of illness. In the appropriate clinical setting, the diagnosis can be made without radiographs. In children with severe illness, and in those who require hospital admission, the diagnosis should be confirmed with radiographs. If possible, etiologic diagnosis should be established in children who require admission to the hospital and in those who fail to respond to initial therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H13#H13\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of pneumonia should be considered in infants and children with respiratory complaints, particularly cough, tachypnea, retractions, and abnormal lung examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2,3,7\">",
"     2,3,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of pneumonia can be made clinically in children with fever and historical or physical examination evidence of an infectious process with symptoms or signs of respiratory distress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7\">",
"     7",
"    </a>",
"    ]. Tachypnea, nasal flaring, grunting, retractions, rales, and decreased breath sounds increase the likelihood of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,9,30,92\">",
"     4,9,30,92",
"    </a>",
"    ]. The absence of tachypnea is helpful in excluding pneumonia; the absence of the other signs is not. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Tachypnea'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In developing countries where there is a high prevalence of pneumonia, the presence of a single positive respiratory sign increases the certainty of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"     4",
"    </a>",
"    ]. The World Health Organization uses tachypnea (&gt;60",
"    <span class=\"nowrap\">",
"     breaths/min",
"    </span>",
"    in infants &lt;2 months; &gt;50",
"    <span class=\"nowrap\">",
"     breaths/min",
"    </span>",
"    in infants 2 to 12 months; and &gt;40",
"    <span class=\"nowrap\">",
"     breaths/min",
"    </span>",
"    in children 1 to 5 years; and &gt;20",
"    <span class=\"nowrap\">",
"     breaths/min",
"    </span>",
"    in children &ge;5 years) as the sole criterion to define pneumonia in children with cough or difficulty breathing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/15\">",
"     15",
"    </a>",
"    ]. In developed countries with a lower prevalence of pneumonia, multiple respiratory signs are necessary to increase the certainty of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4,93\">",
"     4,93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Radiographic confirmation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of infiltrates on chest radiograph confirms the diagnosis of pneumonia in children with compatible clinical findings. Radiographs should be obtained in children in whom the diagnosis is uncertain and in those with severe, complicated, or recurrent pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1,2,94\">",
"     1,2,94",
"    </a>",
"    ]. Radiographic confirmation is not necessary in children with mild, uncomplicated lower respiratory tract infection who will be treated as outpatients. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Indications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Radiographic findings cannot reliably distinguish between bacterial, atypical bacterial, and viral etiologies of pneumonia. Radiographic findings should be used in conjunction with clinical and microbiologic data to make therapeutic decisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H3#H3\">",
"     \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Empiric therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H12#H12\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Etiologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiologic agent is suggested by host characteristics, clinical presentation, epidemiologic considerations, and, to some degree, the results of nonspecific laboratory tests and chest radiographic patterns (",
"    <a class=\"graphic graphic_table graphicRef52021 \" href=\"mobipreview.htm?22/2/22573\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Clues to etiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Etiologic clues'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link&amp;anchor=H14#H14\">",
"     \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'Etiologic agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Specific microbiologic tests can be used to confirm the etiologic diagnosis. Confirmation of etiologic diagnosis is not necessary in mildly ill patients who can be treated empirically in the outpatient setting. Confirmation of etiologic diagnosis should be attempted in children who are admitted to the hospital or are suspected to be infected with an unusual pathogen, or a pathogen that requires treatment that differs from standard empiric regimens, so that therapy can be directed toward the appropriate pathogen. Etiologic diagnosis also is necessary in children who fail to respond to initial therapy. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Microbiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H28\">",
"     'Critical microbes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H12#H12\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although pneumonia is highly probable in a child with fever, tachypnea, cough, and infiltrate(s) on chest radiograph, alternate diagnoses and coincident conditions must be considered in children who fail to respond to therapy or have an unusual",
"    <span class=\"nowrap\">",
"     presentation/course",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/7\">",
"     7",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The Table lists a number of other conditions that can mimic an infectious pneumonia (",
"    <a class=\"graphic graphic_table graphicRef65148 \" href=\"mobipreview.htm?24/33/25117\">",
"     table 5",
"    </a>",
"    ). History",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated clinical features usually help to distinguish the conditions in the table from infectious pneumonia. In some cases, laboratory studies or additional imaging may be necessary.",
"   </p>",
"   <p>",
"    Foreign body aspiration must be considered in young children. The aspiration event may not have been witnessed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link&amp;anchor=H3#H3\">",
"     \"Airway foreign bodies in children\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of tachypnea, with or without fever and cough, in infants and young children include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/95\">",
"     95",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchiolitis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16074?source=see_link&amp;anchor=H7#H7\">",
"       \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Heart failure",
"     </li>",
"     <li>",
"      Sepsis",
"     </li>",
"     <li>",
"      Metabolic acidosis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6330?source=see_link&amp;anchor=H15#H15\">",
"       \"Approach to the child with metabolic acidosis\", section on 'Clinical evaluation and diagnosis'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These conditions usually can be distinguished from pneumonia by history, examination, and laboratory tests.",
"   </p>",
"   <p>",
"    Lemierre syndrome (jugular vein suppurative thrombophlebitis) is an important consideration in adolescents and young adults whose illness began with pharyngitis. In Lemierre syndrome, the vessels of the carotid sheath become infected (typically with",
"    <em>",
"     Fusobacterium",
"    </em>",
"    spp), leading to bacteremia and metastatic spread of infection to the lungs and mediastinum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/0/2055?source=see_link&amp;anchor=H11#H11\">",
"     \"Suppurative (septic) thrombophlebitis\", section on 'Jugular vein'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Community-acquired pneumonia (CAP) can be misdiagnosed in young children with asthma who have viral respiratory infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/96\">",
"     96",
"    </a>",
"    ]. Many such children have respiratory distress and may have hypoxemia. The diagnosis of CAP and treatment with antibiotics must be carefully considered in young children who have a prodrome compatible with a viral respiratory infection and wheezing, even if there are pulmonary infiltrates (versus atelectasis) on chest radiograph. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26010?source=see_link&amp;anchor=H9#H9\">",
"     \"Chronic asthma in children younger than 12 years: Evaluation and diagnosis\", section on 'Viral URI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rare, noninfectious lung diseases may present with an intercurrent infectious illness. Pulmonary alveolar proteinosis, eosinophilic pneumonia, acute interstitial pneumonitis, and cryptogenic organizing pneumonia are entities that should be considered, especially if the acute illness is atypical or the radiographic and clinical findings do not resolve as expected with uncomplicated CAP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/62/8168?source=see_link\">",
"     \"Clinical manifestations and etiology of pulmonary alveolar proteinosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/14/1255?source=see_link\">",
"     \"Idiopathic acute eosinophilic pneumonia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22792?source=see_link\">",
"     \"Acute interstitial pneumonia (Hamman-Rich syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19402?source=see_link\">",
"     \"Cryptogenic organizing pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294532\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial pneumonias are more likely than atypical bacterial or viral pneumonias to be associated with complications involving the respiratory tract. Complications of bacterial pneumonia include pleural effusion (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef86360 graphicRef86361 \" href=\"mobipreview.htm?38/31/39414\">",
"     image 1A-B",
"    </a>",
"    ), empyema, pneumatoceles, necrotizing pneumonia (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef86362 \" href=\"mobipreview.htm?19/30/19941\">",
"     image 2",
"    </a>",
"    ), and lung abscesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294655\">",
"    <span class=\"h2\">",
"     Pleural effusion and empyema",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features, evaluation, and management of parapneumonic effusion and empyema in children are discussed separately. Hypoalbuminemia is common in children with parapneumonic effusions and hypogammaglobulinemia may be encountered. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Blood tests'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/34/9770?source=see_link\">",
"     \"Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27882?source=see_link\">",
"     \"Management and prognosis of parapneumonic effusion and empyema in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294662\">",
"    <span class=\"h2\">",
"     Necrotizing pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrotizing pneumonia, necrosis, and liquefaction of lung parenchyma, is a serious complication of community-acquired pneumonia (CAP). Necrotizing pneumonia usually follows pneumonia caused by particularly virulent bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/94\">",
"     94",
"    </a>",
"    ].",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    (especially serotype 3 and serogroup 19) is the most common cause of necrotizing pneumonia (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef86362 \" href=\"mobipreview.htm?19/30/19941\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/97-102\">",
"     97-102",
"    </a>",
"    ]. Necrotizing pneumonia also may occur with",
"    <em>",
"     S. aureus",
"    </em>",
"    and group A streptococcus and has been reported due to",
"    <em>",
"     M. pneumoniae",
"    </em>",
"    ,",
"    <em>",
"     Legionella",
"    </em>",
"    , and",
"    <em>",
"     Aspergillus",
"    </em>",
"    . [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/102-106\">",
"     102-106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical manifestations of necrotizing pneumonia are similar to those of uncomplicated pneumonia, but they are more severe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/107,108\">",
"     107,108",
"    </a>",
"    ]. Necrotizing pneumonia should be considered in a child with prolonged fever or septic appearance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/94\">",
"     94",
"    </a>",
"    ]. The diagnosis can be confirmed by chest radiograph (which demonstrates a radiolucent lesion) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53664 \" href=\"mobipreview.htm?27/28/28096\">",
"     image 4",
"    </a>",
"    ) or contrast-enhanced computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/109\">",
"     109",
"    </a>",
"    ]; the findings on chest radiograph may lag behind those of computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/105\">",
"     105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pleural",
"    <span class=\"nowrap\">",
"     effusion/empyema",
"    </span>",
"    generally accompanies necrotizing pneumonia whereas bronchopleural fistula, pneumatocele, or abscess formation (which typically is insidious) is much less common. Drainage of the pleural fluid collection is frequently required but pneumonectomy is rarely needed. (See",
"    <a class=\"local\" href=\"#H2294676\">",
"     'Pneumatocele'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H2294669\">",
"     'Lung abscess'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Treatment of necrotizing pneumonia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H96270984#H96270984\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Complicated CAP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294669\">",
"    <span class=\"h2\">",
"     Lung abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lung abscess is an accumulation of inflammatory cells, accompanied by tissue destruction or necrosis that produces one or more cavities in the lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44\">",
"     44",
"    </a>",
"    ]. Aspiration is the most important predisposing factor for lung abscess, which may develop one to two weeks after the aspiration event; other predisposing factors include airway obstruction and congenitally abnormal lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44\">",
"     44",
"    </a>",
"    ].",
"    <em>",
"     S. aureus",
"    </em>",
"    is the organism most frequently involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical manifestations of lung abscess are nonspecific and similar to those of pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44\">",
"     44",
"    </a>",
"    ]. They include fever, cough, dyspnea, chest pain, anorexia, hemoptysis, and putrid breath [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44,94,110-112\">",
"     44,94,110-112",
"    </a>",
"    ]. The course may be indolent.",
"   </p>",
"   <p>",
"    The diagnosis is suggested by a chest radiograph demonstrating a thick-walled cavity with an air-fluid level (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53664 \" href=\"mobipreview.htm?27/28/28096\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44\">",
"     44",
"    </a>",
"    ], and confirmed by contrast-enhanced computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/109\">",
"     109",
"    </a>",
"    ]. Lung abscess is often accompanied by parapneumonic effusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/113,114\">",
"     113,114",
"    </a>",
"    ]. Lung abscess should be suspected when consolidation is unusually persistent, when pneumonia remains persistently round or mass-like, and when the volume of the involved lobe is increased (as suggested by a bulging fissure) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/44,115\">",
"     44,115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interventional radiology may be helpful in obtaining a specimen from the abscess cavity for diagnostic studies. Treatment of lung abscess is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H96270984#H96270984\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Complicated CAP'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common complication of lung abscess is intracavitary hemorrhage. This can cause hemoptysis or spillage of the abscess contents with spread of infection to other areas of the lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/107\">",
"     107",
"    </a>",
"    ]. Other complications of lung abscess include empyema, bronchopleural fistula, septicemia, cerebral abscess, and inappropriate secretion of antidiuretic hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294676\">",
"    <span class=\"h2\">",
"     Pneumatocele",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumatoceles are thin-walled, air-containing cysts of the lungs. They are classically associated with",
"    <em>",
"     S. aureus",
"    </em>",
"    , but may occur with a variety of organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. Pneumatoceles frequently occur in association with empyema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/116\">",
"     116",
"    </a>",
"    ]. In most cases, pneumatoceles involute spontaneously, and long-term lung function is normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/116,118,119\">",
"     116,118,119",
"    </a>",
"    ]. However, on occasion, pneumatoceles result in pneumothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2294683\">",
"    <span class=\"h2\">",
"     Hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyponatremia (serum sodium concentration &le;135",
"    <span class=\"nowrap\">",
"     meq/L)",
"    </span>",
"    occurs in approximately 45 percent of children with CAP and one-third of children hospitalized with CAP, but is usually mild [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/120-122\">",
"     120-122",
"    </a>",
"    ]. Inappropriate secretion of antidiuretic hormone (ADH) is the most frequent cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/3/38970/abstract/120,121\">",
"     120,121",
"    </a>",
"    ]. Hyponatremia is associated with increased length of hospital stay, complications, and mortality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7913?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)\", section on 'Pulmonary disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476673345\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR HOSPITALIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for hospitalization are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link&amp;anchor=H3#H3\">",
"     \"Inpatient treatment of pneumonia in children\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/17/14611?source=see_link\">",
"       \"Patient information: Pneumonia in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presenting signs and symptoms of community-acquired pneumonia (CAP) are nonspecific; no single symptom or sign is pathognomonic for pneumonia in children. The combination of fever and cough is suggestive of pneumonia, but the presentation may be subtle, or misleading (eg, abdominal pain or nuchal rigidity). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history should focus on features that can help to define the clinical syndrome (eg, pneumonia, bronchiolitis) and narrow the list of potential pathogens (",
"      <a class=\"graphic graphic_table graphicRef52510 \" href=\"mobipreview.htm?8/59/9149\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=see_link&amp;anchor=H14#H14\">",
"       \"Epidemiology, pathogenesis, and etiology of pneumonia in children\", section on 'Etiologic agents'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Examination findings that have been correlated with radiographic pneumonia include tachypnea, increased work of breathing (retractions, nasal flaring, grunting, use of accessory muscles), hypoxemia, and adventitious lung sounds. Combinations of findings are more predictive than single findings. The absence of tachypnea is useful in excluding pneumonia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and examination are used to determine the severity of illness (",
"      <a class=\"graphic graphic_table graphicRef72015 \" href=\"mobipreview.htm?28/35/29244\">",
"       table 3",
"      </a>",
"      ), which determines, in part, the need for radiologic and laboratory evaluation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Severity assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neither clinical nor radiologic features reliably distinguish between bacterial, atypical bacterial, and viral pneumonia. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clues to etiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Etiologic clues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiographs are not necessary for children with pneumonia who are well enough to be treated as outpatients. We suggest that chest radiographs be obtained for the following indications:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Severe disease (",
"      <a class=\"graphic graphic_table graphicRef72015 \" href=\"mobipreview.htm?28/35/29244\">",
"       table 3",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Severity assessment'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Confirmation of the diagnosis when clinical findings are inconclusive",
"     </li>",
"     <li>",
"      Exclusion of alternate explanations for respiratory distress (see",
"      <a class=\"local\" href=\"#H33\">",
"       'Differential diagnosis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Evaluation for complications (see",
"      <a class=\"local\" href=\"#H2294532\">",
"       'Complications'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Exclusion of occult pneumonia in young children (3 to 36 months) with fever &gt;39&ordm;C, leukocytosis (white blood cell count",
"      <span class=\"nowrap\">",
"       &gt;20,000/microL),",
"      </span>",
"      and no obvious focus of infection (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Radiologic evaluation'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Routine laboratory evaluation is not necessary for children with clinical evidence of mild uncomplicated lower respiratory tract infection who will be treated as outpatients unless the findings will help in deciding whether antimicrobial therapy is necessary. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that attempts be made to establish an etiologic diagnosis in children with CAP who require hospital admission. A complete blood count with differential and blood culture should be obtained in all such patients. If produced, a good quality sputum should be submitted for Gram stain and culture. Other specimens for microbiologic testing should be obtained as indicated by the clinical scenario. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Attempts also should be made to establish (or exclude) an etiologic diagnosis in patients suspected to have CAP caused by pathogens that require treatment regimens that differ from standard empiric regimens. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Critical microbes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alternate diagnoses and coincident conditions must be considered in children who fail to respond to therapy or who have an unusual presentation or course (",
"      <a class=\"graphic graphic_table graphicRef65148 \" href=\"mobipreview.htm?24/33/25117\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H33\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=see_link&amp;anchor=H13#H13\">",
"       \"Outpatient treatment of community-acquired pneumonia in children\", section on 'Treatment failure'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=see_link\">",
"       \"Inpatient treatment of pneumonia in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complications of CAP in children include pleural effusion and empyema, necrotizing pneumonia, lung abscess, pneumatocele, and hyponatremia. (See",
"      <a class=\"local\" href=\"#H2294532\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/1\">",
"      Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/2\">",
"      Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011; 66 Suppl 2:ii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/3\">",
"      Murphy CG, van de Pol AC, Harper MB, Bachur RG. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med 2007; 14:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/4\">",
"      Margolis P, Gadomski A. The rational clinical examination. Does this infant have pneumonia? JAMA 1998; 279:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/5\">",
"      Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999; 33:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/6\">",
"      Bradley JS. Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. Pediatr Infect Dis J 2002; 21:592.",
"     </a>",
"    </li>",
"    <li>",
"     Community acquired pneumonia guideline team, Cincinnati Children's Hospital Medical Center. Evidence-based care guidelines for medical management of community acquired pneumonia in children 60 days to 17 years of age. Guideline 14. www.cincinnatichildrens.org/svc/alpha/h/health-policy/ev-based/pneumonia.htm (Accessed on September 22, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/8\">",
"      Jadavji T, Law B, Lebel MH, et al. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ 1997; 156:S703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/9\">",
"      Pereira JC, Escuder MM. The importance of clinical symptoms and signs in the diagnosis of community-acquired pneumonia. J Trop Pediatr 1998; 44:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/10\">",
"      McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002; 346:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/11\">",
"      Palafox M, Guiscafr&eacute; H, Reyes H, et al. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000; 82:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/12\">",
"      Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr (Phila) 2005; 44:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/13\">",
"      Lynch T, Platt R, Gouin S, et al. Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs? Pediatrics 2004; 113:e186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/14\">",
"      Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1998; 18:31.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. The management of acute respiratory infections in children. In: Practical guidelines for outpatient care. World Health Organization, Geneva 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/16\">",
"      Russell G. Community acquired pneumonia. Arch Dis Child 2001; 85:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/17\">",
"      Simoes EA, Roark R, Berman S, et al. Respiratory rate: measurement of variability over time and accuracy at different counting periods. Arch Dis Child 1991; 66:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/18\">",
"      Gadomski AM, Khallaf N, el Ansary S, Black RE. Assessment of respiratory rate and chest indrawing in children with ARI by primary care physicians in Egypt. Bull World Health Organ 1993; 71:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/19\">",
"      Berman S, Simoes EA, Lanata C. Respiratory rate and pneumonia in infancy. Arch Dis Child 1991; 66:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/20\">",
"      Gadomski AM, Permutt T, Stanton B. Correcting respiratory rate for the presence of fever. J Clin Epidemiol 1994; 47:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/21\">",
"      Margolis PA, Ferkol TW, Marsocci S, et al. Accuracy of the clinical examination in detecting hypoxemia in infants with respiratory illness. J Pediatr 1994; 124:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/22\">",
"      Heulitt MJ, Ablow RC, Santos CC, et al. Febrile infants less than 3 months old: value of chest radiography. Radiology 1988; 167:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/23\">",
"      Harari M, Shann F, Spooner V, et al. Clinical signs of pneumonia in children. Lancet 1991; 338:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/24\">",
"      Campbell H, Byass P, Lamont AC, et al. Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet 1989; 1:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/25\">",
"      Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1986; 5:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/26\">",
"      Korppi M, Don M, Valent F, Canciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr 2008; 97:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/27\">",
"      Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev 2012; 10:CD009175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/28\">",
"      British Thoracic Society Standards of Care Committee. British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002; 57 Suppl 1:i1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/29\">",
"      Tan TQ, Mason EO Jr, Barson WJ, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998; 102:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/30\">",
"      Leventhal JM. Clinical predictors of pneumonia as a guide to ordering chest roentgenograms. Clin Pediatr (Phila) 1982; 21:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/31\">",
"      Tipple MA, Beem MO, Saxon EM. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics 1979; 63:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/32\">",
"      Turner RB, Lande AE, Chase P, et al. Pneumonia in pediatric outpatients: cause and clinical manifestations. J Pediatr 1987; 111:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/33\">",
"      Taylor JA, Del Beccaro M, Done S, Winters W. Establishing clinically relevant standards for tachypnea in febrile children younger than 2 years. Arch Pediatr Adolesc Med 1995; 149:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/34\">",
"      Alario AJ, McCarthy PL, Markowitz R, et al. Usefulness of chest radiographs in children with acute lower respiratory tract disease. J Pediatr 1987; 111:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/35\">",
"      Virkki R, Juven T, Rikalainen H, et al. Differentiation of bacterial and viral pneumonia in children. Thorax 2002; 57:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/36\">",
"      Korppi M, Kiekara O, Heiskanen-Kosma T, Soimakallio S. Comparison of radiological findings and microbial aetiology of childhood pneumonia. Acta Paediatr 1993; 82:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/37\">",
"      Bettenay FA, de Campo JF, McCrossin DB. Differentiating bacterial from viral pneumonias in children. Pediatr Radiol 1988; 18:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/38\">",
"      Bruns AH, Oosterheert JJ, El Moussaoui R, et al. Pneumonia recovery: discrepancies in perspectives of the radiologist, physician and patient. J Gen Intern Med 2010; 25:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/39\">",
"      Davies HD, Wang EE, Manson D, et al. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. Pediatr Infect Dis J 1996; 15:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/40\">",
"      Kramer MS, Roberts-Br&auml;uer R, Williams RL. Bias and 'overcall' in interpreting chest radiographs in young febrile children. Pediatrics 1992; 90:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/41\">",
"      Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet 1998; 351:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/42\">",
"      Ablin DS, Newell JD 2nd. Diagnostic imaging for evaluation of the pediatric chest. Clin Chest Med 1987; 8:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/43\">",
"      Gaisie G, Dominguez R, Young LW. Comparison of AP supine vs PA upright methods of chest roentgenography in infants and young children. J Natl Med Assoc 1984; 76:171.",
"     </a>",
"    </li>",
"    <li>",
"     Miller MA, Ben-Ami T, Daum RS. Bacterial pneumonia in neonates and older children. In: Pediatric Respiratory Medicine, Taussig LM, Landau LI (Eds), Mosby, St. Louis 1999. p.595.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/45\">",
"      Kiekara O, Korppi M, Tanska S, Soimakallio S. Radiological diagnosis of pneumonia in children. Ann Med 1996; 28:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/46\">",
"      Kuhn JP, Brody AS. High-resolution CT of pediatric lung disease. Radiol Clin North Am 2002; 40:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/47\">",
"      Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clin Pediatr (Phila) 1989; 28:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/48\">",
"      McCarthy PL, Spiesel SZ, Stashwick CA, et al. Radiographic findings and etiologic diagnosis in ambulatory childhood pneumonias. Clin Pediatr (Phila) 1981; 20:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/49\">",
"      Clements H, Stephenson T, Gabriel V, et al. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child 2000; 83:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/50\">",
"      Lahti E, Peltola V, Virkki R, Ruuskanen O. Influenza pneumonia. Pediatr Infect Dis J 2006; 25:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/51\">",
"      Simpson W, Hacking PM, Court SD, Gardner PS. The radiological findings in respiratory syncytial virus infection in children. II. The correlation of radiological categories with clinical and virological findings. Pediatr Radiol 1974; 2:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/52\">",
"      Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health 1990; 26:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/53\">",
"      Finnegan OC, Fowles SJ, White RJ. Radiographic appearances of mycoplasma pneumonia. Thorax 1981; 36:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/54\">",
"      Griscom NT. Pneumonia in children and some of its variants. Radiology 1988; 167:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/55\">",
"      McLennan MK. Radiology rounds. Round pneumonia. Can Fam Physician 1998; 44:751, 757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/56\">",
"      Kim YW, Donnelly LF. Round pneumonia: imaging findings in a large series of children. Pediatr Radiol 2007; 37:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/57\">",
"      Redd SC, Patrick E, Vreuls R, et al. Comparison of the clinical and radiographic diagnosis of paediatric pneumonia. Trans R Soc Trop Med Hyg 1994; 88:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/58\">",
"      Shuttleworth DB, Charney E. Leukocyte count in childhood pneumonia. Am J Dis Child 1971; 122:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/59\">",
"      Peltola V, Mertsola J, Ruuskanen O. Comparison of total white blood cell count and serum C-reactive protein levels in confirmed bacterial and viral infections. J Pediatr 2006; 149:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/60\">",
"      Tabain I, Ljubin-Sternak S, Cepin-Bogovi�� J, et al. Adenovirus respiratory infections in hospitalized children: clinical findings in relation to species and serotypes. Pediatr Infect Dis J 2012; 31:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/61\">",
"      Chen SP, Huang YC, Chiu CH, et al. Clinical features of radiologically confirmed pneumonia due to adenovirus in children. J Clin Virol 2013; 56:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/62\">",
"      Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J 2008; 27:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/63\">",
"      Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/64\">",
"      Sch&uuml;tzle H, Forster J, Superti-Furga A, Berner R. Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis. Eur J Pediatr 2009; 168:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/65\">",
"      Toikka P, Irjala K, Juv&eacute;n T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/66\">",
"      van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/67\">",
"      Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int 2004; 46:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/68\">",
"      Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings. Pediatr Pulmonol 2003; 35:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/69\">",
"      Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. Am Fam Physician 2004; 70:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/70\">",
"      McCracken GH Jr. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J 2000; 19:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/71\">",
"      Sandora TJ, Harper MB. Pneumonia in hospitalized children. Pediatr Clin North Am 2005; 52:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/72\">",
"      Hickey RW, Bowman MJ, Smith GA. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department. Ann Emerg Med 1996; 27:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/73\">",
"      Shah SS, Dugan MH, Bell LM, et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr Infect Dis J 2011; 30:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/74\">",
"      Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/75\">",
"      Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006; 25:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/76\">",
"      St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009; 44:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/77\">",
"      Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J 1989; 8:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/78\">",
"      Lahti E, Peltola V, Waris M, et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax 2009; 64:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/79\">",
"      Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/80\">",
"      Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/81\">",
"      Rein MF, Gwaltney JM Jr, O'Brien WM, et al. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA 1978; 239:2671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/82\">",
"      Honda J, Yano T, Kusaba M, et al. Clinical use of capillary PCR to diagnose Mycoplasma pneumonia. J Clin Microbiol 2000; 38:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/83\">",
"      Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/84\">",
"      Vuori-Holopainen E, Salo E, Sax&eacute;n H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis 2002; 34:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/85\">",
"      Kornecki A, Shemie SD. Open lung biopsy in children with respiratory failure. Crit Care Med 2001; 29:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/86\">",
"      Hayes-Jordan A, Benaim E, Richardson S, et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002; 37:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/87\">",
"      De Schutter I, De Wachter E, Crokaert F, et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011; 52:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/88\">",
"      Loens K, Van Heirstraeten L, Malhotra-Kumar S, et al. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol 2009; 47:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/89\">",
"      de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000; 15:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/90\">",
"      Kirkpatrick MB, Bass JB Jr. Quantitative bacterial cultures of bronchoalveolar lavage fluids and protected brush catheter specimens from normal subjects. Am Rev Respir Dis 1989; 139:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/91\">",
"      Naiditch JA, Barsness KA, Rothstein DH. The utility of surgical lung biopsy in immunocompromised children. J Pediatr 2013; 162:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/92\">",
"      Crain EF, Bulas D, Bijur PE, Goldman HS. Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age? Pediatrics 1991; 88:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/93\">",
"      Wingerter SL, Bachur RG, Monuteaux MC, Neuman MI. Application of the world health organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department. Pediatr Infect Dis J 2012; 31:561.",
"     </a>",
"    </li>",
"    <li>",
"     Mani CS, Murray DL. Acute pneumonia and its complications. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG.  (Eds), Elsevier Saunders, Edinburgh 2012. p.235.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/95\">",
"      Gaston B. Pneumonia. Pediatr Rev 2002; 23:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/96\">",
"      Clark CE, Coote JM, Silver DA, Halpin DM. Asthma after childhood pneumonia: six year follow up study. BMJ 2000; 320:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/97\">",
"      Chen KC, Su YT, Lin WL, et al. Clinical analysis of necrotizing pneumonia in children: three-year experience in a single medical center. Acta Paediatr Taiwan 2003; 44:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/98\">",
"      Kerem E, Bar Ziv Y, Rudenski B, et al. Bacteremic necrotizing pneumococcal pneumonia in children. Am J Respir Crit Care Med 1994; 149:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/99\">",
"      McCarthy VP, Patamasucon P, Gaines T, Lucas MA. Necrotizing pneumococcal pneumonia in childhood. Pediatr Pulmonol 1999; 28:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/100\">",
"      Ramphul N, Eastham KM, Freeman R, et al. Cavitatory lung disease complicating empyema in children. Pediatr Pulmonol 2006; 41:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/101\">",
"      Bender JM, Ampofo K, Korgenski K, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis 2008; 46:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/102\">",
"      Sawicki GS, Lu FL, Valim C, et al. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J 2008; 31:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/103\">",
"      Cengiz AB, Kanra G, Ca��lar M, et al. Fatal necrotizing pneumonia caused by group A streptococcus. J Paediatr Child Health 2004; 40:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/104\">",
"      Wang RS, Wang SY, Hsieh KS, et al. Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients: report of five cases and review of literature. Pediatr Infect Dis J 2004; 23:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/105\">",
"      Hodina M, Hanquinet S, Cotting J, et al. Imaging of cavitary necrosis in complicated childhood pneumonia. Eur Radiol 2002; 12:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/106\">",
"      Schwartz KL, Nourse C. Panton-Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature. Eur J Pediatr 2012; 171:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/107\">",
"      Groskin SA, Panicek DM, Ewing DK, et al. Bacterial lung abscess: a review of the radiographic and clinical features of 50 cases. J Thorac Imaging 1991; 6:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/108\">",
"      Emanuel B, Shulman ST. Lung abscess in infants and children. Clin Pediatr (Phila) 1995; 34:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/109\">",
"      Donnelly LF, Klosterman LA. The yield of CT of children who have complicated pneumonia and noncontributory chest radiography. AJR Am J Roentgenol 1998; 170:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/110\">",
"      Tan TQ, Seilheimer DK, Kaplan SL. Pediatric lung abscess: clinical management and outcome. Pediatr Infect Dis J 1995; 14:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/111\">",
"      Lorber B. \"Bad breath\": presenting manifestation of anaerobic pulmonary infection. Am Rev Respir Dis 1975; 112:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/112\">",
"      Brook I. Lung abscesses and pleural empyema in children. Adv Pediatr Infect Dis 1993; 8:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/113\">",
"      Brook I, Finegold SM. Bacteriology and therapy of lung abscess in children. J Pediatr 1979; 94:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/114\">",
"      Hacimustafaoglu M, Celebi S, Sarimehmet H, et al. Necrotizing pneumonia in children. Acta Paediatr 2004; 93:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/115\">",
"      Johnson JF, Shiels WE, White CB, Williams BD. Concealed pulmonary abscess: diagnosis by computed tomography. Pediatrics 1986; 78:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/116\">",
"      Kunyoshi V, Cataneo DC, Cataneo AJ. Complicated pneumonias with empyema and/or pneumatocele in children. Pediatr Surg Int 2006; 22:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/117\">",
"      Amitai I, Mogle P, Godfrey S, Aviad I. Pneumatocele in infants and children. Report of 12 cases. Clin Pediatr (Phila) 1983; 22:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/118\">",
"      Ceruti E, Contreras J, Neira M. Staphylococcal pneumonia in childhood. Long-term follow-up including pulmonary function studies. Am J Dis Child 1971; 122:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/119\">",
"      Soto M, Demis T, Landau LI. Pulmonary function following staphylococcal pneumonia in children. Aust Paediatr J 1983; 19:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/120\">",
"      Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Pediatr 1992; 29:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/121\">",
"      Dhawan A, Narang A, Singhi S. Hyponatraemia and the inappropriate ADH syndrome in pneumonia. Ann Trop Paediatr 1992; 12:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/3/38970/abstract/122\">",
"      Don M, Valerio G, Korppi M, Canciani M. Hyponatremia in pediatric community-acquired pneumonia. Pediatr Nephrol 2008; 23:2247.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5986 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-7D7969DF47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38970=[""].join("\n");
var outline_f38_3_38970=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - General appearance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Fever",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Tachypnea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Respiratory distress",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Lung examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Severity assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clues to etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      RADIOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Views",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Etiologic clues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Blood tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H254167804\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Cultures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Rapid diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Other tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Invasive studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Critical microbes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Radiographic confirmation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Etiologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2294532\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294655\">",
"      Pleural effusion and empyema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294662\">",
"      Necrotizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294669\">",
"      Lung abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294676\">",
"      Pneumatocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2294683\">",
"      Hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H476673345\">",
"      INDICATIONS FOR HOSPITALIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5986\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5986|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?16/16/16641\" title=\"diagnostic image 1A\">",
"      Pleural effusion radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?33/60/34753\" title=\"diagnostic image 1B\">",
"      Pleural effusion CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/30/19941\" title=\"diagnostic image 2\">",
"      Necrotizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?1/6/1121\" title=\"diagnostic image 3\">",
"      M pneumoniae radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/28/28096\" title=\"diagnostic image 4\">",
"      Pneumococcal pneumonia complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5986|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/12/6350\" title=\"picture 1A\">",
"      Boy with measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/26/4512\" title=\"picture 1B\">",
"      Truncal rash in measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/3/36927\" title=\"picture 2\">",
"      Rash of primary varicella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/28/32194\" title=\"picture 3A\">",
"      Herpes simplex virus hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/0/17410\" title=\"picture 3B\">",
"      Herpes simplex labialis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/0/21507\" title=\"picture 4\">",
"      Pneumococcus in sputum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5986|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/59/9149\" title=\"table 1\">",
"      Pediatric pneumonia history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/57/6045\" title=\"table 2\">",
"      Pediatric pneumonia examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/35/29244\" title=\"table 3\">",
"      Severity of pneumonia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/2/22573\" title=\"table 4\">",
"      Etiologic clues to pediatric pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/33/25117\" title=\"table 5\">",
"      Noninfectious mimics of pediatric pneumonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22792?source=related_link\">",
"      Acute interstitial pneumonia (Hamman-Rich syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/11/6330?source=related_link\">",
"      Approach to the child with metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=related_link\">",
"      Blood cultures for the detection of bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16074?source=related_link\">",
"      Bronchiolitis in infants and children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27992?source=related_link\">",
"      Chlamydia trachomatis infections in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26010?source=related_link\">",
"      Chronic asthma in children younger than 12 years: Evaluation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33480?source=related_link\">",
"      Clinical features of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/19/38199?source=related_link\">",
"      Clinical manifestations and diagnosis of Legionella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22599?source=related_link\">",
"      Clinical manifestations and diagnosis of avian influenza",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/62/8168?source=related_link\">",
"      Clinical manifestations and etiology of pulmonary alveolar proteinosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/11/43192?source=related_link\">",
"      Clinical presentation and diagnosis of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19402?source=related_link\">",
"      Cryptogenic organizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/40/37513?source=related_link\">",
"      Diagnosis and treatment of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21881?source=related_link\">",
"      Diagnosis and treatment of pulmonary histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/55/2938?source=related_link\">",
"      Epidemiology, pathogenesis, and etiology of pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/34/9770?source=related_link\">",
"      Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/14/22762?source=related_link\">",
"      Fever without a source in children 3 to 36 months of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/14/38119?source=related_link\">",
"      Hantavirus cardiopulmonary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/33/33304?source=related_link\">",
"      Human metapneumovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/14/1255?source=related_link\">",
"      Idiopathic acute eosinophilic pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25354?source=related_link\">",
"      Inpatient treatment of pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27882?source=related_link\">",
"      Management and prognosis of parapneumonic effusion and empyema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/79?source=related_link\">",
"      Mycology, pathogenesis, and epidemiology of blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/35/6713?source=related_link\">",
"      Mycoplasma pneumoniae infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/46/27369?source=related_link\">",
"      Outpatient treatment of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36808?source=related_link\">",
"      Parainfluenza viruses in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/46/7913?source=related_link\">",
"      Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/17/14611?source=related_link\">",
"      Patient information: Pneumonia in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35001?source=related_link\">",
"      Pneumococcal pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33062?source=related_link\">",
"      Pneumonia caused by Chlamydophila (Chlamydia) species in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/425?source=related_link\">",
"      Primary coccidioidal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/0/2055?source=related_link\">",
"      Suppurative (septic) thrombophlebitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29912?source=related_link\">",
"      Treatment of blastomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_3_38971="Criteria CIM";
var content_f38_3_38971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F76493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F76493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested diagnostic research criteria for critical illness myopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major diagnostic features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Sensory nerve amplitudes &gt;80 percent of the lower limit of normal in two or more nerves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Needle EMG with short-duration, low-amplitude MUPs with early or normal full recruitment, with or without fibrillation potentials",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Absence of a decremental response on repetitive nerve stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Muscle histopathologic findings of myopathy with myosin loss",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Supportive features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Motor amplitudes &lt;80 percent lower limit of normal in two or more nerves without conduction block",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Elevated serum CK (best assessed in the first week of illness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Demonstration of muscle inexcitability",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    By definition, patients are or were critically ill, and weakness should have started after onset of critical illness.",
"    <br>",
"     For a",
"     <i>",
"      definite diagnosis of critical illness myopathy",
"     </i>",
"     , patients should have all four major features and one or more supportive features.",
"     <br>",
"      For",
"      <i>",
"       probable critical illness myopathy",
"      </i>",
"      , patients should have any three major features and one or more supportive feature.",
"      <br>",
"       For",
"       <i>",
"        possible critical illness myopathy",
"       </i>",
"       , patients should have either major features 1 and 3, or 2 and 3, and one or more supportive feature.",
"       <div class=\"footnotes\">",
"        EMG: Electromyography; MUPs: Motor unit potentials; CK: Creatine kinase.",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38971=[""].join("\n");
var outline_f38_3_38971=null;
var title_f38_3_38972="ATS impairment classification";
var content_f38_3_38972=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The American Thoracic Society classification scheme for respiratory impairment",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Parameter*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Normal",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mildly impaired",
"       </td>",
"       <td class=\"subtitle1\">",
"        Moderately impaired",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severely impaired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FVC",
"       </td>",
"       <td>",
"        &ge;80%",
"predicted",
"       </td>",
"       <td>",
"        60 to 79% predicted",
"       </td>",
"       <td>",
"        51 to 59% predicted",
"       </td>",
"       <td>",
"        &le;50%",
"predicted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FEV1",
"       </td>",
"       <td>",
"        &ge;80%",
"predicted",
"       </td>",
"       <td>",
"        60 to 79% predicted",
"       </td>",
"       <td>",
"        41 to 59% predicted",
"       </td>",
"       <td>",
"        &le;40%",
"predicted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FEV1/FVC x 100",
"       </td>",
"       <td>",
"        &ge;75%",
"       </td>",
"       <td>",
"        60 to 74%",
"       </td>",
"       <td>",
"        41 to 59%",
"       </td>",
"       <td>",
"        &le;40%",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        DLCOsb",
"       </td>",
"       <td>",
"        &ge;80%",
"predicted",
"       </td>",
"       <td>",
"        60 to 79% predicted",
"       </td>",
"       <td>",
"        41 to 59% predicted",
"       </td>",
"       <td>",
"        &le;40%",
"predicted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         VO2 max",
"        </strong>",
"        (Impairment based on ability to do job",
"comfortably at 40 percent VO2 max).",
"       </td>",
"       <td>",
"        &ge;25",
"mL/kg/min (Capable of all but most strenuous jobs).",
"       </td>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        15 to 25",
"mL/kg/min and average metabolic work of job is less than 40 percent of",
"VO2 max. (Should be able to perform that job comfortably).",
"       </td>",
"       <td>",
"        &le;15",
"mL/kg/min (Unable to do most jobs due to discomfort even traveling to",
"and from work).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FVC: forced vital capacity; FEV1: forced expiratory volume in the first second; DLCOsb: single-breath carbon monoxide diffusing capacity of the lungs; V02 max: maximum aerobic power.",
"     <br>",
"      * Predicted values based on height, age, and sex of white Americans. These prediction values should be used when applying the American Thoracic Society criteria for respiratory impairment.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from American Thoracic Society. Am Rev Respir Dis 1986; 133:1205.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38972=[""].join("\n");
var outline_f38_3_38972=null;
var title_f38_3_38973="Six month outcome EPISTENT";
var content_f38_3_38973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Abciximab improves the outcome at six months after stenting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 205px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the EPISTENT trial of 2399 patients, Kaplan-Meier estimates of the incidence of the primary endpoint (death or myocardial infarction) was lower in those treated with abciximab after stenting compared to those undergoing angioplasty with abcixmab therapy (p = 0.01) or stenting with placebo (p &lt;0.001) treatment (5.6, 7.8, and 11.4 percent, respectively).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Lincoff AM, Califf RM, Moliterno DJ, et al, for the EPISTENT Investigators, N Engl J Med 1999; 341:319.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38973=[""].join("\n");
var outline_f38_3_38973=null;
var title_f38_3_38974="Causes of torsional nystagmus";
var content_f38_3_38974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Causes of torsional nystagmus in 41 patients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 278px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     The numbers in parentheses associated with the pie graph represent the percent of patients with each cause.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38974=[""].join("\n");
var outline_f38_3_38974=null;
var title_f38_3_38975="Tarsal coalition";
var content_f38_3_38975=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66078&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tarsal coalition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 388px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Yd23t8x6+tN3t/eP50P99vrTaAHb2/vH86N7f3j+dNooAdvb+8fzra8NM2+4+Y9F7/WsOtvw19+4+g/rQBvbm/vH86Qs2PvH86KQ9KQhNx/vH86RnbH3j+dLTW6UxjCzZ+8fzpNzf3j+dIaKQhyu24cnr61u687f8Il1P+tTv7GsBPvj61u67n/hEz/11X+RpjOI3t/eP50m9v7x/OkooAXe394/nU0BIUyMxwOmTUUaF3CivRfg94R/4SjxOklxFu0rT8STZ6O2flT8SMn2BoA1IvAun6X8N59a8SyTQ39xD5tuA5BQkfu1292bqR2BrydxIWyGPPXmvSPjR4w/4SXxI1rZy7tLsCY4yv3ZJOjP9Ow9h7155QAR7woXcSfrTbiQlgiscL15709m8pN38R4Uf1qqM96AHb2/vH86N7f3j+dJRQAu9v7x/Oje394/nSUUALvb+8fzo3t/eP50lFAC72/vH86Xc394/nTRSigBdzf3j+dG5vU/nRS0hBub+8fzpdzf3j+dJRQAu5v7x/Oje394/nSUUALvb+8fzoDtkfMfzpKB1FAHZXrsdGs/mP3PWsTe394/nWze/wDIGtP92sSmMdvb+8fzp4dv7x/OoqeKAHb2/vH86N7f3j+dJRSESIzf3jVPXHb+zn+Y/eHf3q1H3qprn/IOf/eFMZze9v7x/Oje394/nTaKAHb2/vH86N7f3j+dNooAdvb+8fzrrry3fWJrDUbDU7O1t4LW3hczXaxSWzxRqrkR53NllZwUBzu/vZFcfRQB3IkS/vtF1a31G2gtdPhgS4ElwsckbR8sVjzufccsNgOS3ODmtbQ3j8Q+NPCl7ps9rb21reRJLbz3CQvGftJcbUJ+YEMPuA8g5xxnzCt7wD/yPfhz/sJW3/o1aAMN/vt9abTn++31ptABRRRQAVteGvv3H0X+tYtbfhr79x9F/rQBu0hpaQ0hDKG6UUjdOaYyPvRRRSEC/eX61u69/wAimf8Arqv8jWEn3x9a3deP/FJ/9tV/kaYzhqKO1SQpuJJ+6KANfQNOs7syrqGrW+l/KCrzRO4bJxj5QcepNeq/DvxZZeBXuvCnie2WFHlLm+gbekiuowWxztK4ww7HpXM2Gs+GG8ORpb6RpMOrW8f73+0opJRckDqjqwAY+jDFcXrWq3etalJfag6tPIFX5FCKqqMKqqOAAAABQB6d4u+E0bQDUfBV4l7ZSDcts0gY4/2H6N9Dg/WvKGheOZ4pUaN4yVdWGCpHUGtXw74n1fw7I7aRevCrjDRkB0PvtPGfesm+uJJXkeVy88zF5HJ5JJyf1oArTP5kmf4RwBTKKKACiilNACUUUUAFFFFAC0opM0uaBBS0UUgCiiigAooooAKB1FFC9RQB2N5/yBLP/drDrcvP+QHZ/wC6aw6YxaUUlKOtADqKQUtIQqdaq65/yDn/AN4fzq0vWqmt/wDINf8A3h/OmNHNUUUUAFFFFABRRRQAVveAf+R78Of9hK2/9GrWDW94B/5Hvw5/2Erb/wBGrQBhv99vrTac/wB9vrTaACiiigAra8NffuPov9axa2vDX37j6L/WgDdFIaKD0oENprmn1G9AxtBopDSEKv3x9a2tcP8AxSp/66r/ACNYiffFbWt/8ir/ANtV/kaYHFgEkAdaskBFCDt19zTIF2qZD16CloGdF4Gsby71nzLXSrXUoIVP2hLs7YFQjBLOSNvsc5p3jnTdF07U410C/S5ikTdLEj+YsD90EmBvHoaoWuoX15p1toMdxFDZPPvwxEas7YGZG7gds9Kj1rRr/RdQay1O2eCYcrnlXHZlPQj3FAFFcKpdug6e5qqxLMSepqS4cEhV+6v6moqACiiigAooooAKKKCCOoOKAHIu44qykCADIyfeooOx960rZN3I/GgClJCuOBj6VWdShrWuo9uPeqUybloAqg0opvQ0opCHUUUUAFFFFABQOoooHWgDsLr/AJAdn/u1iVt3P/ICs/8AdNYlMYUtJS96AHClpgpwpCFFVda/5Br/AO8tWqqaz/yDpPqtAHN0UUUxhRRRQAUUUUAFb3gH/ke/Dn/YStv/AEatYNb3gH/ke/Dn/YStv/Rq0AYb/fb602nP99vrTaACiiigAra8N/fuPoP61i1teGvv3H0X+tAG5QaKQ0AFRN1qU1E3WgBKQ0tNNIQJ98fWtvW/+RV/7ar/ACNYiffH1rb1v/kVv+2q/wAjTGcWrFeQalVw3sahooA6Dw/BpZNzda3K5t7dQVtYm2yXLE4Cg9h3J9Kn8TeJ7jVrC0sltreysLXP2a2hyfLB6/MxJNc5HJtI3crSSuZHLH8B6UAMFFFFABRRRQAUUAZOBUhiOPegCWGLPPepngwOelLa8gfrVxtu0/KfzoAy0XaxFaNmSCw9s1Qf/WVctuhPqMUhFiZd8Rx1HNUmHFXlB7UyWIFSQOfamMx512tUYq3crlc1UoAcKWkpaQgooooAKB1ooHWgDr7n/kBWn+6axa2bj/kA2n0NY1MYUUUUALSrSUo60AOqlrH/ACD3/wB4VdqlrP8Ax4P/ALwpCOdooopjCiiigAooooAK3vAP/I9+HP8AsJW3/o1awa3vAP8AyPfhz/sJW3/o1aAMN/vt9abTn++31ptABRRRQAVteG/vXH0X+tYtbXhv71x9B/WgDcpDRRQAhqI9TUp6Goj1pMTCmtTqYaECFT74+tbWt/8AIq/9tV/kaxU++PrWzrn/ACK4/wCuq/yNMZxlFFFABRRRQAUUAZPFP8s+1ADACSAOtSGFscGnwRkHLCrvl/ICB0FAFGBPX71XTEAnHJqJcDB9DVpnO04AxQBUQlHGPWrRlHoaouSXGAavW8ZkjDbee9AFGc4l/Grdm5BA27vTnFUroH5jg8Gp7GT5h7igRrJnGfK/JqWQMUI+VM+nJNRDdjPantkDmgZm3C7QyntxWdWhdPkt71n0AOFLTRS0hC0UUUAFA60UDrQB1s//ACArX6Gsetif/kBWv0NY9MYUUUUAFKKSlFAD6paz/wAeD/Ufzq7VLWf+PB/qP50hHO0UUUxhRRRQAUUUUAFb3gH/AJHvw5/2Erb/ANGrWDW94B/5Hvw5/wBhK2/9GrQBhv8Afb602nP99vrTaACiiigAra8N/euPoP61i1teG/vXH0X+tAG3RRR2oAQ1EalPSoqTBhTGp9MNAkKn3x9a2dc/5Fcf9dV/kaxU+8PrWzrp/wCKYX/rqv8AI0xnG0UUUAFFFFAEkIy1W/KJQNmqdv8AfbNaYPyDFAiCLGMHtUwZtvXiq0jbHanxFnVQvJNAETH5se9X0iOPm59qrSRhGzjkda0rEiVWVuq9/agZRmUByB2NW9N+7L7YNVZ1IlcN1Bq3YBvKkwCS2BQIq3cWyaRD68VDb/KDgc5yKvXMbMuWGGXj8KpqMUDNuPDW6sAPmHNEiBoyCOgyKbZ5+ypn1NS5A75oA5yZOpqlWrdRlJHXH0rMcYcigBtOptLmgBaWkzRmkIWikpaAOslP/Ehtfoax+c1rSH/in7X8axz1pjH0UCigApe9JS0APFUtZ/48H+o/nVwdKp6z/wAeD/UfzpCOdooopjCiiigAooooAK3vAP8AyPfhz/sJW3/o1awa3vAP/I9+HP8AsJW3/o1aAMN/vt9abTn++31ptABRRRQAVteG/v3H0H9axa2vDf3rj6D+tAG32paSg0AI3SoqlbpUVJiYhpp6080w9aAQJ94fWtjXf+RZX/rqv8jWQv3h9a19e/5FlP8ArqP5GmM46iiigAoPSiigBbfiQj1rUiJ8sE/pWSPlcH3rVszvBXuOaQitdgAZA5NWdKGGwed3T2ou4wJOnUUaedsyZ7NTAfdptmPoeam044Z89CuKdcDzBg9R0IqK3Zo3IAGfUjOKBktxH5hz0foT60ts0gj2hyg746052c8lyT7ii2UkE980ANuA4UjexHvzVRVycDrnFaM68MR6VSUc5oEb1vbKYlzIkcajALcZqcWcLIfKmSQ+gaqdrEGAMvzMR3qxJAmMgAEdxxQMzNUttqFjncp7+lc9dLiTPrXSahHN5XMm9Bzg9qwL5cDPoaAKlFFFABSgUUo6UhCYpaKDQB1Tf8gC2/GsfvWwf+QDb/jWMetMCRaWkXpS0DCiiigB4qnrP/Hg/wBRVwdKp6z/AMeD/UfzpCOdooopjCiiigAooooAK3vAP/I9+HP+wlbf+jVrBre8A/8AI9+HP+wlbf8Ao1aAMN/vt9abTn++31ptABRRRQAVteG/v3H0X+tYtbXhv79x9F/rQBt0tJQaAGt0NR1K3Q1FSEwNMPWn0w9aECBPvD61sa9/yLSD/pqP5GshPvL9a1te/wCRaT/rqP5GmM4+ilNJQAUUUUAIa09P/wBcCehB/lWY3TmtOxAyCT2oEWLgb0BHVf5VXhJR8jrmrzmHHAkY+oHFUmx5hK8DPFAy2XkK/eH0A4qJMmXLdamjX5DnmoyAGBoAssMKuan0+MO78dOaWSLCsx6IKm0Jd0sv+5QBBdqyxbiMDp9ar2kHmvz90GtHVlxDD6Fiao2cgikG7JUn8qBGy8QhKbScFasRxgryuQwoCCVVPIUA/MRTUncqQoGARjPYUDM26ytvPuI4GPxzXM32AtdFrDlEVCfmY7jXN3pyv40AVKKKKAFFLSUtIQUUUGgDqM50GD8ayDWsvOgwfU1kmgB604VGv51IKYwooooAevSqes/8eD/Ufzq4tU9Z/wCPB/qP50hHO0UUUxhRRRQAUUUUAFb3gH/ke/Dn/YStv/Rq1g1veAf+R78Of9hK2/8ARq0AYb/fb602nP8Afb602gAooooAK2vDf3rj6L/WsWtrw39+4+i/1oA26DS02gBG6VHUjHio6TEwph60+mHrQgQJ94fWtfXv+Raj/wCuo/kayU+8PrWtr3/ItR/9dR/I0xnHmnLGzcKM/Sm10/hMkb8f3v6VtTjDkc5puzS0dt7+T7CZzflP02nNDRuv3lx9a7ybP2t+TjdUfiAE28LgnqKOaj/K/vX/AMiGpwpRjwBkn3q9CCgAdSPqDW3YZ+2Qjn71dHqLFp87ugx17+lHNR/lf3r/AORDU41JoymCSPwNRSlc5Gceu0118TEvj1HHPetiRQ9uEcscDB+tHNR/lf3r/wCRDU4CGaIQgM+G9Nppk0kZkOxiV9dp5rr5VeKQDcTjuOalYHy8EnvRzUf5X96/+RDU56e6he1dYizM23ojf4U7Rru3t5JTO7ICmBlG/wAK9D0pjFAjAncABjPXinXxG7KxkuDkhzwOKOaj/K/vX/yIannmqXlvNbxCJ2ZgT/A3+FZu4bScPj/cb/CvQ5Z5GjJ3jJ4+laNhKxUxM29XPQHrRzUf5X96/wDkQ1ONTVbH+xY4fOxcYAdPLbP8qit7y2/jdxk8nyn/AMK6GTEGuFVZhgbjzXY20jMq8kEc8Uc1H+V/ev8A5ENTxfVpTc3sjxxylOi/u26flWNdQTMBiKTr/dIr6G+0OAzSMVAGetZ9yyToWMvPPVqL0f5X96/+RCzPn8wSDqjD6ik8tvSvT/EJETttJLH34Fc8xPcnNHNR/lf3r/5ENTkdhox64/OunfJPeq82cUc1H+V/ev8A5EWpz/4r+dBrQuehrO7fjTlGm6fPBNa9Xf8ARBrc6hP+QDB9TWSetaqH/iQw/U1lHrXOMUU9TUYqRTTGhaKKKAHLVTWf+PB/qP51aXrVXWf+PB/qP50hHO0UUUxhRRRQAUUUUAFb3gH/AJHvw5/2Erb/ANGrWDW94B/5Hvw5/wBhK2/9GrQBhv8Afb602nP99vrTaACiiigAra8N/fuPov8AWsWtrw39+4+g/rQBt0lLSUAB5FRGpWOBUVJiYUwjFPph60IBU+8PrWtr/wDyLUX/AF1H8jWQn3h9a19f/wCRbi/66j+RpjOQIrpvCfWQf7X9K5k103hLG98/3v6VtH+DL1X5SF1Ni6wLpz707UI/P0ksOq81XlfMrEcnJq3aP+4dW6E4NYjMnSgDexeg5NbLuWJ4Xn1rNihNrNJ78Kfar64ePIweaAHQqBIAQML1NbdthkYEAk+lYhTbIPmxz1xWlBIU5yRznNAFe/Ch8gtgGlAJiJzjHOakvznJ4znI4qHzd0e0DAHoPegDd02TFunJ9enenTSFywIfcfUdaoWEvyhcAL0ORzWgzYDMWwSvcYOaAKIRkZgwyAc461fs+GGAB3HFUJrtVGN27cMHBpq3kz7RHGMDqTQBSvZSdYdwTkEAYrtoIniswSwEjnjPpXD6cu/UMzYJJ4x9a9E1NFCA8jCYBJ65FAGFN5kjMC+B1wT70kahZgDz60yaTChfxGeKj3EyD5RnOQ3SgBdS0zz8L5Y2uP8AJ+tcJcRNExDAgivRrOd42wTxnCknP+e9c/4rsV+zfaY124fkUAciwqrMMCrbdaq3INAGdcjg8Vm9vxrUnHWsutl/BfqvyZPU6eP/AJAUP1NZR61pw/8AIDj/AN41mHrWAwHWpFqMU9aY0O7UUUUAOXrVTWf+PB/qP51bWqms/wDHg/1H86QjnaKKKYwooooAKKKKACt7wD/yPfhz/sJW3/o1awa3vAP/ACPfhz/sJW3/AKNWgDDf77fWm05/vt9abQAUUUUAFbXhv71x9B/WsWtrw3964+i/1oA26SlpaAGsOKiqVulRUmJhTGp9MNAIVPvD61ra/wD8i3F/11H8jWSn3x9a1tf/AORbi/66j+RpjOQNdH4ZO1Jz6H+lc6eldB4e4tLhv9rH6VtH+DL1X5SJ6miDub+p6VdgyY+AMMO1UoiMnceDVqN9rADkdvrWJRpXFv5tkMBdyDNUY/lQNnp2xVyCQsoUk8jvVYRlJXVScdR24oAe44VucHmiOUhuvy5qRgqgcqMDIFCqnUnGPXpQA5pDNG2eec0+BBtzzjHORTlcdE3YPOT/AIUsCsuevTnFAD03RsNoB9KutFcXEfLBT+fFV1jYPGMZYmtWIsihVClhzkUAVhpojh8wklehPr70sKA52429DjmtDJjfa23aRkZ6YrOuXdmk2rtVT2PQUAKLEpOQCOV3AjsetdT5pnt0DnLbB8hHX/GuctJ5GWLcFKocsfUHua0bW5DWbBSPkPBHVR9aAIZ4MMzR/OoB+UnBBquI2DLvVcdSM9K0POMkhLEMDyMd6fcIzS/JhWRdx4GaAM+XzYo1+5lj/L/9dOmhFxZSwOeJFP5gVHNufYWwzHPWmiUR+XlmLgj2xQBwEiGORkYcqcGqk4yDW54jhEOqSlRhXO4VjSikIzZRzzWT2ranUg596xe1br+C/VfkxdTpYP8AkBR/7xrMPU1pW/8AyAk/3jWaeprAYCpFFRipFpjFFFFFADl61U1n/jwf6j+dW161U1n/AI8H+o/nSEc7RRRTGFFFFABRRRQAVveAf+R78Of9hK2/9GrWDW94B/5Hvw5/2Erb/wBGrQBhv99vrTac/wB9vrTaACiiigAra8N/fuPoP61i1teG/v3H0X+tAG2aDS02gAbkVEetSnpUVJiYU006mtQAJ94fWtbxB/yLcP8A11H8jWSn3x9a1fEH/IuQ/wDXX+lMZyVdFofy2Lnuzn+Vc6eldDpOP7PwePmP9K1j/Bl6r8pE9S9EQMZ59vWrMS8HK4qmG2uNhx74q3CCoO7jdxmsii3Ewiwck9zTLiUu24E/WnxKGYhRx6elWBEgRc8kdR6UAVYo5ZmUAFie7VopaqQwmOXHYVJbxSSyCK1id5GHAQZYio0O6QDJBPH4/wCNAEyxbwQq4CgH60GN1Y4JCg5962NJgMoO5WPy4xx0qxf2cnlMUUDHBwlAGSGEfLFSwyPfmt3S5TPGiIgXZ8pOOprEaN2Me4ZJ7qOTVy2v/KjwFYspwQB/KgC9d27NCwZhlHx9KzLmBmnMasS23nH9a27IidWaPGGXkn1/pniob22VE3RKxkwA+4/qKAMix/1ssW4FGQjg0afMY38st98FT9c8VNJAyOrImwr3pUi2ygsoGWDcHofWgBLKTc+cASKa3HUMASAQV55wQc1kWkQiu/m24OSf1H61rDaLZXPVuCTyKAM2+QqxIjI44ANZTOxcs689Cfp/kVtXaMF/dJ82ck/yrMvAFwDgEjAx6+tAHP6+m8K56gZBrAfgV0WuttijTBzjgnvXPyDINAGfP19qwu1b9wOeawO1bL+C/Vfkyep0tr/yAk/3jWYeprStT/xI0/3qzT1NYDAVItMFSCmCCiiigY4VU1n/AI8H+o/nVtaqaz/x4P8AUfzpCOdooopjCiiigAooooAK3vAP/I9+HP8AsJW3/o1awa3vAP8AyPfhz/sJW3/o1aAMN/vt9abTn++31ptABRRRQAVteG/v3H0X+tYtbPhz71x9F/rQBu02nU2gBG6VHUpHFRUmJhTDT6YaAQqffH1rV8Qf8i5B/wBdf6VlJ95a1fEP/IuQf9df6UxnInpXQ6RgWA5HLkfyrnzXQaQCbHH+0a2j/Bl6r8pE9S9EpyMdjzVtQUxnnP5VWh4GMZ5qWR8MAOprEotRShM4PNXoGLIfMPA9PSs+0UcbvXmtCMHIGOe2O9AHtPwh0iyh8Ppqaxb7y4dkMjDO1QcbR6e9eVa5CE13UlUABblwFHpuNez/AAjH/FEWu7JxPJ/6FXk+uxY8RampByLmTOB1GaALugMu7a3HIOPUYrovILO2VHlsSeueTXLWa+Ry3yuPuA+hro7CVmtSS2RjkelAGJqemiB2dGPy8jH8JrFVcS7w3J5JPQV12qMjqY2GNww3ycZ9a5xkKSYbYBnAJGfxoAn0yXypdyuBuPIPQ1swyK8zRBRucYDHnOKxEVUkAbn5/TFTT6jBbuhDnGSCByaALV1FiWXzWZmwDgdCKz48K4DnHZQean1HUI54w9urMSuDjtWHO88oyzhRxwtAGlezI06FSGIXkA+lXoNRRFjRx1HNVbG3RlEjjg8jBq+bEKmV2kk85Xkj29qAIJ7tJC7bshCCo2/4Gs28yyF+c9sGr91b+UWwF644HUVTliYRtjtzj/61AHN6+cyQjGAErGkHP4Vt6yCzxn2PFZEg5J6DFAGZcAk81znaumuBkVzP8NbL+C/Vfkyep0dn/wAgMf71Zx6mtGy/5AY/3qz26msBgKkHSmLT6Y0FFFFADlqprP8Ax4P9R/OrYFVNZ/48H+o/nSEc7RRRTGFFFFABRRRQAVveAf8Ake/Dn/YStv8A0atYNb3gH/ke/Dn/AGErb/0atAGG/wB9vrTac/32+tNoAKKKKACtnw5964+i/wBaxq2vDf37j6D+tAG3RS02gAPSojUp6VEetJgwprU6mmgSBPvj61q+If8AkXIP+uv9Kyk++PrWp4h/5F23/wCuv9KYzk+1bujt/oxHXk1hGtfS+ISQf4jWsf4MvVflInqa6Ns5J59Kfbne27qewqpkk4J/Kp4G2PnHHpWRRpxDDZxkgVYjwGKkkdwff0qONf3e6MkhhU0QJZWyR2IoA9++EI/4oiA9SJ5B+teZ65G6+JtXwflFy/X6+lem/B8k+DEz2uJPzyK828TRn/hKNXODgXD8d+aAGk/OisgYZHQ8Yq7aZjSb5vlzkY6nms3dHHLtMfPUnNXLUhfL2rgFTyT0oA1JH8xVD4AOMnGefasq4jDb8AAA9cZNW5pAMdABggDqTVO9y0aSJxuPzf4UAZixPNPiNSyjuTxxUB0yd2JID8468CteyykfIA6gD+tMO9GJPJ6nmgCvHaGDaH2sCPujimPDGA5wRk8Lx6VIWOQ3VCc49qVuGUHndhiSeepFAD9MkVFCsh2k5FbWUYuE7DheM1gwLvUgL0Hr0q/Ecu5ZtmDgE9T+NAEtyqHfzj5evXFZsxURlBhWwcsR1q5dKQhOCUIGTms6RdkT7yS3HB9ODQBz+tJuCyAcdOKxJhkk101xGJI3TGTnjmueuo2jdlYdKAMm44GOetcv/DXWXQGPxrk+3+fWtl/BfqvyZPU6Ox/5Af8AwKs9vvGtCw/5AZ/3qz26msRir1p4pi0+gaCiiigBy1U1n/jwf6j+dWxVTWf+PB/qP50hHO0UUUxhRRRQAUUUUAFb3gH/AJHvw5/2Erb/ANGrWDW94B/5Hvw5/wBhK2/9GrQBhv8Afb602nP99vrTaACiiigAra8N/fuPoP61i1teG/v3H0H9aANukpTR2oARulRHrUp6VEetJgwppp1NagQJ98fWtTxD/wAi7b/9df6Vlp99frWp4h/5F23/AOuv9KYzk619N4g/4F/hWRWvpv8AqPoxrWP8GXqvykT1NMKCBxUkQy1JGMqOmcVJCvzVkUaelktHJGe3zCr9pGz9en8zWZZuI5gR9K17LD71GSRzmgD3P4P/APInYb/n5f8ApXnnihMeKdZAHzm4PI7CvQ/g4QfCUv8A19N/Ja4TxZGR4r1zPGZs5/KgDJ2p58hkY/KAdvXk1aROkjN8rJxjpn1oMYN45yG3KoAxRKsZZlyMKABz1oAh+6I1xknHGeRTog8iEMSm7kiq8koW6LHrxyOQBV61jAO9cEMewoAdBEI5QhG6P+970XUCqAwXjOOvXPSrgiMYkyPvH+fenx2nmqygEgHuetAGO0RzEQOOjD0NWobGabb5EOWUgZxxW9b21lbR+ZNsY4+ZnPGahufEMEQIRiy+ka4oAis9AuVLlgigkHJp66C6qd7rsBJHf1quPEi7gI0clu7McipG8QjftkBAH91smgBJtLeKErvGMdh3rGv7YxqWZcnPykdxjFdPBqST4x8w9MYI/CoLv7POokUDK8EY6mgDgWjZJGD8t6iqeq2iugkUHJGcjvXR6hBCAZB8wzzt9RWdcxhwQANoGM9KAOEuweR+OK5H+Guzv12zSAdASK4z+Gtl/BfqvyZPU6Ow/wCQI3+9We33jWhp/wDyBG/3qz2+8axGOQU6mpTqBhRRS0AKtVNZ/wCPB/qP51bWqms/8eD/AFH86QjnaKKKYwooooAKKKKACt7wD/yPfhz/ALCVt/6NWsGt7wD/AMj34c/7CVt/6NWgDDf77fWm05/vt9abQAUUUUAFbXhv79x9B/WsWtrw3964+i/1oA26SlNFACHpUR61KelRnrSYMSmtTqa1AgT74+taniH/AJF23/66/wBKy0++PrWp4h/5F23/AOuv9KYzk62NN/1H/Aj/AErHrb0n/UdvvGtY/wAGXqvykT1NaAdsVOqncM0yFcHjnNWwv0rIoRQRzWxpKhpBtJV+wNZmDgGrenttkXDbcHOaAPfvg8gTwtPjP/H0xx+ArkPFkBPjHVWZc5fC/iBzXXfByYTeGLnGOLkg/wDfK1yHjm9EHi/UkYrxIDg9vlFAFJISbgybsr0Bx7dvxpskI3KpUn5evrVE6vFtIL7SePlGab/bKn/lu2Dzh4+PzoAnlt3O/bGFJIPSlg3wxssuVA+7jpUdvqJJBaMOoOQc5FWw0UwBPT0oA0oOLfMmdyqDkdMdqrXd2YYlW3wXBG5gOv0FLaRzBnVPnhxyrcgVaiiVozsAUEd+DQBii3muDmaRg5JO3qT7e1Sx6YzR4iiYd/mPWtq1gjQM4wXBB59auFGwSMAKckg9KAOabTGRRuWPIPTHNU5LUI53AD02GunlVg7ruyo6eprIuY9km7aD147fWgDKkMkYyrMFHvzVoahvTyXVh3LZ56VBdyFBhDkjjOKrFwHLqPlYcjpQBLcSL86bP93A6fU1DOu1XJwQE7duKfsBiGNwB447VDcuogl7Kq7aAODvvmldscE1xH8Nd3eINzjPA71wn8NbL+C/Vfkyep0Wnf8AIGf/AHqoP941f0z/AJAz/wC9VB/vGsBjkp1ItLTGFFFFADlqprP/AB4P9R/Ora1U1n/jwf6j+dIRztFFFMYUUUUAFFFFABW94B/5Hvw5/wBhK2/9GrWDW94B/wCR78Of9hK2/wDRq0AYb/fb602nP99vrTaACiiigAra8N/fuPoP61i1teG/v3H0X+tAG2aKDRQAh6VG3WpaibrQDEpGpaQ0hCJ98fWtXxF/yLtv/wBdf6VlJ99frWr4j/5F22/66n+VMZyVbmkDMA/3jWHW/oozbn/eNax/gy9V+UieptQDgZq2o49Dmq0QPBq/GMLjisihAvXPFTW0e6RUUck4prKMDjrVzS1xqEO7kbhxQB7Z8D49nhq/Uj/l75/75Fcj8RbFn8aao5HGUIz/ALor0P4VKq6LebFAUXGeOM/KKwvGwgTxNeiVcuwQ8d/lH+FAHBRaOCGMjEckbAMn61Y/sMRvhrZumfv5P5V0sk0MSBo0wz/xH6VnXN3JLcHd0VODj2FAGMNNMCl43BTup7fUUlvlGJwB6itaYEkSDOAPpj/JrOkYkqONx64oA29IZW/i4AyB/WthUzyY1yD6dM1zOlPJG6Kn3t2CvqO9dlZjPml/LCopLFuNoAyST6AA5oGZM9oIJDngDkc8CponEi4A4kBVx05PQ1NqsRY5lG0eWJFJ6EFgox9SwHvkVFbtsMb4Xy3zsDMN3GM4XqccZIBxmgCoxYH5xs3HGT1NVLmPcRkfKDhj05remtWKyyNJAQr7C3mptV923bnOA2eMdc8YrOuYZgGWQqMDlQ4LYOSrEdQDg4yBnBxQI5nU4FEa7uW6cdqxyjx5I+4fxrrZ7aVkVvKA3AgAsMsQMnaCctgcnGcd8Vl/2e7xTeUhfy0aWQ44RFGWYnsAOc0AY63LhWBxuHGDVW7nJidDxnn61fm065k+zFYJN1y5SIEY8zBAOPYFgM9OaomxmeOWWIQyxRZDPHMjqTt3HaVY7sLyducDk4oA5e9Qlnzx3rz7+GvR9QyN+BzXnH8NbL+C/Vfkyep0Wl/8giT/AHqoN981f0r/AJBEn+9VFvvmsRjxRQKKBhS0lFAD16VT1n/jwf6j+dXBVPWf+PB/qP50hHO0UUUxhRRRQAUUUUAFb3gH/ke/Dn/YStv/AEatYNb3gH/ke/Dn/YStv/Rq0AYb/fb602nP99vrTaACiiigAra8NffuPoP61i1t+Gvv3H0X+tAG3SU6kNACVG45p9NegBlIaWikIRPvj61qeJOPDtqP+mp/lWYn31+taniX/kXrX/rqf5UxnI10WhjNr06Ma52ul0If6F/wI/0raP8ABl6r8pE9Tbt1xjpV2MDr2qtCnAxV0JjFYlB1JzyO1WrBsXkL8cN0qHYAOeBU1qMSowHRhQB9B/C0Y0i9QkfLKvX/AHa5f4g/8jVdcYIWPBz7Cur+GCBNPv06nzUJ/Fa5n4gr/wAVbdL2MSnGM/w0DMmdAIzG2Qc5AxngmqzKfLmIX5s8H6dqulGeeNVUqygJn3GDSyhVjy4YMzsfbPt+dAjOmPyfLyHwMenrVFiskjE9ATj6VpzQGMxpIhyORwfXNI9ntdWiQlWOOexNADtJieS9jUrtCjJx1xXRWxkil3qAwDAMDzkZ7/yxVjS7GOK0LvGVkOQCfQUs0eHOcnP3ccc0DMeWxmS1tnnKsz3XmysxDM0aDEaE8ZI2p0wASxwTirE2yeyjtorNm8yVBMwdFCxKwbywTzgsBnHYY75q+VEliRKCCh5x79hVVUXLRABeQQf1xTAHikl1VJ47Rmgs3hMKb0VpTG0hA4+VFxJnJy2Qc9RjHe0bTY7USRNL5UUU0jR4O54rRoBGg6ksxBycAZ710drJy8gXcgYDPQ4BzzVHxRqW28u7SNLdFHkwLNwDEuInd8Y5JMgUn0OAMgmkBkalErhZBCZrhIjboPMCxhSzElj97q5yF6gAcdax5gVgvoVR286KaNNxxlnjZQzc+rZ710c979pBntnW2Wf98pm8q3eK3DNnGSVUlTANzHJy2ACDWfvtLm9MryrFZSSsV2KWJi3ffA6kddvAz19gCMU3LQ6nZSq80Ii89XliYBwJBGo2ZzggIfzH1qhqN3uguY3t5RKI5oYQWU8S28cTPIQeuUL4G7O7GRjNdDqd5bmPUZ90MKPKdwi2xrEv2VSsaiRcufM4CgfeJJ6Yqn4gnsZtL3SutvdKPNeNNhJTa/lx9AfvqVCjLHcjEgZyAefamo2SMvevNB0/OvUdUjxE2eTXlw6fnW3/AC5fqvyZL3Og0r/kESf71U2+/VzSf+QTL9aqH75rEoUUUUUAFHeiigB4qnrP/Hg/1H86uCqesf8AHg/1H86QjnaKKKYwooooAKKKKACt7wD/AMj34c/7CVt/6NWsGt7wD/yPfhz/ALCVt/6NWgDDf77fWm05/vt9abQAUUUUAFbfhr79x9F/rWJW34Z+/cfRf60AblIadTTSENpH6UtIwpjI6KO9FIQL99frWr4m/wCQBaf9dT/KstPvj61qeJv+RftP+up/lQByFdToC5sV9N5rlyOK6zw6udOHU/Oa2j/Bl6r8pC6m9AvyjtVzt71DEoKjFT4IPH5+tZFCgFiAoJY8BR3Nadppd4ZUJtZ1UsOWQgUeHojJq9kCP+WgOK9nUBEXfkoTyRxigDQ+GEbLDqiued8X4fKa534gxbvGMue8Sc/8BruvByj/AImDLg7mTp9DWD42toJNfdpAu4xL149aYzkrOYY37VLKhAGOS2PWniDc9smWIBJIx1yASK0bezsyqI3yMqsfk4yT0rV0rT7YuSsspKtvGe3GKQHOpYS3UfnRI3zNhiei/wCcVtrYW1oE3tvO0MR1yfatO+S3trQ25+SIjIAzyfc1DC1rOm1nwFT5CB/KmAkakwBwxO88ZHFU7q3Em3MhG0FsGtaKNEtQm/O7OTWdeNm8Oxjyo4I6CgCKHdJOBtxxjmq93aNbys6KrKDgHd39asOcIdj5PCikvb2GGaSJQd6KCwz1oAo/aBBHG6klpLlLdgDtHzK5JPHP3P1q1fXCv9pR9yLbJCsswO4s7+XgBMdAJVyc9cgDvTUU3MchWeaJHdZA0D7GBHAOeo6mlmgzsilnuZ4YZCyJJMxDnOcsM/MQeQTnBFIDJlmR4LoMiDyjJu/0xcIUdFxI+35SA5YgBhwACSwqplJdUsrJgyGVj+83ByR5gQYx2Oc889OB0rWmstl40gublpGQqknmH90hIbCDovIU8Dqo9BVPT9OuJLyKOK8vI18xpJWE7BmJbczMepJPNAjDkurec3LEWmyGPfiPUgyj51X55PLCoACTwGyRgdao6xBCkci7HaZEnKhrhFc+WCQFTHzgjktldoPTIIrW1G4lS5m8m8u2QEogaUkIMg/KOg5A+nauf1Dzfs8tubicwyszTL5hJlLHLbz1OT19cn1oA5bVF+XHfnNeTjpXruqLy+cng/jXkQ6Vt/y5fqvyZL3Og0b/AJBU/wBaqH75q3ov/ILnHvVUj5zWJQUUUUAFKKKB1oAeKpax/wAeD/Ufzq7VLWP+Qe/1H86QjnaKKKYwooooAKKKKACt7wD/AMj34c/7CVt/6NWsGt7wD/yPfhz/ALCVt/6NWgDDf77fWm05/vt9abQAUUUUAFbfhn79x9F/rWJW34Z+/cfRf60AbtIelLSGkIZQelFKaYyI9aSlbrSUhCr94fWtXxP/AMi9af8AXU/yrKX7w+tavif/AJF60/66n+VAHJN0/Ct3SNXtbK1EU3mlgxJ2Jkc1iY4pCo7VrCpyxcWk07b36X7NdwaOyi8U6ch5W5/79f8A16lHi3Td2WW5Pp+6/wDr1xG2jbVe1j/Ivx/zCzPStC8daPY6pDcTpelEJPyw5PT613Z+M3hZ0RfK1b5T8oFsv/xVfPLCmjg5o9rH+Rfj/mLXufVfgn4y6En2uMabr1w7lWCw2qtgDPq4qTxB4xGvat9osPDfiV0MYUA2ag8deN9eAeB9QFprVuxPyyfIa+mvCEHmGKVBxjdnNP2sf5F+P+Y/mYVheam25/8AhDvE7LkZ2WS//F10Vlrd9EpDeCvFxUnPFjH/APHK9M0eL9zKOmTmte3G20kH1/lR7WP8i/H/ADHbzPEtT1bVL1gU8F+LSnYGzQZ/8iVXhvdWSLnwV4r3+n2RMf8Aoyva7T5SOuOtawOQCOho9rH+Rfj/AJhbzPB31fVRCUTwV4szjjNmnXHP/LSqj3mrNLvHg3xZz1Bs0/8Ajle+yJknFMKYPtR7WP8AIvx/zCzPBxqGrhAD4M8Vs5bcSbJMY9v3lZeo6nqHnvLP4R8Sqp6l7Rc8f8Dr6CuyANmeT/KuI+Idyum6FLLx50v7qIe57/h1o9rH+Rfj/mFvM8ck+JWmacrpdaXrUEgbkG1XAwf96qzfGjwsxQmLVlYcsVth1/76rzr4gS+WkhDEk8ZrzsUvax/kX4/5i1PokfGbwoNh8nWCVzx9nXH/AKFSt8aPCyWrJbWuqRyt1P2Zef8Ax6vnlVp1HtY/yL8f8w17nrh+JWhklmi1A5/6YD/Gqk/xA0SVCPLv8+8I/wAa8uoo9rH+Rfj/AJhbzO4vvF2mTK3lpdZIx80X/wBeuBHSpcCmsKU6vNHlUUvv/VsLG7ov/INn+tVj941Z0T/kHXH1FVm6mshiUUUUALQOtFKOtADqpax/yD3+o/nV2qesf8g6T/eFIRzlFFFMYUUUUAFFFFABW94B/wCR78Of9hK2/wDRq1g1veAf+R78Of8AYStv/Rq0AYb/AH2+tNpz/fb602gAooooAK2/DP37j6L/AFrErb8M/fuPov8AWgDdoNFFIQykpTSUxjH65ptPemUhCp99frWr4n/5F+z/AOuh/kKyk++v1rV8Uf8AIAs/+uh/kKAOVooopjCiiigANRsMGpKa44oAsWExjdSpwyHcK+wPg3crqnhWG5GC2Np/CvjVGKsGHavqb9nHURH4Wijc5UzPkexNCBHvmhJmFx6cVq7cQMPY1U0lAu/bypwQa0GHyEe1MZSijODirkX3BTBhVPNOiIIOPWgB5GajlYIhZugqSqF5JvbA+6KQiupaaYsw715X8ZLvfqlvaZ+SCEuR7n/6wr1q1UbgB25NeF/FifzPEuoHP3QqfpTGfP8A8Q2yAfV64Ycmu58fDMCn0YVw6DmpJJKKKKYwooooAKRvumlpG+6aANvQ/wDkG3FVm+8as6H/AMg64/CqzdT9aAEpaSloAKcKSlFIQtU9Y/5Br/7y/wA6uVU1n/kGv/vLQBzdFFFMYUUUUAFFFFABW94B/wCR78Of9hK2/wDRq1g1veAf+R78Of8AYStv/Rq0AYb/AH2+tNpz/fb602gAooooAK2/DP37j6L/AFrErb8M/fuPov8AWgDdooopCGHrSU5qbTGDdKiqU8io2HNDExU++v1rV8U/8gCy/wCujfyFZSffX61reKf+QBY/9dG/kKQHJ0UUUxhRRS0AJSHkU40lAER64r3b4K6g2l2yI4JgY5YDqPevDEXdMq+pFe1fD5NiqOxGDQI+sPCN8l3bkRuHQKCCK6BhkEV5h8MHaO+njDEDywcdutekyTFIHcrnbngUDHCIEU6NNmRmsSPxCjrxA2cetS6fqjXV+IyoVSpwM0DNeT7hqhIKvyZKHFU2HNNAiSAcM3tXzf8AECbztc1RjzmZh+Rx/SvpONdsBPcivmDxeS+p3xHO6Z/5mkDPJvGkZe0k9RzXBJXpXiePfbyAjqtebqMCgQtFFOoAbRSmkoAKQ9DS0UAbehDOn3P0FVn+8at6B/x4XP0qpJ980AJSgUg604UAApaKKQgqrrXGmv8A7y/zq0OtVtc/5Bz/AO8P500NHM0UUUAFFFFABRRRQAVveAf+R78Of9hK2/8ARq1g1veAf+R78Of9hK2/9GrQBhv99vrTac/32+tNoAKKKKACtvwz9+4+i/1rErb8M/fuPov9aAN2iiikIQ9KbTj0pppjQVEwwalqN/0oAI/vr9a1vFP/ACALH/ro38hWTH99frWt4p/5ANh/vt/IUhHKGil7UmKADFKKSloAQ0lKaSmMn0+MyX8I9817Z4DjwoOK8f8AD8W+/wB2PuivbPBMW2JeOooA9k+GzH+2HU94T/MV6dMAYpQa8t+HK7dd4/55MP1FeqsPlfNMZwds+Cy56Ejmr+lSbdWtzwAWxx7iqDqFurgdMOf51Pbfu763YH7sin9aQjuW6VVkX5/ardQSjBGKBkhGISPavl3xQCL+7IHPmv8A+hV9SD7n4V8x+K0xqt6uDxK/8zQI8019Mo30rzCVdsrj0Y16xrifJ6jpXluorsvpl/2s0AVxT6aOtOpCEoNLSUAJSU6kPWmBuaB/x5XP0qpJ98/Wregf8ed39KqSffP1oGIKfTRTqQgooooAVetVdc/5Bz/7w/nVpOtVdc/5Bz/7wpjRzNFFFABRRRQAUUUUAFb3gH/ke/Dn/YStv/Rq1g1veAf+R78Of9hK2/8ARq0AYb/fb602nP8Afb602gAooooAK2/DP37j6L/WsStvwz964+i/1oA3aKKKQgPSmU89KYRQNCU1+lPprgkcUwGx/fFa/in/AJAOn/77fyFZMYO9cjvWx4qBGgadn++/8hSEcnSGlpp60AGaXNNopgKTSUUUDOj8JQ5aR8dTivafCce23UkdhXk/hOMJaRkj7xzXr3h1gtsnGMgUAenfDwj+3U/65t/SvVn6H6V5N8P2H9vRf7jfyr1hzjj2pjOJvxt1K4Ud2pNuCG7g5qXVBjVJO2QDTTkigDt1O5QR0IzSMKjsW3WcDeqD+VTHpSEIOlfN3jSIJr2pJ3Erj9a+kh0r5/8AiPD5XijUVx1bd+YoA8r1yMFWwOfavLPEEezUnP8AeFesarja4wc15n4rjAnRx34oAwhS5opKQhaTNJRTGOpDQDSnpSEbfh8f6Hd/Sqj/AHz9aveHFzaXf+7VOQfvDTGIKWkpaQgooooAcnWqmuf8g5/94VcSqeuf8g5/94fzpjOZooooAKKKKACiiigAre8A/wDI9+HP+wlbf+jVrBre8A/8j34c/wCwlbf+jVoA95b4D+GCxP2/Wuv/AD2i/wDjdJ/wobwx/wA/+tf9/ov/AI3RRQAf8KG8Mf8AP/rX/f6L/wCN0f8AChvDH/P/AK1/3+i/+N0UUAH/AAobwx/z/wCtf9/ov/jdXtL+B/hy3aTy7/WfmAzmWL/43RRQBof8KY8P/wDP/rH/AH8i/wDjdJ/wpjQM/wDIQ1j/AL+xf/G6KKQhf+FL+H/+ghrH/f2L/wCN0n/Cl/D/AP0ENY/7+Rf/ABuiigBD8F/D+f8AkIax/wB/Yv8A43Sf8KW8P/8AQQ1j/v7F/wDG6KKYxV+C/h8MD/aGscf9NIv/AI3Wjq/wd0C90q2hlvtWCxsSCssYPIHX937UUUAY3/Ci/DWP+QhrX/f6L/43TT8C/Df/AEENa/7+xf8AxuiigB3/AAorw1/0ENa/7/Rf/G6b/wAKL8Nf9BDWv+/0X/xuiigBw+BXhr/oIa1/3+i/+N0f8KK8NZ/5CGtf9/ov/jdFFIR1ek/Brw7b28QS61U49Zk/+IrstN+G+iwIAst8frKP/iaKKY0dJonhTT9OvEnt2uC6ggbnBH8q6Zo1JBOeOOtFFAzNutItp7jzHMm7GOGpP7GthjBl/wC+qKKANK3iWGFI0ztUYGakoooEA4rjfFHg3TNY1GS6umuVldQD5bgDj8KKKAORu/hVoEud02oDPpKv/wATXJ6/8FPDdxHzd6smD/DNH/VDRRQBhf8ACivDX/QQ1r/v9F/8bo/4UT4Z/wCf/Wv+/wBF/wDG6KKQhR8CfDP/AD/61/3+i/8AjdJ/wonwz/z/AOtf9/ov/jdFFADv+FE+Gcf8f2s/9/ov/jdSL8CPDBxm+1n/AL/R/wDxuiimM1LX4KeG7LT5fIu9W3OcFjNGTj/visl/gr4fLE/2hrH/AH9i/wDjdFFACf8AClPD3/QQ1j/v7F/8bpf+FKeHv+ghrH/f2L/43RRSEH/ClPD3/QQ1j/v7F/8AG6P+FKeHv+ghrH/f2L/43RRQA4fBbw+P+YhrH/f2L/43Va9+CXh2a3dH1DWdpIP+ti/+N0UUxmb/AMKG8Mf8/wDrX/f6L/43R/wobwx/z/61/wB/ov8A43RRQAf8KG8Mf8/+tf8Af6L/AON0f8KG8Mf8/wDrX/f6L/43RRQAf8KG8Mf8/wDrX/f6L/43R/wobwx/z/61/wB/ov8A43RRQAf8KG8Mf8/+tf8Af6L/AON1o+HPgj4bsPEOl3cN7rBlt7qKVQ0sRBKuCM/u+nFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Congenital coalition of the tarsal navicular, the cuboid bone, and the calcaneus causing \"Peroneal flatfoot.\"",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_3_38975=[""].join("\n");
var outline_f38_3_38975=null;
